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Abstract 
This thesis investigates the effect of various physical and chemical surface modification methods on the 
permeation of topically applied pharmaceutical compounds through poly(dimethylsiloxane) (PDMS), a 
polymer frequently employed as a model barrier in in vitro skin permeation studies. Such studies are 
essential for safety, risk assessment, and quality control purposes, in addition to assisting in the design 
and development of efficacious topically applied medicines. The commercial availability, legal status, 
ease of handling, and the reproducibility of the permeation data associated with polymeric skin mimics 
renders them an attractive alternative to biological tissue. However, over-predictions of percutaneous 
absorption observed following the use of such membranes are a significant disadvantage when 
attempting to obtain quantitative toxicological data. Accordingly, the aims of the work presented in this 
thesis were to both reduce the permeability of PDMS to pharmaceutical compounds, and to increase 
correlation between permeation data obtained using the synthetic substitute and data obtained similarly 
using suitable biological tissue.   
Primarily, the potential of an air plasma pre-treatment to produce a lamellae-type structure in PDMS, 
endeavouring to more accurately model the architectural, physical, and chemical properties of the human 
stratum corneum, was investigated. Reductions in the permeability coefficient of up to 54.4 % were 
observed, rendering the modified system promising. Correlation analysis revealed an increase in 
correlation between the data collected using the modified synthetic substitute (R2 = 0.86) and a self-
collated library of literature-derived epidermal tissue permeability data, relating to eighteen compounds 
and spanning a range of typical penetrants, compared to similar analysis using data obtained using the 
native substitute ( R2 = 0.75), suggesting an increase in the predictive capability.  
 It was hypothesised that an N2 plasma treatment may provide suitable surface functional groups on the 
PDMS substrate, namely amine groups, for the covalent attachment of biomolecules via an N,N'-
dicylohexylcarbodiimide (DCC) coupling reaction, enabling the production of a skin mimic displaying 
enhanced biorelevance. Therefore, the effect of an N2 plasma pre-treatment on the permeation of a subset 
of the eighteen compounds investigated. It was found that the N2 plasma pre-treatment was advantageous 
in terms of offering a greater reduction in permeability, since longer treatment times could be employed 
i.e. reductions of up to 61.8 % were observed. However, significant surface oxidation was still observed, 
with only a marginal increase in nitrogen containing functionalities compared with the air plasma 
analogue i.e. 0.31 %. Furthermore, the treatment did not offer any additional increase in correlation 
between epidermal-derived data than previously observed.   
Further chemical methods of biomolecule attachment were pursued for use in the development of a lipid- 
proteinaceous bilayer model, initiated in both cases by surface amination using an alkoxysilane. This 
was followed by a DCC coupling to an amino acid in the former approach, and use of a glutaraldehyde 
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linker molecule to attach the same amino acid, namely lysine, in the latter approach. In either case, no 
further reductions in the permeation of the pharmaceutical compounds tested were observed, with 
respect to that through plasma treated PDMS. 
In summary, the air plasma treatment of PDMS was found to be a promising approach to simultaneously 
reducing the permeability of a silicone skin mimic and increasing correlation with data obtained in 
similar studies employing biological tissue. Further, the covalent coupling of biomolecules to the surface 
of PDMS following surface amine group generation, via both plasma and wet chemical methods, 
appeared not to compromise the integrity the PDMS membranes relating to such applications, rendering 
the techniques compatible with the production of biorelevant semi-synthetic skin mimics.  
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Chapter 1 Introduction  
1.1.  Topical and Transdermal Drug Delivery  
The skin is the largest organ in the human body (Feingold, 2007a), contributing 16 % of the body 
weight of an individual (Liu et al., 2014), with a multitude of functions ranging from protective and 
barrier functions, to homeostasis and sensory functions.  Regardless of its role in the defence of the 
internal organs, and the protection from chemicals, ultraviolet radiation, pathogens and allergens 
(Feingold, 2007c), the skin offers a valuable method of drug administration, in particular under 
circumstances in which the drug would otherwise degrade in the gastrointestinal tract (Aldwaikat et 
al., 2015) or be destroyed by the liver following oral administration (Shahzad et al., 2015). 
Additionally, topical and transdermal drug delivery offers an alternative to oral administration in the 
hope of improved  patient compliance, minimises systemic delivery to other sites (Mahdi et al., 2016), 
lacks the generation of potentially dangerous medical waste as with hypodermic injections (Liu et al., 
2014), and eliminates the risks associated with needle re-use, in particular in developing countries 
(Bartosova et al., 2012; Partidos et al., 2003). Consequently, the development of novel formulations 
to overcome the barrier function of the skin has gained an increasing amount of economic support from 
the pharmaceutical community (Akomeah et al., 2007; Misra et al., 2014), and the ability to evaluate 
the efficacy of such formulations is as relevant as ever. Furthermore, a rise in awareness of diseases 
such as skin cancer has consequently caused a rise in the topical application of chemicals, and, in the 
case of formulations such as sunscreen, the target site may not necessitate full penetration of the agent 
through the epidermis, and the concept of reapplication and, resultantly, increased exposure places 
further emphasis on evaluating possible percutaneous absorption (Klimová et al., 2015; Varvaresou, 
2006). 
1.2.  The Structure of Human Skin 
The structure of human skin can be described in terms of three distinct layers: the epidermis, the dermis 
and the underlying subcutaneous tissue (Shahzad et al., 2015) (Figure 1.1).  The epidermis is the 
outermost layer, and can be further divided, from a histological perspective, into the stratum corneum 
(horny layer), stratum granulosum (granular layer), stratum spinosum (spinous cell layer), and the 
stratum basale (basal cell layer) (Ng et al., 2015). The lower three layers, i.e. the granular, spinous and 
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basal cell layer, are collectively referred to as the viable epidermis, 95 % of which consists of viable, 
keratin-synthesizing cells, namely keratinocytes. Over thirty different molecules of keratin, the key 
structural protein of the epidermis, have been identified. The keratinocytes originate from the basal 
cell layer, and simultaneously differentiate and migrate through the epidermal layers towards the 
outermost layer, the stratum corneum (Tobin, 2006). The keratinocytes become enucleated and 
flattened as they journey towards the superficial layer, and upon arrival, lack cellular organelles. This 
principal barrier comprises of 15-26 layers of fully keratinised corneocytes, dependant on anatomic 
position, surrounded by a lipid rich cornified envelope (Choe et al., 2016; Menon et al., 2012; Tobin, 
2006), and consists of approximately 15-20 % lipid and 40 % protein by weight (Lee et al., 2010; Moss 
et al., 2015).  Keratinocytes are significantly involved in the response to physical or pathogenic injury, 
for example, by secreting cytokines or ‘signalling molecules’, prompting growth and repair, in addition 
to the synthesis of vitamin D (Powell, 2007) .  
Figure 1.1 Schematic representation of the structure of human skin, adapted from Powell (Powell, 
2007). 
 
The barrier function of the skin from exogenous substances is localised in the stratum corneum (Godin 
et al., 2007; Proksch et al., 2008), thus the rate-limiting step of transdermal absorption is considered 
to be the passing of molecules across this layer (Godin et al., 2007; Guy, 2013; Herkenne et al., 2006). 
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At optical microscope level, the organisation of this layer can be represented by a ‘bricks and mortar’ 
structure, comprising of  corneocyte ‘bricks’ and intercellular lipid ‘mortar’ (Hoath, 2014). The 
‘mortar’ originates inside lamellar bodies, secretory organelles released prior to cornification, allowing 
for the complete surrounding of the corneocyte ‘bricks’ (Feingold et al., 2014) (Figure 1.2).  The 
intercellular lipids consists of 15 % free fatty acids, 25 % cholesterol and 50 % ceramides (Barba et 
al., 2014; Feingold, 2007b), and the profound ability of the stratum corneum to prevent the ingress of 
xenobiotics can be attributed to the lamellar organisation of the intercellular lipids. Two lamellar 
phases are known to be present: a short periodicity phase, with a repeat distance of ~ 6 nm, and a long 
periodicity phase, with a repeat distance of ~ 13 nm (Thakoersing et al., 2012). 
Ceramides are the most abundant lipid class in the stratum corneum, the general structure of which 
consists of a fatty acid amide linked to a sphingoid base. To date, fifteen subclasses of unbound 
ceramide have been identified in the stratum corneum. Each are the product of one of five sphingoid 
bases, linked to an α-hydroxy, ω-hydroxy, non-hydroxylated, or ω-esterified fatty acid, along with two 
other ceramides further acylated at the hydroxyl position on the sphingoid base (Meckfessel et al., 
2014; Rabionet et al., 2014). The saturated nature of several ceramide subclasses, along with the 
occurrence of hydrogen bonding between ceramide head groups, permits tight packing of the lamellae 
(Notman et al., 2013). As such, the stratum corneum lipids are known to be in the crystalline phase 
(Mojumdar et al., 2014).  
The interactions between the various lipid classes are thought to be incredibly diverse and play an 
essential role in controlling membrane permeability, and a major driving force for characterisation lies 
in understanding barrier disruption in a number of diseases. It has been suggested that cholesterol 
provides much needed fluidity to stacked membrane sheets of stratum corneum lipids in intercellular 
spaces, which may be brittle in its absence (Madison, 2003; Mojumdar et al., 2015), and ceramides 
play a central role in the water holding capacity of the stratum corneum. Alterations in the quantities 
of ceramides in the skin is linked to diseases such as atopic dermatitis and psoriasis, as a result of 
increased transepidermal water loss (Imokawa et al., 1986). It is thought that unsaturated free fatty 
acids play a role in disrupting barrier organisation (Meckfessel et al., 2014), along with short chain 
saturated fatty acids and triglycerides which are suspected of being present only as sebaceous 
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contaminants (Harding, 2004). Linoleic acid in particular is believed to be integral in the control of 
transepidermal water loss (Prottey, 1976), and is one of only two unbound unsaturated stratum corneum 
fatty acids, the other identified as oleic acid (Menon et al., 2012).  
1.3.  Overcoming the Barrier 
Transport across the stratum corneum is known to occur by passive diffusion (Singh et al., 1993), and 
three potential routes of transport across the stratum corneum are frequently proposed: diffusion 
through the intercellular lipid lamellae, diffusion through the corneocytes, and diffusion down hair 
follicles and eccrine sweat glands (Trommer et al., 2006). The relative importance of each route is 
regularly the subject of debate, in particular the latter, since the appendages represent a mere 0.1 % of 
the total area of the skin (Lane, 2013),  a fraction of which become closed and blocked by dried sebum 
and corneocytes lost to desquamation. Further, in open follicles, the ingress of permeant must compete 
with the outward flow of sebum (Moss et al., 2015; Wosicka et al., 2010). Pioneering work by Potts 
and Guy, aiming to construct a model to predict the skin permeability based on readily obtainable 
physicochemical properties, observed no requirement to include parameters describing diffusion 
through an appendageal pathway (Potts et al., 1992). The work is frequently cited, and the large dataset 
upon which the model was developed has led to many scientists disregarding the contributions of 
appendageal diffusion.  Despite immense doubt surrounding the importance of this route in passive 
diffusion, great interest surrounds exploiting this potential route for the delivery of xenobiotics that do 
not possess the adequate physicochemical properties to permeate via the two former routes (Lane, 
2013), for example, nanoparticles (Patzelt et al., 2017). 
Between 90 and 100 % of the water in the stratum corneum is believed to be deposited intracellularly 
(Norlén, 2006), therefore, the transcellular route presents a pathway which requires the constant 
partitioning of the permeant between the hydrated, keratin filament filled corneocytes and the lipophilic 
intercellular lamellae (Bolzinger et al., 2012). On this basis, it may be understood that few penetrants 
possess adequate physicochemical properties to transverse the stratum corneum via this route. 
Moreover, the polar head groups of the intercellular lipids may provide a less disjointed route through 
the stratum corneum for penetrants able to partition into the corneocyte aqueous environment (Benson 
et al., 2011; Cannon et al., 2011). The intercellular lipids represent the only continuous route through 
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the stratum corneum (Hoath, 2014), thus, this route has attracted much attention as the potential 
pathway for most compounds known to overcome the barrier. Further, the topical application of 
organic solvents and surfactants is known to simultaneously disrupt the ordered crystalline bilayer 
organisation of the intercellular lipids and disrupt stratum corneum barrier function (Barba et al., 2016; 
Barba et al., 2014; Lemery et al., 2015).   
 
Figure 1.2 'Bricks and mortar' stratum corneum model and potential penetrant routes, adapted from 
Benson et al. (Benson et al., 2011). 
1.4. In Vitro Determination of Percutaneous Absorption 
It is clear that the desire to exploit the benefits of topical administration necessitates a method of 
quantitatively assessing the ability of a xenobiotic to overcome the barrier, both primitively when 
considering possible candidates for transdermal delivery, and later during formulation development.  
The ability to ascertain the performance of topical formulations and transdermal drug delivery systems 
(TDDS) prior to clinical trials provides a significant financial advantage (Simon et al., 2016).  
Conversely, the development of cosmetic, dermatologic, and personal care products demands insight 
into the potential of both active ingredients and excipients to penetrate the skin i.e. the entrance of 
xenobiotics into the systemic circulation should be considered, even when this is not the intended end 
point (El Hussein et al., 2007; Klimová et al., 2015; Pineau et al., 2012; Wasukan et al., 2015). 
In order to ascertain such information, in vitro diffusion cell experiments are routinely undertaken. 
Typically, the experimental setup includes a donor compartment, containing a reservoir of penetrant, 
physically separated from a receptor compartment by suitable biological tissue (OECD). Receptor 
solution is generally an aqueous buffer solution, such as buffered isotonic saline, and the donor 
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reservoir is often the formulation of interest, a TDDS, or an aqueous solution of a single, or 
combinations of, active pharmaceutical ingredients (APIs), depending on the desired outcome of the 
experiment (OECD). The penetrant is, in principle, able to pass from the donor compartment, across 
the membrane, and into the receptor solution, in the case of skin, by molecular diffusion. The extent of 
permeation is determined by collection of aliquots of receptor solution at predetermined time intervals, 
followed by a suitable quantitative spectroscopic assay, or scintillation technique in the case of 
radiolabelled penetrants (Moss et al., 2015).  
Under simplistic experimental conditions, the tissue may be assumed to be an isotropic membrane. If 
the loss of permeant from the donor region as a result of the transport of permeant across the membrane 
is negligible, and the concentration of permeant in the receptor region is effectively zero, after a period 
of time (Tlag) flux across the membrane will be constant i.e. steady-state conditions are attained 
(Avdeef, 2012). Under steady-state conditions, the transfer of permeant across the membrane is 
described by Fick’s first law of diffusion (Avdeef, 2012; Benson et al., 2011; Moss et al., 2015): 
J = D
∂C
∂x
                                                                  Equation 1.1 
Where J is the permeant flux per membrane unit area, commonly reported in units µg cm-2 s-1, D 
represents the diffusion coefficient, commonly reported in units cm2 s-1, C represents the concentration 
of permeant in units μg cm-3, and x is a spatial coordinate normal to the membrane surface in units of 
cm. 
It can be seen that in the system represented in Figure 1.3, whereby steady-state has been attained, the 
concentration gradient across the membrane, δC/δx, is constant, i.e. a plot of concentration of drug 
within the membrane as a function of distance across the membrane is linear. Thus, Equation 1.1 can 
be written: 
Jss= D
[C0-Ch]
h
                                                               Equation 1.2 
Where C0 represents the concentration of permeant within the membrane at position 0 i.e. adjacent to 
the donor compartment, and Ch represents the concentration of permeant within the membrane at 
position h, i.e. adjacent to the receiver compartment. From a practical perspective, these concentrations 
are difficult to ascertain, and for convenience can be approximated using a term describing the 
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partitioning of permeant between the aqueous solutions and the membrane, permitting the use of the 
aqueous concentrations, which are more easily ascertained using quantitative spectroscopic methods 
(Avdeef, 2012). Equation 1.2 becomes: 
Jss =DK
[CD-CR]
h
                                                            Equation 1.3 
Where K is the vehicle membrane partition coefficient, CD and CR are the permeant concentrations in 
the donor and receptor compartments, respectively. 
Figure 1.3 Steady-state diffusion in a typical in vitro permeation experiment, adapted from Avdeef 
(Avdeef, 2012). 
Equation 1.3 is significantly more employable than Equation 1.2, since K can be determined using 
simple partitioning experiments. However, determination of D is considerably more difficult. For this 
reason, the kinetic parameter, D, the thermodynamic parameter, K, along with the membrane thickness, 
h, in Equation 1.3 are combined yielding the permeability coefficient, Kp. Equation 1.3 can therefore 
be rewritten: 
Jss = Kp (C
D-CR)                                                              Equation 1.4 
Where Kp represents the permeability coefficient, and CD and CR represent the concentration of 
permeant in the donor and receiver compartment, respectively. 
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This equation can be further simplified as represented in Equation 1.5 by the equivalence of the term 
(CD – CR), and CD, since the concentration of permeant in the receptor compartment is effectively zero. 
In practical terms, to ensure this assumption holds, the concentration of permeant in the receptor 
medium should not exceed 10 % that of the donor (Moss et al., 2015). Providing this is met, Equation 
1.5 can then be applied: 
Jss = KpC
D                                                                 Equation 1.5 
Equation 1.5 implies that the permeability coefficient is easily obtained from a diffusion cell 
experiment, provided the assumptions mentioned previously are met with appropriate experimental 
design. The permeability coefficient provides a convenient approach to comparing possible candidates 
for transdermal delivery, and as such, significant quantities of permeability data have been published 
in this form, such as that by Flynn in 1990, the largest collection of skin permeability data of its time 
(Flynn, 1990). Since its publication, numerous efforts to extend the dataset have been reported 
(Mitragotri, 2003; Thomas et al., 2007), and more recently, even larger datasets have been collated, 
including data of up to 283 compounds (Baba et al., 2015). 
Kp can also be described by Equation 1.6, thus it can be seen that its use as a descriptor of membrane 
permeation enables the separation of the two underlying transport processes: the partition coefficient, 
K, a thermodynamic quantity describing the partitioning of drug between the donor solution and the 
membrane, and the diffusion coefficient D, a kinetic parameter describing the mobility of the permeant 
within the membrane (Du Plessis et al., 2002a): 
 Kp = K (
D
h
)                                                                 Equation 1.6 
Data is ordinarily examined as a plot of cumulative quantity of permeant entering the donor chamber 
per unit area versus time (Figure 1.4). In experiments whereby the donor medium contains a finite dose 
of drug e.g. a formulation or a defined concentration of drug below the solubility limit in the vehicle, 
the passing of drug across the membrane, after a period of lag time, Tlag, will become constant. The 
gradient of this section i.e. the cumulative quantity of permeant passing through the membrane per unit 
area per unit time is defined as the steady state flux, Jss, and the x-intercept of this section of the profile 
can be used to determine Tlag (Cannon et al., 2011). Over time, the concentration of drug in the donor 
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chamber will become depleted, and the implications of this are that the rate of diffusion through the 
membrane will be slower, as a result of a reduction in concentration gradient across the membrane 
(Moss et al., 2015). This experimental setup is most often used as a measure of product performance 
and the theoretical therapeutic levels which may be achievable in vivo, and so many argue this approach 
provides the most clinically relevant data (Pranitha et al., 2014; Synovec et al., 2013). 
                      
Figure 1.4 Typical in vitro permeation data obtained under finite dose conditions, 
adapted from  Mangelsdorf et al. (Mangelsdorf et al., 2006). 
Since flux is proportional to the concentration gradient, flux generally increases with increasing donor 
solution concentration until saturation occurs and maximum thermodynamic activity has been reached. 
Under infinite dose conditions, whereby the donor solution consists of a saturated solution of drug with 
excess permeant present, the steady-state flux across the membrane will be linear, and can be used to 
determine D and K as described in Equation 1.6. In practical terms, this implies that the maximum 
therapeutic dose will be achieved using a formulation in which the drug is at saturation point. 
Accordingly, super-saturated solutions, in which the thermodynamic activity of the drug is above 1, 
have been extensively investigated to enhance the likelihood of achieving therapeutic levels of drug in 
vivo (Pellett et al., 1997; Santos et al., 2011).  
Two types of vertical diffusion cell are commonly used to obtain this data: static Franz type and flow-
through or ‘Bronaugh’ type cells (Figure 1.5). Franz type cells possess a finite receptor compartment, 
whereby accumulation of penetrant under the membrane and diffusion layers are avoided by stirring, 
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typically with a magnetic stirrer bar. Conversely, the receptor compartment of flow through type cells 
is constantly replenished with fresh receptor solution by means of a pump system. Both cell types can 
be used to obtain the same information, however, experimental conditions may deem one cell type 
more appropriate. For example, since the maintenance of sink conditions, generally defined as the 
receptor solution concentration remaining ≤ 10 % that of the donor (Moss et al., 2015), will provide 
the most accurate representation of the rapid clearance of penetrant from the viable tissue in vivo, in 
cases where permeation is rapid, the flow through type diffusion cells may prove more valuable 
(Addicks et al., 1987). However, sink conditions in static type diffusion cells may also be controlled 
by frequent sampling intervals, extraction of large sample volumes and replacement with fresh receptor 
medium (Ng, Rouse, Sanderson, Meidan, et al., 2010), or the presence of solubility enhancers, such as 
bovine serum albumin, in the receptor medium (Schreiber et al., 2005).   
 
Figure 1.5  Franz type (left) and flow through type (right) diffusion cells. 
1.5. Properties of the Permeant  
The ability to estimate the diffusion coefficient (D) and partition coefficient (K) in Equation 1.6 by 
performing in vitro studies, in conjunction with an understanding of the properties which influence 
each parameter, may assist in both the design of appropriate candidates for transdermal drug delivery, 
and formulation development.  
The stratum corneum partition coefficient, K, of a potential penetrant describes the ratio of 
concentrations of the penetrant in the stratum corneum to that in the vehicle at equilibrium. As such, it 
is dependent on the relative solubility of the penetrant in each of the phases. Since the stratum corneum 
is primarily a lipophilic barrier, it is generally accepted that increases in lipophilicity are associated 
with an increase in transport across the barrier, and that the barrier is orders of magnitude less 
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permeable to the ionised form of a penetrant (Benson et al., 2011; Moss et al., 2015). The presence of 
proteins within this principle layer results in the presence of both anionic and cationic groups; these 
groups, in conjunction with the lipophilic nature of the stratum corneum, render the barrier 1-2 orders 
of magnitude less permeable to the ionised form of a compound compared with the unionised form of 
the same compound (Bartosova et al., 2012). In actuality, the permeation of highly lipophilic molecules 
(log10 P > 3) will become limited by poor clearance from the viable tissue as a result of low partitioning 
into this underlying aqueous environment. It is therefore understood that permeants displaying 
intermediate lipophilicity, i.e. 1 < log10 P < 3, are the most suitable candidates for transdermal delivery 
(Moss et al., 2015).  Further, since increasing the quantity of penetrant in a vehicle generally results in 
an increase in flux, it may be possible to compensate for the lower fluxes observed with ionised 
compounds with a greater solubility in the vehicle (Hadgraft et al., 2000). Ion-pairing offers an 
alternative penetration enhancement strategy to overcome the relatively low permeability of the 
stratum corneum to ionised species; the interaction of a charged API with organic counter-ions has 
been reported to yield species with greater lipophilicity and, subsequently, higher fluxes (Tan et al., 
2009; Trotta et al., 2003).   
The diffusion coefficient of a penetrant is heavily influenced by both molecular size and temperature 
(Akomeah et al., 2004; Shahzad et al., 2015), as described by the Stokes-Einstein equation, i.e. the 
diffusion coefficient of a penetrant is inversely proportional to the hydrodynamic radius, and 
proportional to temperature (Moss et al., 2015).  Molecular weight is most commonly used as a 
substitute for molecular size, since this information is substantially easier to obtain. As such, in general, 
a ceiling of 500 Da is used for transdermal candidates (Benson et al., 2011; Moss et al., 2015).  The 
dependence of D on temperature has also generated substantial interest in thermophoresis as a method 
to increase the permeation of API across human skin. Increases in drug transport across the skin have 
been observed with increases in temperature (Shahzad et al., 2015), and a notable study attributed this 
to both increases in the diffusion coefficient of the API, namely lidocaine, in the vehicle and the barrier, 
along with temperature-induced structural changes to the intercellular lipids of the stratum corneum 
(Wood et al., 2012).   
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The amphipathic structure of the lipid classes that together form the stratum corneum intercellular lipid 
lamellar has generated substantial interest in the role of hydrogen bonding in the permeation of 
xenobiotics. Fundamental work by El Tayar et al. (Tayar et al., 1991) examined the permeability 
coefficients of 61 penetrants extracted from literature, subdivided into four datasets, namely alcohols 
and steroid hormones, hydrocortisone 21-esters, phenolic compounds, and miscellaneous compounds. 
The authors performed linear regression analysis in order to determine the relationship between Kp 
values extracted from literature, the stratum corneum partition coefficient (K), and its common 
surrogate, log10 Poct, the n-heptane-water partition coefficient (log10 Phept), molecular weight, and ∆log10 
Poct-hep. The latter was found, in preliminary analysis, to directly illustrate the hydrogen bond donor 
acidity of the penetrant.  
Analysis of dataset one, containing alcohols and steroid hormones, found that although the 
permeability coefficients of alcohol and steroid compounds displayed good correlation with log10 P 
values, correlation existed only within each chemical functionality i.e. alcohols and steroids were 
considered separately. Further, no correlation was found with water accessible surface areas or 
molecular weight. The only comprehensive correlation found was with ∆log10 Poct-hep, indicating the 
dependence of the permeability coefficient on the hydrogen bonding capacity of the penetrant (r = 
0.901, n = 21). Analysis of dataset two, containing miscellaneous compounds, yielded the same 
observation (r = 0.817, n = 8). The authors inferred that the negative dependence of Kp on ∆log10 Poct-
hep indicates that compounds which are strong hydrogen bond donors permeate more poorly, as a 
consequence of interactions with the wealth of hydrogen bond accepting groups available in the 
intercellular lipid lamellae.  Analysis of the remaining two datasets found limited correlation with the 
same parameter, however, noteworthy observations were made. The sharp decline in log10 Kp of 
hydrocortisone 21-esters at ∆log10 Poct-hep ≥ 4, and the presence of only one out of a total of thirty values 
> 4 in the two earlier datasets, resulted in the conclusion that above a value of 6, Kp becomes less 
dependent on ∆log10 Poct-hep. Further, correlation in the dataset containing phenolic compounds was 
obtained by the removal of the most lipophilic compounds, and led the authors to conclude that the 
phenolic compounds are able to permeate by two routes, which the authors found unsurprising taking 
into account that phenols are known to denature proteins and are subsequently damaging to the skin 
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(Tayar et al., 1991). This work represents only one example of a large body of literature investigating, 
and emphasising, the role hydrogen bonding plays in transdermal diffusion (Du Plessis et al., 2002a, 
2002b; Pugh et al., 1996).  
1.6. Modelling Transdermal Absorption 
1.6.1. Human tissue 
The use of ex vivo human skin obtained from cadavers or cosmetic surgery, typically abdominoplasties 
and mammoplasties, is often considered the most suitable barrier, since in principle its use will provide 
the most relevant data. However, availability issues often impede its use, and under circumstances 
when the tissue is available, deconvolution of the data can be problematic as a result of the various 
storage conditions employed, such as freezing, and disinfectant procedures exercised previous to the 
skin entering the laboratory (Abd et al., 2016). The range of skin preparation protocols used for such 
studies adds further convolution; use of full thickness skin (FTS), split thickness skin (STS), heat 
separated epidermis (HtSE), and isolated stratum corneum (ISC) have all been reported in permeation 
studies (Akomeah, 2007; Netzlaff et al., 2007; Roy et al., 1993; Schreiber et al., 2005). The latter three 
types are all accepted in OECD guideline 428 (OECD), with the former permitted (providing a 
thickness of < 1 mm is used and adequate justification is provided). STS is typically prepared using a 
dermatome, and the reproducibility of the product is subject to the consistency of the individual 
performing the separation (Barbero et al., 2009). ISC membranes are usually enzymatically isolated, 
for example with trypsin (Netzlaff et al., 2007); the resultant membranes are usually fragile and 
necessitate an underlying synthetic support, the choice of which must be justified and found not to 
contribute to the barrier function (Barbero et al., 2009).  For these reasons, along with the dependence 
of skin permeability on age, anatomic location, race and sex (Akomeah et al., 2007; Mohammed et al., 
2012; Roskos, 1989), alternatives to human skin are widely employed in these studies, frequently in 
pursuit of more reproducible data. 
1.6.2. Animal Tissue 
The wider availability of animal skin has led to its historic use in permeability studies. The most 
frequently reported substitutes include skin excised from rats (Özgüney et al., 2006), mice 
(Balakrishnan et al., 2009), guinea pigs (Dalton et al., 2015), rabbits (Nicoli et al., 2006), and pigs 
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(Qvist et al., 2000). Tissue from more exotic species, such as snakes (Lu et al., 1992; Yuan et al., 
2005), have been investigated as potential surrogates, along with skin from various species of fish 
(Másson et al., 2002), but it is apparent that the availability of such tissues should be questioned. It is 
generally accepted that the use of animal tissues results in an overestimation of percutaneous 
absorption (Lu et al., 1992), thought to be as a consequence of differences in lipid composition and 
morphology (Stahl et al., 2009), thus making it increasingly difficult to extrapolate the data to man. 
Reported overestimations in skin permeation include 3.5-fold with rabbit skin (Chowhan et al., 1978), 
11-fold with rat skin (Ravenzwaay et al., 2004), and 100-fold with nude mouse skin (Lu et al., 1992). 
Porcine tissue is thought to be the most similar to human skin from a histological perspective (Jacobi 
et al., 2007), and has subsequently attracted particular interest as a substitute (Barbero et al., 2009). 
Numerous attempts have been made to characterise the properties of porcine skin, and correlate the 
data to man (Sekkat et al., 2002). Despite these efforts, overestimations of percutaneous absorption 
have still been reported with its use (Luo et al., 2016). Moreover, issues with data reproducibility are 
frequently reported. For example, the preparation technique required for each species may vary; the 
use of heat separated epidermis (HtSE) poses problems when using skin from certain species, such as 
the pig, for which the hair shafts are left in the dermis, leaving the epidermis perforated (Barbero et 
al., 2009). Hair follicle density is also known to differ between species, and the relative importance of 
this route in the species selected must be accounted for (Stahl et al., 2011).   
The last decade has observed a profound move away from the use of animal tissues in the evaluation 
of the safety and the efficacy of cosmetic products, topical and transdermal formulations, and for risk 
assessment purposes, both as result of increased criticism of the quality of the data obtained, and 
quandary surrounding the ethical nature of such studies. Notably, the Registration, Evaluation, 
Authorisation and restriction of Chemicals (REACH), which came into force on 1st June 2007, 
necessitates the registration of all chemicals imported into the EU in quantities ≥ 1 tonne per year. The 
legislation demands the submission of all dossiers containing relevant data, such as dermal toxicity, 
skin corrosion, and skin irritation, to the European Chemicals Agency (ECHA) by 31st May 2018.  The 
Health and Safety Executive (HSE) estimate that for a single substance, which has undergone no prior 
testing, obtaining all relevant data for registration may require up to 5,000 laboratory animals. In excess 
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of 14,000 substances were registered between the introduction of REACH to UK law and June 2016 
(www.hse.gov.uk/reach/resources/animaltesting). 
The scale of testing has prompted significant ethical consideration regarding the methods by which the 
necessary data is obtained. REACH recommends, therefore, where appropriate, scientists are to work 
in line with the principles of the 3Rs i.e. Reduce, Refine, and Replace the usage of laboratory animals. 
As such, REACH also aims to ‘promote the use of alternative methods for the assessment of hazardous 
properties’. Alternative methods must meet criteria set by the European Centre for the Validation of 
Alternative Methods (ECVAM) and be appropriately validated prior to acceptance. Four in vitro test 
methods for determining skin corrosivity have been accepted i.e. the use of commercially available 
reconstructed human skin models EpiSkin™, Epiderm™, SkinEthic™, and epiCS,®. The former three 
models, along with the LabCyte EPI-MODEL, have all been accepted for use in the skin irritation test, 
and are outlined in REACH Commission Regulation (EC) No 761/2009, and OECD Test No. 431 and 
439. 
The acceptance of reconstructed human skin models occasioned the replacement of a test that had 
historically been performed in laboratory animals, and marked a watershed in reducing the dependence 
on animal models. For example, ethical dispute surrounding the testing of cosmetics on animal models 
has led to the prohibition of the entry onto the market of cosmetics for which either the final 
formulation, or ingredients or combinations of ingredients, have been tested on animal models after 
the establishment and acceptance of an alternative method by the OECD. The legislation, introduced 
in 2003,  provided a 6 year deadline for the ban on non-compliant products, and a lengthier, 10 year 
deadline for the completion of toxicological assessment (Salvador et al., 2007). The incorporation of 
models such as EpiSkin™, a subsidiary of L’Oréal, into OECD Test Guidelines 431 and 439 for skin 
corrosivity and irritation, has made testing of cosmetics on animals for these endpoints obsolete, and 
unlawful. To date, no alternative methods have been accepted or validated for use in OECD Test 428 
for skin absorption. A change in paradigm and shifting attitudes towards the use of laboratory animals, 
from a legal, ethical, and data quality perspective, has led to increasing efforts to find alternative 
models.   
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1.6.3. Alternative Models 
1.6.3.1. Cell Culture Models 
The successful displacement of laboratory animal based approaches to evaluating skin irritation, and 
the widespread acceptance of reconstructed human epidermis (RHE) models for such purpose (OECD) 
has led to substantial interest in the assessment of their suitability as an alternative to ex vivo 
permeability studies employing animal tissue. The models consist of a three-dimensional tissue culture 
grown from keratinocytes, and possess an epidermis with a partially differentiated stratum corneum, 
basal, spinous, and granular layers, and in the case of living skin equivalent (LSE) models, an 
underlying dermis. These models appear promising from a histological perspective. Nevertheless, there 
is a stark difference between the requirements of the skin irritation and skin permeability test. The skin 
irritation test necessitates that the test candidate is able to transverse the model stratum corneum barrier, 
enabling the assessment of cell viability in underlying layers of tissue. As such, commission regulation 
(EC) No 761/2009 states ‘the stratum corneum and its lipid composition should be sufficient to resist 
the rapid penetration of cytotoxic marker substances’. Notably, the regulation does not necessitate that 
the barrier function of cultured stratum corneum is equivalent to that of human tissue, and, as a result 
of extensive testing, it is generally accepted that skin equivalent models overestimate permeation in 
comparison to that predicted by equivalent isolated human tissue (Batheja et al., 2009; Roy et al., 
1993), reportedly as a consequence of stratum corneum immaturity (Küchler et al., 2013; Williams, 
2006). Despite their acceptance in OECD guidelines 431 (OECD) and 439 (OECD) for corrosivity and 
irritation  testing, low reproducibility, poor robustness with regards to direct application of semisolids, 
along with a high cost, have resulted in the failure of RHE models to obtain widespread acceptance 
(Batheja et al., 2009; Engesland et al., 2015; Moss et al., 2015). Generally, studies have concluded that 
currently accessible LSE and RHE models have limited use within in vitro permeation studies (Flaten 
et al., 2015; Netzlaff et al., 2007; Roy et al., 1993; Schmook et al., 2001). 
An example of these studies aimed to compare the permeation of two penetrants, namely caffeine and 
testosterone, through cadaver skin, porcine skin, SkinEthic™ and EpiDerm™, aiming to devise a 
standard experimental protocol for the use of HRE models during in vitro permeation studies. The use 
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of testosterone necessitated the presence of solubility enhancers in the receptor medium in order to 
maintain sink conditions. Upon the inclusion of 0.5 % Ipegal®, a non-ionic surfactant, the authors 
reported an 85 % reduction in the EpiDerm™ model viability, leading the authors to perform a 250 
reduction in the dose of testosterone (Schreiber et al., 2005). It is apparent that this approach to 
overcoming the problems associated with the higher permeability of HRE models, in conjunction with 
the poor solubility of lipophilic compounds in physiologically conducive receptor medium, is 
unsuitable should the test aim be to evaluate the performance of a formulation or TDDS. 
A further study used hydrocortisone, terbinafine, salicylic acid and clotrimozole to evaluate the barrier 
function of SkinEthic™ HRE and Graftskin™ LSE in comparison to rat, human and porcine skin. It 
was found that porcine skin modelled human skin most appropriately, since results were in the same 
order of magnitude for both flux through the skin, and concentrations in the skin. However, although 
Graftskin™ displayed substantial barrier properties with regards to salicylic acid, an overestimation of 
flux and skin concentration in human skin was observed with other, more hydrophobic compounds. A 
similar scenario was reflected in the use of Skinethic™, with which a skin concentration of salicylic 
acid was obtained akin to human skin, despite a sevenfold higher flux. In the case of hydrocortisone, 
terbinafine and clotrimozole, permeation values overestimated that of human skin by up to a factor of 
around 800 (Schmook et al., 2001).  As of yet, these models are only applicable to comparative studies, 
analogous to artificial membranes (Williams, 2006).  
1.6.3.2. Quantitative Structure-Permeability Relationships 
The early recognition that the physicochemical properties of the permeant play a crucial role in the 
extent of permeation, and the likelihood of achieving therapeutic levels of an API in vivo, has led to 
extensive work aiming to quantify these observations and derive mathematical relationships to aid the 
prediction of percutaneous absorption. Pioneering work by Potts and Guy (Potts et al., 1992) 
established a relationship between log10 KO/W, molecular weight (MW) and permeability coefficient 
values extracted from the Flynn dataset (Flynn, 1990), and has been described as being the first ‘widely 
accepted’ QSPR model (Karadzovska, Brooks, et al., 2013). Like many more recent QSPR models, 
the model was derived on empirical data obtained for steady-state transport across excised human 
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epidermal tissue (Baba et al., 2017; Lee et al., 2010; Moss et al., 2002), and as such, the model output 
is the human skin permeability coefficient, Kp. The mechanistic foundations of the model lie in the 
assumption that steady-state transport across the stratum corneum can be described by Equation 1.6 in 
Section 1.4. Taking a logarithmic form of this equation, likening the membrane/water partition 
coefficient to log10 KO/W, and assuming an exponential relationship between the membrane diffusivity 
and molecular weight (i.e. free-volume theory), yielded the following model: 
log
10
Kp= -6.3 + 0.71 log10 KOW
- 0.0061 MW                                 Equation 1.7 
The authors found no requirement to include any descriptors to outline permeation through aqueous 
appendageal routes, and found that the relatively high permeability of more hydrophilic compounds 
could be accounted for by their low molecular weight, and subsequent high diffusivity in the lipid 
lamellae (Potts et al., 1992).  The model assumes that the stratum corneum is the rate limiting barrier 
to permeation, any interactions between the stratum corneum and the vehicle have no influence on the 
permeation of the compound in question, and the absence of chemical and physical permeation 
enhancers such as surfactants or sonophoresis. The simplicity of the model, partnered with its 
predictive power (R2 = 0.86), the large dataset upon which it was developed i.e. 90 compounds from a 
wide range of therapeutic classes, the selection of readily available predictors, and the substantiated 
mechanistic foundations upon which it was developed, has resulted in the model becoming the most 
frequently cited of its kind (Mitragotri et al., 2011). 
 
The appeal of replacing labour intensive, time-consuming, and potentially costly permeation studies 
with predictive models is clear, and QSPRs in particular, may provide mechanistic insight upon the 
importance of molecular properties on transdermal permeation.  As such, a large variety of QSPRs are 
available in literature, which differ greatly in their mechanistic justification. For example, work by one 
author alone, namely Mitragotri, proposed four models based on numerous routes through the stratum 
corneum. Mitragotri anticipated that the over-all permeability coefficient (Kp) of a compound is 
compiled of four permeability coefficients, each for a different potential route through the stratum 
corneum. The author postulated that free volume diffusion through lipid bilayers, diffusion along lipid 
bilayers, diffusion through the appendages, and diffusion through defects in the lipid bilayers were all 
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feasible routes through the stratum corneum. Mitragotri categorised the permeants into high molecular 
weight hydrophobic drugs, low molecular weight hydrophobic drugs, high molecular weight 
hydrophilic drugs, and low molecular weight hydrophilic drugs, and stated that the relative importance 
of each route was variable and category-dependent (Mitragotri, 2003).  
The stark contrast between the Potts and Guy model, and those proposed by Mitragotri, outlines an 
interesting feature of QSPR models; there is no universal model. Understanding the relative importance 
of the appendageal route may serve as a prerequisite for selecting a model. Even more simply, care 
must be taken in considering the nature of the permeation data upon which the model was derived, and 
what model is the most suitable for not only the compound, but for both the expected level of exposure, 
and the vehicle or dosage form. For example, work by Moss et al. identified that steroidal compounds 
are frequently observed to be outliers in QSPR models based on the Flynn dataset, such as that by Potts 
and Guy. The authors acknowledge that the data for these compounds in the Flynn dataset were 
extracted from a single literature source, which since its publication, has been shown to display poor 
comparability with more recent data, and thought to be subject to error. Thus, the data for these 
compounds was replaced by that from more recent sources, resulting in the following model: 
log
10
Kp= -2.39 + 0.74 log10 KOW
- 0.0091 MW                                 Equation 1.8 
An increased fit of the steroid data to the model led the authors to conclude that the permeability 
coefficients of steroidal compounds can now be predicted using a QSPR developed on permeation data 
including that of compounds from other therapeutic classes. The removal of data thought to be subject 
to error, and its replacement with data from more recent literature, led the authors to conclude that the 
dataset presented was the most comprehensive (n = 116), and appropriate, for the development of 
QSPRs (Moss et al., 2002). 
Multiple models have also been developed upon smaller bodies of compounds, and even single 
therapeutic classes (Liou et al., 2009), or single penetrants with multiple chemical permeation 
enhancers (Kang et al., 2007). Further, many models, such as that by Potts and Guy, do not incorporate 
terms to describe formulation effects, and as such it is increasingly difficult to extrapolate the data to 
studies comparing existing and innovative TDDS’s (Mitragotri et al., 2011). It is apparent that whilst 
QSPRs provide a useful tool, for example, in the large scale screening of potential candidates for topical 
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and transdermal delivery, careful consideration of the relevance of the model, and therefore model 
output, must be made. 
1.6.3.3. Parallel Artificial Membrane Permeability Assay (PAMPA) 
The PAMPA technique is a less labour intensive, automated alternative to the Franz diffusion cell 
method, and its high throughput capability provides potential for a primary screening technique. 
PAMPA, traditionally used to evaluate blood-brain barrier permeability and gastrointestinal absorption 
(Karadzovska & Riviere, 2013), comprises of a 96-well filter plate coated with a liquid artificial 
membrane (Ottaviani et al., 2006), and appropriate selection of membrane has allowed for the scope 
of this technique to be extended to the prediction of human skin permeability. Examples of such 
membranes include a mixture of 30 % isopropyl and 70 % silicone (Markovic et al., 2012), and 
ceramide analogues, termed certramides (Sinkó et al., 2012; Sinkó et al., 2009).  
The authors of the latter work, endeavoured to determine the effect of the introduction of ceramide 
analogues to the PAMPA system via the use of three model drugs and lipid-matrix membranes 
consisting of 55 % certramide, 22.5 % cholesterol and 22.5 % stearic acid. Ceramides represent 50 % 
of the stratum corneum lipids (Feingold et al., 2014), and as such, are of significant interest in 
biomimetic systems. However, low storage temperatures (-20 °C) and a high associated cost deem 
them unsuitable for high throughput systems. The synthesised analogues were all saturated, unlike 
naturally occurring ceramides, enabling ease of handling, however, possessed similar hydrogen bond 
donor and acceptor capabilities in a small head group, analogous to naturally occurring ceramides. It 
was determined that the introduction of certramides resulted in substantial effects on the permeability 
of the three model compounds, described as being a function of alkyl-chain length (Sinkó et al., 2009), 
and that the presence of both hydrophilic and hydrophobic species representative of the multi-lamellar 
assembly of human skin provided a promising method of evaluating percutaneous absorption (Sinkó 
et al., 2012).   
In further work with the system, others evaluated the predictability of the model by the correlation of  
Kp values, extracted from literature and in house, with the effective permeability coefficients (Pe), 
obtained as the model output (Ottaviani et al., 2006). The authors note an important feature of literature 
permeability data; the use of varying experimental protocols has resulted in an apparent lack of highly 
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standardised skin penetration data. Consequently, the model was developed on smaller, but more 
standardised collections of data, ranging in size from seven compounds (in-house developed database) 
to more than one hundred compounds, twenty-two of which were used in the study. Concerning the in-
house database, determination coefficients (R2), representing the correlation between human skin 
permeability data and PAMPA permeability data, range from 0.05 – 0.88 with varying ratios of 
components and certramide alkyl chain length. Because of the use of various skin preparation types, 
ranging from ISC to FTS, and the use of different experiment temperatures, database three, the most 
comprehensive database sourced from literature, containing more than one hundred compounds, was 
further separated into smaller datasets as little as four compounds in size. Although the work provides 
promise in terms of more accurately representing the multi-lamellar assembly of human skin, and 
acknowledges the gap in existing literature in terms of highly standardised referenced data, the model 
is yet to be extended to large bodies of compounds (Sinkó et al., 2012).  
1.6.3.4. Strat-M® 
The removal of lot-to-lot variability, safety, and storage limitations associated with using synthetic 
membrane based skin mimics has resulted in heightened interest in commercially available membranes, 
one such example being Strat-M
®
. The Strat-M
®
 model consists of two superficial layers of 
polyethersulfone, offering the greatest diffusional resistance, and an underlying polyolefin layer with 
greater porosity (www.merckmillipore.com).   
Work by Sugibayashi et al. aimed to physically characterise the membrane, evaluate the permeability 
of Strat-M
®
, and subsequently, evaluate the membranes suitability as a skin mimic. Using scanning 
electron microscopy, the authors confirmed the presence of three distinct polymeric layers, decreasing 
in density towards the bottom of the vertical cross-section. The authors also found varying layer 
thicknesses, with the outside layer measuring 52.3 ± 0.5 μm, the intermediate layer measuring 76.7 ± 
5.07 μm, and the lower layer measuring 196 ± 7.37 μm, and confirmed the presence of lipids, primarily 
in the top two layers. The authors conducted Franz cell diffusion studies, employing thirteen 
compounds, each applied to the membrane as saturated solutions in phosphate buffered saline. The 
Franz cell studies were also conducted using human skin and hairless rat skin as the barrier to diffusion, 
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and the permeability, diffusion, and partition coefficients were calculated for all three membranes. 
Good correlation was found between permeability coefficients obtained with all three membranes, but 
the authors noted, in general, an elevated permeability with regards to Strat-M
®
. Permeation 
experiments using lidocaine were conducted at varying pH to enable the calculation of the permeability 
coefficients of the unionised and ionised species. The authors found enhanced permeability of ionised 
species through Strat-M
® 
compared with human skin, in conjunction with elevated diffusion 
coefficients for hydrophilic compounds. This was attributed to the lower tortuosity of hydrophilic 
routes through the porous membrane structure. It was concluded that the model appears promising on 
the basis of good correlation between the permeability coefficients through Strat-M
® and those through 
human skin. However, the physicochemical properties of the permeant should be considered, since the 
relative contribution of diffusion through aqueous routes in the synthetic substitute has been found to 
be greater. Additionally, it was noted that more extensive studies using TDDS’s are necessary before 
the predictability of the membrane can be extrapolated to formulation design  (Uchida et al., 2015).  
1.6.3.5. Poly(dimethylsiloxane) 
The use of polymeric membranes is an attractive alternative to the use of biological tissue as a result 
of increased obtainability, reduced cost, and lot-to-lot invariability. Further, polymeric membranes 
prove particularly useful in large scale studies (Ng, Rouse, Sanderson, Meidan, et al., 2010), whereby 
studies in animals may be considered unethical, and attaining large quantities of human skin may be 
unachievable. The use of poly(dimethylsiloxane) in permeation studies is reported as early as the 
1980’s (Jetzer et al., 1986), since which a significant body of literature reporting its use as a model 
barrier has been established, including multiple studies successfully correlating the data to that 
obtained with excised human skin  (Mertz et al., 2014; Wasdo et al., 2009). 
Silicone membranes have found greater use in skin mimicry than alternative isotropic synthetic 
membranes, such as cellulose nitrate (Lombardi Borgia et al., 2008), polyethersulfone, or 
polycarbonate (Ng, Rouse, Sanderson, & Eccleston, 2010), since mechanistically diffusion through the 
stratum corneum is more accurately represented with non-porous systems. More specifically, diffusion 
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through PDMS occurs via a solution-diffusion type mechanism, i.e. the penetrant dissolves in the 
membrane, and transverses the membrane down a concentration gradient. Further, differences in the 
quantity of permeant passing through the membrane occur as a function of the concentration of 
permeant in the membrane and the diffusivity of the permeant in the membrane (Wijmans et al., 1995), 
processes which are described by the partition coefficient, K, and the diffusion coefficient, D, discussed 
in Section 1.4. As such, diffusion through PDMS is rate limiting, in contrast to diffusion through porous 
membranes, which occurs via a sieving type mechanism (Ng et al., 2012). The latter membrane type 
has found extensive use in quality control, such as assessing inter-batch uniformity, whereby the 
structure allows the formation of vehicle filled pores, resulting in the membrane acting as an extension 
of the vehicle and only as a physical support to prevent semisolid becoming dispersed within the 
receptor medium (Ng, Rouse, Sanderson, & Eccleston, 2010).  These membrane types allow for the 
evaluation of the kinetic aspect of mass transport i.e. diffusion, devoid of the thermodynamic aspect 
i.e. partitioning (Fiala et al., 2008). This scenario is not true in vivo, and application of these membrane 
types to skin mimicry may result in a complete misunderstanding of vehicle effects.  
On the contrary, silicone membranes have facilitated an increase in understanding of vehicle effects 
(Cross et al., 2001; Oliveira et al., 2010; Oliveira et al., 2012), the effect of ion-pairing (Trotta et al., 
2003), and excipients, such as surfactants (Waters et al., 2013). Moreover, the use of silicone 
membranes has provided insight into supersaturation as a prospective method of increasing the 
thermodynamic activity of the penetrant, and thus increasing the maximum flux of API across a rate-
limiting barrier (Pellett et al., 1997; Santos et al., 2011). One example of these studies notes the use of 
silicone membranes as a convenient approach to separating the influence of supersaturation on the flux 
of drug, from alterations in flux as a consequence of vehicle interactions with epidermal tissue (Pellett 
et al., 1997).  
Likewise, silicone membranes have facilitated the understanding of thermophoresis, enabling the 
separation of the concomitant processes occurring during percutaneous adsorption i.e. partitioning and 
diffusion. The authors note a lack of approved TDDS’s which exploit the known positive dependence 
of percutaneous absorption on increases in temperature. The authors attribute this to a lack of clarity 
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surrounding the relative influence of heat application on diffusion, partitioning, structural changes to 
the stratum corneum, and local blood flow, increases in all of which could contribute to greater plasma 
levels of API. Two synthetic membranes were used, namely regenerated cellulose and silicone, along 
with human epidermal sheet, to evaluate the effect of temperature increases over the range of 27 – 45 
°C, on the diffusion and partitioning of lidocaine, along with structural changes to the stratum corneum 
lipids. Permeation data gathered using regenerated cellulose membrane indicated increases in 
permeation with increases in temperature, which were explained by increases in the diffusion 
coefficient and drug release from the vehicle, since transport is not governed by membrane partitioning 
in porous membranes.  Increases in transport were also observed across silicone membrane, which 
were explained primarily by increases in membrane diffusivity, since minimal variations in partitioning 
were observed across the temperature range. The most profound effect of temperature alteration was 
observed with human epidermal sheet, for which a 519.2 % enhancement in diffusion coefficient was 
observed (calculated relative to that at 32 °C) following an increase in temperature to 45 °C. The 
partitioning of lidocaine increased only by 24.2 % across this temperature range, thus, significant 
increases in permeation were attributed to increases in the diffusion coefficient. The diffusion 
coefficient of lidocaine in silicone membrane was found to increase only by 29.3 % across this 
temperature range, and release from the vehicle increased only by 44.6 % (Wood et al., 2012).  
The authors concluded that the noteworthy increase in membrane diffusivity observed with epidermal 
tissue was a consequence of decreased barrier function following structural rearrangement of the 
stratum corneum intercellular lipids. Previous studies, utilising differential scanning calorimetry (DSC) 
and Fourier transform - infrared spectroscopy (FTIR), have identified multiple phase transitions of the 
stratum corneum intercellular lipids in the temperature ranges  35 – 42  °C, 65 – 75  °C, 78 – 86  °C, 
and 90 – 115 °C, the lowest of which the authors note is most relevant to the development of 
thermophoretic transdermal drug delivery systems (Harrison et al., 1996; Wood et al., 2012). Within 
this temperature range, a ‘solid to fluid’ transition of the lipid lamellae is thought to occur as a 
consequence of the increased mobility of the ceramide, cholesterol and fatty acid acyl chains, along 
with a change in the crystalline structure from orthombic to hexagonal. Further, the authors highlight 
that such changes may be capitalised for the purpose of skin permeation enhancement, since phase 
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transitions below 75 °C are thought to be reversible, allowing for the restoration of barrier function 
following device removal, and are most likely responsible for the increase in membrane diffusivity 
observed in this study given the temperature range employed. Interestingly, the authors acknowledge 
the practicality of using silicone membranes for the deconvolution of permeability data, and note the 
appropriateness of silicone membranes to model the stratum corneum on the macroscopic scale. 
However, the authors also note the lack of ‘ordered bilayers’, which may inhibit in vitro – in vivo 
correlation (Wood et al., 2012).   
Interestingly, the role of hydrogen bonding in skin permeation has been modelled ingeniously in 
silicone membranes, using PDMS impregnated with toluene to model the scenario where penetrant-
membrane hydrogen bonding would be at a minimum, and PDMS impregnated with octanol to emulate 
the hydrogen bonding capability of the stratum corneum. Six model penetrants were selected over a 
narrow molecular weight range in order to elucidate the effect of the presence of phenol, ether, 
carboxylic acid (with and without intramolecular hydrogen bonding), and alcohol functionalities on 
the permeability coefficient (Kp) and steady state flux (Jss) of penetrant across membranes with, and 
without, the capacity to hydrogen bond with the penetrant. The authors reported lower diffusion and 
subsequently, lower Kp values for all 6 penetrants when the barrier was impregnated with octanol, 
when hydrogen bonding was likely, in comparison to when the barrier was impregnated with toluene, 
when hydrogen bonding was unlikely. Further, the use of Kp as a descriptor enabled the separation of 
partition phenomena from diffusion phenomena, which was vital in order to deconvolute the lower 
permeation data, since a change in membrane environment would induce changes in both partition and 
diffusion. The authors expressed the variations in each parameter as ratios of toluene/octanol i.e. 
Ktoluene/Koctanol and Dtoluene/Doctanol for the partition and diffusion coefficients respectively, and found that 
the most prevalent change was in the diffusion coefficient, which was attributed to amplified hydrogen 
bonding effects in the membrane (Du Plessis et al., 2002a).  The work is another notable example of 
when silicone membranes have been used to understand mechanistically the events which may 
determine the ability of a penetrant to overcome the formidable stratum corneum barrier, and the 
likelihood of therapeutic levels of API being achieved in vivo, without the use of animal skin or cadaver 
skin.  
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The use of silicone membranes as substitutes for biological tissue in permeability studies is irrefutably 
attractive from a data interpretation perspective, since synthetic substitutes offer batch-to-batch 
uniformity, which human skin lacks, are highly chemically characterised, and are sufficiently available 
to facilitate large scale studies and thus may minimise expensive clinical studies (Feldstein et al., 1998; 
Houk et al., 1988; Waters, 2015). Polymeric substitutes that are appropriate, not only from a logistical 
perspective, but also from a mechanistic perspective, thus are highly attractive. Nonetheless, as with 
many animal and cell culture models, overestimations of percutaneous adsorption are often observed. 
The recurrent use of PDMS can be attributed to the materials successful prediction of ‘trends’ in 
permeability (Geinoz et al., 2002), in a ranking-type approach (Leveque et al., 2006; Sugibayashi et 
al., 2009). Likewise, since the non-porous nature of PDMS permits diffusion via a solution-diffusion 
mechanism, parallel to that offered by human skin, PDMS provides an excellent platform on which to 
base a mechanistically relevant skin mimic. The hydrophobic nature of PDMS provides a reasonable 
representation of the stratum corneum barrier at the macroscopic level, but the structural homogeneity 
of PDMS membranes do not offer a highly tortuous barrier analogous to that offered by the stratum 
corneum. As such, attempts have been made to evaluate more complex, but highly chemically 
characterised, PDMS-containing ‘skin mimics’.  
Polydimethylsiloxane-polycarbonate (PDMS-PC) copolymer membranes have been investigated as 
potential skin mimics, offering a two-phase type structure of hydrophilic PC regions dispersed within 
hydrophobic PDMS. The authors reported permeability coefficients of 14 compounds through the 
synthetic substitute from aqueous donor solutions, and found good correlation with the parameters used 
in the Potts-Guy equation, namely molecular weight and log10 KO/W (R2 = 0.83, n = 9). Further, drug 
delivery through the copolymer from a hydrogel-based TDDS was evaluated, and a linear correlation 
was observed between the delivery from the aqueous solution and delivery from the TDDS. Likewise, 
a linear relationship was observed between delivery from the TDDS and an aqueous solution through 
human epidermal tissue. A linear relationship was also observed between the logarithm of the ratio of 
permeability coefficients from aqueous solutions through both barriers, and the respective logarithm 
obtained from the TDDS. Since epidermal tissue permeability coefficients using aqueous donor 
solutions are readily available, the authors conclude that the employment of the skin-imitating 
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copolymer may provide a robust method of predicting transdermal drug delivery from similar 
hydrogel-based transdermal drug delivery systems (Feldstein et al., 1998).  
Additional copolymer membranes have been evaluated as potential skin mimics in permeability 
studies. Work by Miki et al. prepared poly(ethylene terephthalate) and poly(tetrafluoroethylene) 
membranes, and  poly(vinylidene difluoride) membranes impregnated with poly(dimethylsiloxane) 
and poly(ethylene glycol) (PEG) copolymers,  for use in both Franz cell diffusion studies and a 96 –
well filter plate model. Membranes were also prepared without PEG units in order to evaluate the 
relative contribution of hydrophilic PEG-containing routes through the membrane. The membranes 
were tested using 12 model penetrants in saturated aqueous suspensions, ranging in log10 KO/W from -
4.70 – 3.86. It was found that the limited extent of permeation through the membrane devoid of PEG 
units rendered receptor solution concentrations below the limit of detection of the spectroscopic 
technique for L-dihydroxyphenylalanine, dopamine hydrochloride, and isoproterenol hydrochloride. 
The three compounds represented the lowest log10 KO/W values of the dataset, and the detectability of 
the compounds following the use of the PEG unit containing membrane led the authors to conclude 
that the inclusion of PEG units to the polymeric structure provided an aqueous route through the 
membrane, and overall heteropolar structure. Permeability coefficients obtained using both the PDMS 
and PDMS-PEG membrane were compared with that of epidermal tissue, and an improved correlation 
was found for the PDMS-PEG membrane (R2 = 0.930, n = 12) compared with the PDMS membrane 
(R2 = 0.913, n = 9). Similar correlation was observed with the PDMS-PEG membrane in the 96-well 
plate system with a subset of the compounds (R2 = 0.92, n = 6). The authors conclude the artificial 
membrane system may provide a useful alternative to RHE models, on the basis of its predictive power, 
high-throughput nature, and reduced cost (Miki et al., 2015) .  
Both bodies of work above, utilising PDMS-PC and PDMS-PEG copolymers, highlight substantial 
interest in synthetic systems possessing discrete, polar domains dispersed within an overall 
hydrophobic polymer network, similar to the lamellar structure of the stratum corneum. Despite both 
models demonstrating that heteropolar structures may provide an enhanced model of the stratum 
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corneum, since their publication in 1998 and 2015, respectively, both models still remain tested using 
< 14 compounds.  
Alternative ‘biphasic’ silicone based systems have been tested; INTEGRA® regeneration template, an 
FDA approved membrane for the treatment of burns and for use in reconstructive surgery, has been 
evaluated as a potential surrogate for human skin in permeation studies. The biphasic membrane 
consists of a lipophilic polysiloxane layer and an underlying hydrophilic collagen layer, and the 
rationale underlying the membrane selection resided in the modelling of the highly lipophilic stratum 
corneum and underlying hydrated viable tissue. A plot of flux of eight model compounds (log10 D = -
4.9 – 2.97) through the biphasic membrane versus flux through human skin revealed a direct correlation 
in permeation behaviour (R2 = 0.8517), and it was concluded that the membrane was advantageous in 
terms of uniformity, reduced safety concerns and storage. However, analogous to the work by Miki et 
al. evaluating the suitability of PDMS-PEG copolymers for permeability studies, the work was limited 
to eight compounds, and the structure of the membrane was destroyed upon the addition of a 
hydrophilic surfactant to the receptor solution, namely Brij 98 (Shumilov et al., 2009). Further, the 
sourcing of the collagen from bovine tendon (www.ilstraining.com/imwd/imwd/imwd_it_03.html) 
leads to the requirement of animal tissue, thus opposing the ‘3 R’s’ principles. 
Surprisingly, this tremendous increase in insight, and the increase in technological advances that have 
made silicone membrane modification achievable, is not reflected in the number of reported attempts 
to include biorelevant sites to the structure of PDMS for use in permeability studies. 
1.7. Modification of Poly(dimethylsiloxane) 
1.7.1. Properties of Poly(dimethylsiloxane) 
Poly(dimethylsiloxane) (PDMS) belongs to a group of polymers known as polyorganosiloxanes, or 
silicones, which possess the general structure represented in Figure 1.6, where R = CH3 in the case of 
PDMS. 
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Silicones possess a silicon-oxygen backbone, with bond energies in the range of 450 – 570 kJ mol-1. 
The high bond energies in the polymeric backbone result in polyorganosiloxanes displaying excellent 
thermal stability, with degradation of PDMS only occurring at around 350 °C (Jaeger et al., 2008). 
Silicon is more electropositive than oxygen, displaying values of 1.8 and 3.5 on the Pauling scale of 
electronegativity, respectively, resulting in Si-O bonds being polar (Brydson, 1999), and  partially ionic 
in nature. The properties of polyorganosiloxanes, are subject to the properties of the R-group 
substituents, for example, the shielding of the silicon-oxygen backbone by methyl groups in PDMS 
results in weak intra and intermolecular forces between polymer chains, resulting in high chain 
mobility and elastomeric properties. The high chain mobility of polysiloxane chains allows the polymer 
to exhibit the most thermodynamically favoured state, and is responsible for the low surface energy of 
the polymer (Jaeger et al., 2008). The high conformational freedom of the siloxane chains in PDMS, 
which can  be explained by a lack of steric hindrance as a result of the small molecular volume of the 
methyl group, and methyl functionalisation occurring at alternate atoms in the siloxane backbone, is 
further demonstrated by the materials low glass transition temperature (-123 ºC) (Karki, 2016).  
The elastomeric properties of PDMS, along with its non-toxicity, low chemical reactivity, resistance 
to oxidation, high oxygen permeability (Nishikawa et al., 2008), UV transparency down to 280 nm 
(Makamba et al., 2003), low cost, and ease of fabrication, has led to substantial interest in the material 
for use at biological interfaces such as cell culture (Chuah et al., 2015), oesophageal stents (Karakoy 
et al., 2014), microfluidic devices such as immunoassays (Gunda et al., 2014; Makamba et al., 2003), 
the transplantation of pancreatic islets in diabetes treatments (Shin et al., 2013), catheters (Sankar et 
al., 2017; Tyler et al., 2017), and contact lenses (Chen et al., 2017). However, the surface properties 
of PDMS have limited its aptness for these applications. For example, the materials low surface energy 
and poor wettability has been shown to encourage bacterial colonisation resulting in greater infection 
risk following its use in prosthetic devices (Li et al., 2017; Wu et al., 2014), and the surface 
n 
Figure 1.6 General structure of polyorganosiloxanes. 
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hydrophobicity results in difficulty introducing aqueous samples to the small channels in PDMS based 
microfluidic devices (Zilio et al., 2014).  
The plethora of properties of PDMS deeming it an attractive material in the applications listed above 
have led to the development of an extensive body of literature reporting methods for modifying PDMS. 
Approaches to modifying PDMS include dynamic approaches exploiting the physical adsorption of 
hydrophobic and amphiphilic molecules, surface oxidation by exposure to UV/O3 or plasma treatments 
(Bodas et al., 2007; Egitto et al., 2006; Fu et al., 2010; Wong et al., 2009), surface oxidation by 
chemical treatment (Maji et al., 2012), and covalent approaches (Wu et al., 2011).  
1.7.2. Dynamic modification 
Dynamic methods of modifying the properties of PDMS are frequently reported, attributed to the facile 
nature of the protocols and lack of demand for expensive benchtop plasma generators. The methods 
exploit the physical adsorption of hydrophobic, or hydrophobic portions of, amphiphiles onto PDMS, 
resulting in the display of a specific head group at the polymer surface. Protocols typically utilise 
surfactants as ‘dynamic modifiers’, and range from the exposure of cured PDMS devices to buffer 
solutions containing surfactants (Wang et al., 2006), to the introduction of surfactants to the pre-cured 
monomer mixture (Holczer et al., 2017; Madadi et al., 2013; Seo et al., 2006).  Literature reports 
significant increases in surface hydrophilicity, with post-treatment water contact angles as low as 23° 
(Madadi et al., 2013), on par with those obtained with low-pressure plasma treatments (Kaczorowski 
et al., 2015).  The substantial increase in hydrophilicity is thought to be a consequence of van der 
Waals interactions between the lipophilic tail of the surfactant molecule with PDMS, and the 
presentation of the hydrophilic portion of the amphiphile at the PDMS-aqueous solution interface 
(Makamba et al., 2003). However, the depletion of ‘dynamic modifier’ as a result of diffusion into the 
aqueous phase is a detriment to the approach, and surface hydrophilicity has been found to be a function 
of contact time with aqueous solutions (Seo et al., 2006).  
Interestingly, the occurrence of such phenomena has been observed previously in permeation studies, 
whereby a reduction in permeation of four APIs through PDMS was observed upon inclusion of 
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surfactants in the donor phase. The effect was observed with anionic, cationic, zwitterionic and neutral 
charge state surfactants, tested at three concentration levels. Reductions in permeation were observed 
for the four compounds tested, namely ibuprofen, lidocaine, benzotriazole and benzocaine, and the 
greatest effects were observed with the highest concentration of surfactant present (Bhuiyan et al., 
2017). The findings were in line with previous research published by the same group, whereby a 
reduction in the permeation of methyl and ethyl paraben was observed in the presence of sodium 
dodecyl sulphate (SDS) (Waters et al., 2013), reaching an optimum at the highest concentration of SDS 
tested. In the latter described work, no effect on permeation was observed upon the inclusion of Brij 
35, a non-ionic surfactant, to the donor solution. The findings led the group to conclude that the 
reduction in permeation was a result of the presentation of the anionic head group at the surface of 
PDMS following the physisorption of the hydrophobic tail (Waters et al., 2013).  
1.7.3. Surface Oxidation 
The reversible nature of methods exploiting the physical adsorption of molecules onto PDMS has led 
to research being undertaken endeavouring to establish more robust methods to enhance the properties 
of PDMS, in terms of both its reactivity and wettability. The activation of PDMS surfaces, and 
subsequent increased wettability, can be achieved by surface oxidation, resulting in the cleavage of Si-
CH3 bonds, and the formation of silanol groups (Chen et al., 2007).  
Wet chemical oxidation of PDMS is carried out by exposure to Piranha solution, which typically 
consists of mixtures of H2O2  and H2SO4 in varying ratios (Jang et al., 2006; Koh et al., 2012; Maji et 
al., 2012). Piranha oxidation of PDMS is an inexpensive alternative to plasma based methods, however 
is unattractive from a safety perspective. Addition of H2O2 to H2SO4 is highly exothermic; H2O2 must 
be added dropwise, and the resultant concentration should not exceed 50 %, above which the solution 
becomes explosive (Wu et al., 2008). Thus, physical methods of oxidation by energy exposure offer 
an attractive alternative. 
UV/O3, or UV/ozone, treatment of PDMS is frequently reported in literature, as analogous to the use 
of Piranha solution, surpasses the need for expensive benchtop plasma generators. A typical setup for 
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UV/O3 treatment of PDMS includes a low-pressure mercury lamp in an enclosed vessel containing the 
PDMS sample. Low-pressure mercury lamps emit UV radiation at both 184.9 nm and 253.7 nm, and 
in the presence of an oxygen containing process gas, produce reactive oxygen species (ROS). Diatomic 
oxygen is able to absorb UV radiation at 184.9 nm, resulting in the formation of atomic oxygen, which 
can further react with diatomic oxygen to form ozone. Ozone is also able to absorb UV radiation at 
253.7 nm, resulting in its dissociation to diatomic and atomic oxygen (Egitto et al., 2006). Both ozone 
and atomic oxygen display high reactivity towards PDMS, and the exposure of PDMS to UV radiation 
also results in the formation of organic radicals which are able to form more volatile species, such as 
CO2 and H2O, with atomic oxygen and ozone. The desorption of volatile organic species from the 
surface of PDMS following UV/O3 treatment results in the formation of a thin SiOx type layer (Fu et 
al., 2010). UV/ozone treatments are typically milder than plasma treatments (Wong et al., 2009), and 
require longer treatment times, however, require less financial investment, and can be performed under 
atmospheric pressure with air as the process gas (Egitto et al., 2006).   
The plasma modification of PDMS is widely reported in literature, owing to the simple nature of the 
process, and the short durations of exposure required, generally below five minutes (George et al., 
2017; Keranov et al., 2008; Wu et al., 2011). Plasmas are known as the ‘fourth state of matter’ and are 
gases containing ionised molecules and free radicals formed following energy exposure, normally radio 
frequency discharges (Taubert et al., 2013). Oxygen-containing plasma treatments similarly exploit 
the use of reactive oxygen species (ROS) to form thin SiOx layers at the surface of PDMS, typically in 
the top few nm (Béfahy et al., 2010).  Both UV/O3 and oxygen containing plasma treatments result in 
the formation of a brittle silica-like layer (Cordeiro et al., 2009) (Figure 1.7), with physical properties, 
such as higher surface energy and wettability (Kaczorowski et al., 2015), that are distinguishable from 
the bulk material. 
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Figure 1.7 Oxidation of poly(dimethylsiloxane) following treatment with UV/O3 or oxygen-
containing plasma, adapted from Chen et al. (Chen et al., 2007). 
The hydrophobicity of PDMS is known to be restored over time following plasma and UV/O3 
treatments, in a process termed hydrophobic recovery. The hydrophobic recovery of PDMS has been 
studied extensively, and is thought to be attributed to the diffusion of uncured oligomers though the 
bulk material to the surface, and the reorientation of polar silanol groups toward the bulk. The UV/O3 
and plasma oxidation of PDMS results in strain between the rigid SiOx layer and elastomeric bulk, and 
can lead to crack formation (Lee et al., 2017), which in turn facilitates the diffusion of both oligomers, 
and other low molecular weight species formed during the treatment, to the surface  (Cordeiro et al., 
2009; Tan et al., 2010). The exposure of oxidised PDMS to aqueous solutions has been explored as a 
potential method to extend the lifespan of hydrophilic PDMS surfaces, the success of which is thought 
to be attributed to hydrogen bonding between surface silanol groups and the solution, which may 
prevent reorientation towards the bulk (Ma et al., 2011; Zhao et al., 2012). Other attempts to maintain 
the hydrophilicity of oxidised PDMS include the removal of low molecular weight species, such as 
cyclic siloxanes, formed during the polymerisation process, which are able to diffuse to the surface and 
aid hydrophobic recovery (Eddington et al., 2006; Nguyen et al., 2014), and the use of surface silanol 
groups as a prerequisite to the covalent attachment of hydrophilic molecules. 
1.7.4. Covalent Attachment 
The generation of silanol groups at the surface of PDMS is frequently followed by covalent bond 
generation to hydrophilic molecules, endeavouring to lengthen the enhanced surface hydrophilicity, 
and capitalise the heightened chemical reactivity of oxidised PDMS. Organosilanes, or more 
specifically, alkoxysilanes, have received substantial attention for such purpose, attributed to the 
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requirement of moderate reaction conditions, rudimentary protocols, and the inexpensive nature of the 
reagents (Chuah et al., 2015). The general structure of alkoxysilanes is presented in Figure 1.8. 
 
Figure 1.8 General alkoxysilane structure. 
 
Typical procedures involve the use of methoxy- and ethoxysilanes, where R1 = CH3 and R1 = CH2CH3, 
in Figure 1.8, respectively, and result in self-assembled monolayers (SAMs) of alkoxysilanes, 
represented in Figure 1.9. Protocols generally commence with the plasma oxidation of PDMS, 
followed by its submersion in a solution of alkoxysilane in aqueous alcohol, typically in concentrations 
ranging from 1 %   to 20 %  (Kuddannaya et al., 2013; Nguyen et al., 2016). The reaction precedes 
with the hydrolysis of the alkoxysilane, producing silanol groups, followed by condensation, leading 
to the formation of a siloxane linkage between alkoxysilane molecules. The alkoxysilane layers are 
able to form hydrogen bonds with the PDMS substrate, and further condensation with surface silanols 
results in Si-O-Si bond formation with the substrate (Gunda et al., 2014).  
 
 
[Methoxy(polyethyleneoxy)propyl]trimethoxysilane, or PEG-silane, has been reported to render 
microfluidic channels hydrophilic and resistant to non-specific protein adsorption to PDMS 
microfluidic channels, which is known to be detrimental to device performance (Kovach et al., 2014). 
Conversely, alkoxysilanes in which R2 is an amine-containing functionality, such as (3-
aminopropyl)trimethoxysilane (APTMS) and (3-aminopropyl)triethoxysilane (APTES), have broadly 
been used to enhance the interaction of the substrate with biomolecules, such as antibodies in the case 
1 % APTES 
     EtOH (aq) 
Figure 1.9 Self-assembled monolayer (SAM) formation using (3-aminopropyl)triethoxysilane, adapted 
from Nguyen et al. (Nguyen et al., 2016) 
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of immunoassay development (Gunda et al., 2014; Pinto et al.) and collagen (Wipff et al., 2009), 
laminin and fibronectin (Kuddannaya et al., 2015) for enhanced substrate biocompatibility in cell 
culture applications. 
Despite the abundance of literature reporting methods of enhancing the properties of PDMS, often 
endeavouring to render the polymer more comparable to biological tissue in a bid to increase 
biocompatibility, limited attempts have been made to modify PDMS for use in in vitro measurements 
of percutaneous adsorption. 
1.8. Research Aims 
The research presented in this thesis endeavours to acknowledge, and to rectify, the current gap in the 
number of reported attempts to utilise known methods of tailoring the surface properties and chemistry 
of poly(dimethylsiloxane) to enhance the comparability of the polymer to biological tissue, for use in 
in vitro skin permeability studies. This will be approached according to the following aims:  
 To investigate the potential of an air plasma treatment to produce a lamellar structure of PDMS 
analogous to that of human skin, and to evaluate the predicting capability of the modified skin 
mimic by comparison with an appropriate body of literature permeation data obtained using 
human epidermal tissue.  
 To investigate the potential of a nitrogen plasma treatment to aminate the surface of PDMS, 
and provide suitable sites for the covalent attachment of biomolecules. Further, the predicting 
capability of the ‘aminated’ skin mimic will be evaluated on the basis of comparison with the 
air plasma modified skin mimic, and literature permeation data obtained using human 
epidermal tissue. 
 To compare three potential methods of immobilising amine group containing biomolecules at 
the surface of PDMS, to assist in the development of a method of producing a lipid-protein 
multilayer membrane, similar to the stratum corneum, appropriate for skin permeation assays.  
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Chapter 2 Materials and Methods 
2.1 Materials 
Silatos™ silicone sheeting, dimensions 150 x 200 x 0.13 mm, was purchased from ATOS medical. 
The sheeting consisted of a medical grade, non-sterile, poly(dimethylsiloxane) elastomer, with a 
density of 1102.6 kg m-3. Potassium phosphate dibasic (≥ 98 %), potassium phosphate monobasic (≥ 
99 %), benzoic acid (≥ 99.5 %), benzocaine (≥ 99 %), benzotriazole (≥ 98.5 %), lidocaine (≥ 98 %), 
caffeine (≥ 99 %), acetyl salicylic acid (≥ 99 %), methyl 4-aminobenzoate (98 %), benzocaine (98 %), 
butamben (≥ 98 %), methyl 4-hydroxybenzoate (≥ 99 %), ethyl 4-hydroxybenzoate (99 %), butyl 4-
hydroxybenzoate (≥ 99 %), (3-aminopropyl)triethoxysilane (≥ 98 %), (3-
aminopropyl)trimethoxysilane (97 %), Nα-Boc-L-lysine (99 %), Boc-Lys(Z)-OH ( > 98 %), and N,N′-
dicyclohexylcarbodiimide (99 %)  were purchased from Sigma Aldrich Ltd., Dorset, UK. Salicylic 
acid (> 99.5 %), propyl 4-hydroxybenzoate (≥ 99 %) and 4-dimethylaminoantipyrine (97 %), ethanol 
(> 99 %), dichloromethane (> 99 %), 4 N HCl in 1,4 –dioxane, 1,4-dioxane (99.8 %), HBr (33 % w/w) 
in glacial acetic acid, and ethyl acetate (> 99 %) were purchased from Fisher Scientific Ltd., 
Loughborough, UK. Risocaine (98 %) was purchased from Alfa Aesar, Lancashire, UK. Flurbiprofen 
(> 98 %), ketoprofen (> 98 %) and diclofenac (> 98 %) were purchased from Tokyo Chemical Industry 
Ltd. Ibuprofen (≥ 99 %) was purchased from BASF. All chemicals were used as supplied. 
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Table 2.1 Structure, molecular weight, log10 P, charge, and λmax of pharmaceutical compounds used in 
permeation studies presented in this thesis. 
Caffeine 
Abbreviation CAF 
 
Molecular weight 194.19 g mol-1 
log10 Pi -0.13 
Charge Cationic 
λmax 272 nm 
Ibuprofen 
Abbreviation IBU 
 
Molecular weight 206.28 g mol-1 
log10 Pi 3.72 
Charge Anionic 
λmax 221 nm 
Lidocaine 
Abbreviation LID 
 
Molecular weight 234.34 g mol-1 
log10 Pi 3.63 
Charge Cationic 
λmaxii 230 nm 
Methyl Paraben 
Abbreviation MP 
 
Molecular weight 152.15 g mol-1 
log10 Pi 1.87 
Charge Anionic 
λmax 254 nm 
Ethyl paraben 
Abbreviation EP 
 
Molecular weight 166.17 g mol-1 
log10 Pi 2.40 
Charge Anionic 
λmax 254 nm 
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Propyl paraben 
Abbreviation PP 
 
Molecular weight 180.20 g mol-1 
log10 Pi 2.93 
Charge Anionic 
λmax 254 nm 
Butyl paraben 
Abbreviation BP 
 
Molecular weight 194.23 g mol-1 
log10 Pi 3.46 
Charge Anionic 
λmax 254 nm 
Methyl 4-aminobenzoate 
Abbreviation MAB 
 
Molecular weight 151.16 g mol-1 
log10 Pi 1.41 
Charge Cationic 
λmax 287 nm 
Benzocaine 
Abbreviation EAB 
 
Molecular weight 165.19 
log10 Pi 1.95 
Charge Cationic 
λmax 287 nm 
Risocaine 
Abbreviation PAB 
 
Molecular weight 179.22 g mol-1 
log10 Pi 2.48 
Charge Cationic 
λmax 287 nm 
Butamben 
Abbreviation BAB 
 
Molecular weight 193.24 g mol-1 
log10 Pi 3.01 
Charge Cationic 
λmax 287 nm 
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Aminopyrine 
Abbreviation AMP 
 
Molecular weight 231.29 g mol-1 
log10 Pi 0.76 
Charge Cationic 
λmax 264 nm 
Diclofenac 
Abbreviation DF 
 
Molecular weight 296.15 g mol-1 
log10 Pi 4.06 
Charge Anionic/Cationic 
λmax 275 nm 
Flurbiprofen 
Abbreviation FP 
 
Molecular weight 244.26 g mol-1 
log10 Pi 4.11 
Charge Anionic 
λmax 247 nm 
Ketoprofen 
Abbreviation KTP 
 
Molecular weight 254.28 g mol-1 
log10 Pi 2.81 
Charge Anionic 
λmax 261 nm 
Benzoic acid 
Abbreviation BA 
 
Molecular weight 122.12 g mol-1 
log10 Pi 1.89 
Charge Anionic 
λmax 228 nm 
Salicylic acid 
Abbreviation SA 
 
Molecular weight 138.12 g mol-1 
log10 Pi 2.06 
Charge Anionic 
λmax 234 nm 
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Acetyl salicylic acid 
Abbreviation ASA 
 
Molecular weight 180.16 g mol-1 
log10 Pi 1.19 
Charge Anionic 
λmax 221 nm 
Benzotriazole 
Abbreviation BTA 
 
Molecular weight 119.12 g mol-1 
log10 Pi 1.34 
Charge Cationic 
λmax 260 nm 
i Chemspider, Royal Society of Chemistry. 
ii Taken from Hatanka et al. and Uchida et al. (Hatanaka et al., 2015; Uchida et al., 2015) 
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2.2 Methods 
2.2.1 Air Plasma Modification of Poly(dimethylsiloxane) 
2.2.1.1 Membrane Preparation 
Plasma treatment was performed using a Henniker Plasma HPT-100 Plasma Surface Treatment 
System. The system consisted of a cylindrical process chamber and an aluminium sample tray upon 
which the samples were placed centrally and equidistant from the plasma source. Plasma treatment was 
performed at a process pressure of 0.8 mBar, using air as the process gas, which was introduced at a 
flow rate of 8 SCCM. The plasma was ignited using a radiofrequency power supply set at an output of 
100 W. For preliminary investigations, three treatment times were selected; these were 90, 120 and 
150 seconds. Plasma treatment was performed on both sides of the membrane. 
2.2.1.2 Water Contact Angle Analysis 
The static water contact angle of unmodified PDMS and plasma modified PDMS following a 90 second 
plasma exposure time, was determined by the sessile drop method, using FTÅ1000 contact angle and 
surface measurement instrumentation. For all measurements, Barnstead™ ultrapure water was used, 
and a drop size of 2 μL. The experiment duration for each membrane type was 200 seconds, and 
measurements were taken at three surface locations per membrane.  
2.2.1.3 Scanning Electron Microscopy (SEM) 
SEM analysis was carried out using a JEOL 6060LV SEM. Samples were prepared for analysis by 
coating in a Quorum Technologies SC7620 Sputter coater equipped with an 80 % gold and 20 % 
palladium sputter target, for a total time of 30 seconds. SEM images were obtained in secondary 
electron mode, in triplicate, of unmodified PDMS membrane and plasma modified membrane, at a 
working distance of 15 mm and an acceleration voltage of 15 – 20 kV.  The surface was examined for 
any obvious lesions or artefacts which may alter the permeability of the membrane.   
2.2.1.4 Attenuated Total Reflectance – Fourier Transform Infrared Spectroscopy (ATR-FTIR) 
ATR-FTIR analysis was carried out using a Nicolet 380 FTIR spectrometer in attenuated total 
reflectance mode, equipped with a diamond crystal internal reflection element, in the wavenumber 
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range 400 – 4000 cm-1. Spectra were viewed in Omnic software version 9.2.106, and were collected as 
an average of 300 scans at 4 cm-1 resolution.  
2.2.1.5 X-ray Photoelectron Spectroscopy (XPS) 
X-ray photoelectron spectroscopic analysis of native and plasma treated PDMS was performed using 
a Kratos Axis Ultra DLD instrument with a monochromated aluminium source. Survey scans were 
performed between 1200 and 0 eV binding energy, at 160 eV pass energy and 0.5 eV intervals in order 
to determine surface composition.  Two analysis points were selected per sample, with an analysis area 
of 700 µm by 300 µm. High-resolution spectra were obtained of O 1s, N 1s C 1s and Si 2p at the 
appropriate binding energy range at 20 eV pass energy and 0.05 eV intervals.  
Quantification and curve fitting was performed using Casa XPS software, following the removal of the 
background using a Shirley function, and the use of calculated Schofield factors to account for the 
angle between the X-ray source and the sample, along with the variation of penetration depth with 
energy. The Levenburg-Marquadt algorithm was used to minimise the differences between the data 
points and the envelope i.e. a least squares fitting routine was used. Within the spectra for a given 
element, curves were constrained to have the same full width at half maximum. In the case of high-
resolution spectra of the Si 2p orbital, two peaks corresponding to the Si 2p3/2 and Si 2p1/2 spin states 
were expected, with a peak area ratio of 0.5 and a separation of 0.63 eV. Thus, curve fits of spectra of 
the Si 2p envelope were constrained to pairs of symmetrical peaks with a fixed area ratio of 2:1.   
2.2.1.6 Finite Dose Permeability Studies 
Permeation experiments were carried out using custom made Franz cell apparatus. The cells had an 
orifice of 0.64 cm2 and a receptor volume of 4 mL. Silatos™ silicone sheeting (dimensions 150 x 200 
x 0.13 mm) was cut to appropriate size portions and sealed between the donor and receptor 
compartment using high vacuum silicone grease (Dow Corning®) and a clamp. Experiments were 
carried out in a water bath at 32 °C in accordance with OECD guideline 428. All donor and receptor 
solutions consisted of 0.05 M pH 7.4 phosphate buffer, prepared by dissolving 5.294 g of K2HPO4 and 
2.666 g of KH2PO4 in 1 L of Barnstead™ ultrapure water. The pH was checked with a Jenway 3510 
pH probe, and pH adjustment was performed with HCl where appropriate.  
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The donor solution was prepared by dissolving the permeant in buffer with a final concentration of 
1000 μg mL-1, and the receptor solution consisted of 4 mL of pH 7.4 phosphate buffer in the absence 
of the permeant. 1.5 mL of donor solution was introduced to the donor compartments, which were 
subsequently occluded with Parafilm® to prevent evaporation. All solutions were sonicated and 
introduced to the Franz cell slowly using a syringe in order to minimise bubble formation. Prior to the 
introduction of donor solution, Franz cells were allowed to equilibrate for 30 minutes, and any bubbles 
removed by inversion of the cell. 0.6 mL of solution was removed from the receptor chamber at 45 
minute intervals for a total of six hours, and replaced with fresh, pre-warmed receptor solution. Samples 
of receptor solution were analysed using a Cary 60 UV-Vis spectrophotometer, and the concentration 
of permeant in the receptor chamber was determined using the regression equation of a calibration 
graph constructed using standards covering the concentration range of all samples obtained in the 
permeation study (R2 ≥ 0.99). The cumulative mass of compound permeated after 6 hours was 
calculated, as in previous studies (Bhuiyan et al., 2017). All experiments were performed in triplicate. 
Ibuprofen was selected as a model compound in order to make initial observations regarding the effect 
of plasma modification upon the permeation of drugs across PDMS membrane, along with the effect 
of altering the plasma treatment time. In order to observe the effect of varying physiochemical 
properties of the permeant, further studies were carried out utilising lidocaine, benzotriazole, caffeine 
and benzoic acid.   
Statistical analysis was performed using IBM SPSS Version 22.0. Numerous studies have been 
performed to determine the frequency distribution of permeation data through silicone membranes, in 
order to establish appropriate statistical methods, and have found the data to fit a normal distribution 
(Frum et al., 2007; Khan et al., 2005). Thus, data was treated accordingly. The effect of treatment time 
on permeation was evaluated using one-way ANOVA (α = 0.05), with Levene’s test for equality of 
variance, and a post hoc Games-Howell test. Under circumstances whereby Levene’s test revealed data 
heteroscedasticity, Welch’s F was reported. An independent two tailed T-test and Levene’s test for 
equality of variance was used to compare the cumulative mass of drug permeated through native and 
plasma treated PDMS (α = 0.05) for each of the five compounds tested. 
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2.2.1.7 Infinite Dose Permeability Studies 
Permeation experiments employing eighteen model pharmaceutical compounds were performed under 
infinite dose conditions to allow permeability coefficient (Kp) calculation, namely ibuprofen, lidocaine, 
benzoic acid, methyl paraben, ethyl paraben, propyl paraben, butyl paraben, methyl 4-aminobenzoate, 
benzocaine, risocaine, butamben, salicylic acid, acetyl salicylic acid, aminopyrine, caffeine, 
ketoprofen, flurbiprofen and diclofenac. Franz cells were used as described previously (Section 
2.2.1.6), and experiments were performed in triplicate. Donor solution consisted of a saturated solution 
of drug in pH 7.4 phosphate buffered saline (0.15 M NaCl). Buffer was prepared by dissolving 7.385 
g of dipotassium phosphate, 1.034 g of dihydrogen potassium phosphate and 8.766 g of sodium 
chloride in 1 L of Barnstead™ ultrapure water. pH adjustment was performed with HCl where 
appropriate.   
The donor solution was prepared by the addition of excess quantities of drug to a 10 mL volumetric 
flask containing pH 7.4 phosphate buffered saline. The flasks were equipped with a Teflon stirrer bar 
and mounted on a magnetic stirrer plate in a water bath maintained at 32 °C for 24 hours, and 
subsequently filtered using a Minisart® cellulose acetate filter (pore size 0.45 µm). Receptor solution 
consisted of pH 7.4 phosphate buffered saline (0.15 M NaCl). All solutions were sonicated and 
introduced to the Franz cell slowly using a syringe in order to minimise bubble formation. Prior to the 
injection of donor solution, Franz cells were allowed to equilibrate for 30 minutes, and any bubbles 
removed by inversion of the cell. The donor chambers were filled with 1.5 mL of donor solution in the 
presence of excess drug to ensure maximum thermodynamic activity was maintained, and were 
occluded with Parafilm®. It was noted that the buffer failed to control pH, therefore all donor solution 
pH values were recorded in triplicate (Appendix 11). Samples were extracted from the receptor 
chamber at 30 minute intervals for a total of 6 hours and analysed using a Cary 60 UV-Vis 
spectrophotometer. The concentration of drug in the receptor chamber was determined as previously, 
using the regression equation of a calibration graph constructed using standards covering the 
concentration range of all samples obtained in the permeation study following appropriate dilution (R2 
≥ 0.99).  
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The mass of drug in the receptor chamber was corrected for the previous sample removal and the 
cumulative quantity of drug permeated per cm2 was plotted versus time. The steady-state flux (Jss, units 
µg cm-2 min-1) was calculated from the gradient of the linear portion of the graph. The permeability 
coefficient (Kp, units cm min-1) was obtained by normalisation of Jss with the concentration of permeant 
in the donor chamber. The concentration of permeant in the donor solution was determined by 
extraction of an aliquot of donor solution prepared as described previously, followed by filitration 
using a Minisart® cellulose acetate filter (pore size 0.45 µm), followed by appropriate dilution and 
subsequent quantification using a Cary 60 UV-Vis spectrophotometer, as described previously. 
Statistical analysis was performed with IBM SPPS Version 22.0. An independent two tailed T-test and 
Levene’s test for equality of variance was used to compare steady state flux (Jss) through native and 
plasma treated PDMS (α = 0.05), in line with findings from previous studies (Frum et al., 2007; Khan 
et al., 2005). This was further supported by a Shapiro-Wilk test for normality in both samples of Jss 
data, and Kp data, obtained using plasma treated PDMS. In all cases p > 0.05 indicating no statistically 
significant deviations from normality.  Correlation analysis was executed in line with that reported in 
similar studies (Lee et al., 2010; Miki et al., 2015; Uchida et al., 2015). Bivariate correlation analysis 
with bootstrap confidence intervals was performed where appropriate in order to evaluate the effect of 
various physicochemical properties of the compounds tested on the reduction in Kp observed following 
plasma treatment. For all correlations reported as statistically significant, 95 % bias corrected 
accelerated (BCa) bootstrap confidence intervals, based on 1000 samples, for Pearson’s correlation 
coefficient did not cross zero. Simple linear regression, with bootstrap confidence intervals, was 
performed in order to establish the relationship between the Kpnative, Kpplasma and Kphuman. Similarly, in 
order to correlate the extent of permeation through human skin with various physicochemical 
properties, assumption-free Spearman’s rho was computed.  
2.2.2 N2 Plasma Modification of Poly(dimethylsiloxane)  
2.2.2.1 Membrane Preparation 
Plasma treatment was carried out using a Henniker Plasma HPT-100 Plasma Surface Treatment 
System, as described previously (Section 2.2.1.1), operating at 100 W with N2 as the process gas 
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(99.998 %, O2 free). The process gas was introduced to the plasma process chamber at a flow rate of 8 
SCCM, and the chamber was maintained at a pressure of 0.6 mBar. For preliminary investigations, 
four treatment times were selected i.e. 90, 150, 210 and 300 seconds.  
2.2.2.2 Membrane Characterisation 
SEM, ATR-FTIR and XPS analyses were conducted as described in Sections 2.2.1.3, 2.2.1.4, and 
2.2.1.5, respectively. 
2.2.2.3 Permeation Studies 
Initial comparison with air plasma treatment, and preliminary studies determining treatment time 
effects were carried out as described in Section 2.2.1.7.  In order to enable Kp calculation, the static, 
Franz type diffusion cell was substituted for a PermeGear flow-through type system (Figure 2.1) to 
enable the maintenance of sink conditions when using aqueous solutions of lipophilic compounds, and 
surpass the employment of solubility enhancers, which may interact with the membrane and obscure 
data interpretation. The system consisted of flow through type cells mounted on a heater block, the 
temperature of which was regulated by a water circulator unit mounted inside a water bath. Phosphate 
buffered saline (pH 7.4, 0.15 M NaCl) was pumped through the receptor chambers from a reservoir 
maintained at 32 °C by use of a hotplate stirrer and thermocouple. The cells had a diffusional area of 
0.54 cm-2, and a flow rate of 12 ml hour-1 was found to be adequate for all penetrants, in line with 
previous studies (Addicks et al., 1987), with the exception of caffeine. In the case of caffeine, a flow 
rate of 4 mL hour-1 was used to account for the lower flux and maintain sample concentrations above 
the limit of quantification of the analytical method. The concentration of analyte in the receptor 
medium was maintained at ≤ 10 % that of the donor solution. Donor solution consisted of a saturated 
solution of permeant in pH 7.4 PBS (0.15 M NaCl) with excess permeant present, prepared as described 
previously. The temperature under the membrane was measured using a thermocouple, and it was 
found that a circulating water temperature of 35.1 °C maintained a cell temperature of 32 °C. 
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Figure 2.1 Schematic of the flow-through type system setup. 
Quantitative analysis of the receptor solution was performed using RP-HPLC with a Shimadzu 
Prominence HPLC. The system consisted of a degasser (Shimadzu DGU-20A), pump (Shimadzu LC-
20AT), an auto sampler (Shimadzu SIL-20A HT), a column oven (CTO-10AS VP Shimadzu), and a 
diode array detector (SPD-M20A Shimadzu).  Data analysis was performed with LCSolutions 
software. 
For analysis of all solutions containing parabens, aminobenzoate compounds and caffeine, mobile 
phase A consisted of 0.1 % H3PO4 in ultrapure water, and mobile phase B consisted of acetonitrile. For 
paraben compounds and caffeine, chromatography was performed using a LiChrosphere C18 column 
(4 x 250 mm, 5 µm). The ratios of mobile phase B:A were as follows: methyl paraben 35:65, ethyl 
paraben 35:65, propyl paraben 50:50, butyl paraben 50:50 and caffeine 20:80. A flow rate of 1.0 mL 
min-1 and an injection volume of 20 μL was used for all compounds. The oven was maintained at 40 
°C for all analysis.  
For analysis of all solutions containing aminobenzoate compounds, lidocaine and benzoic acid, 
chromatography was performed using a Waters X-Bridge C18 column (2.1 x 150 mm, 3.5µm). For 
aminobenzoate compounds, the ratios of mobile phase B:A were as follows: methyl 4-aminobenzoate 
30:70, ethyl 4-aminobenzoate 30:70, propyl 4-aminobenzoate 45:55 and butyl 4-aminobenzoate 45:55. 
For lidocaine analysis, mobile phase A consisted of 0.1 % H3PO4 containing 5 mM sodium 1-heptane 
sulfonate and mobile phase B consisted of acetonitrile. The ratio of mobile phase B:A was 30:70. For 
benzoic acid analysis, mobile phase A consisted of 45 mM KH2PO4 and 130 mM H3PO4 and mobile 
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phase B consisted of acetonitrile. The ratio of mobile phase B:A was 25:75. A flow rate of 0.3 mL min-
1 and an injection volume of 20 μL was used for all compounds. The oven was maintained at 40 °C for 
all analysis. All aqueous mobile phases were filtered prior to use. 
The concentration of analyte in the receptor solution was determined from the regression equation of 
a plot of peak area versus concentration of a minimum seven standard solutions covering a minimum 
of 80 to 120 % of the analyte concentration. Linearity was determined by coefficients of determination 
(R2 ≥ 0.999), and intermediate and intra assay precision were determined for all methods using three 
determinations at three concentration levels. Limits of detection (LOD) and limits of quantification 
(LOQ) were determined using the standard deviation of the y-intercept of a regression line as 
recommended by the ICH Guidelines for Validation of Analytical Procedures (Appendix 13). The 
concentration of analyte in the donor solution was determined similarly, following filtration with a 
Minisart® cellulose acetate filter (pore size 0.45 µm) and appropriate dilution.  
Statistical analysis was performed with IBM SPPS Version 22.0. Levene’s test for the homogeneity of 
variance and one-way analysis of variance (One-way ANOVA) with a post hoc Bonferroni test were 
used to compare data obtained from studies evaluating the effect of N2 plasma treatment time on the 
permeation of lidocaine and caffeine. Under circumstances whereby Levene’s test revealed data 
heteroscedasticity, Welch’s F was reported, and post hoc comparisons were performed using a Games-
Howell test. 
2.2.3 Lysine Functionalisation of Poly(dimethylsiloxane) 
2.2.3.1 Lysine attachment to N2 plasma treated PDMS using N,N'-Dicyclohexylcarbodiimide 
(DCC) 
PDMS sheeting was cut to an appropriately sized square (4 cm x 4 cm) and was subject to N2 plasma 
treatment for 90 seconds, on one side of the membrane, using a Henniker Plasma HPT-100 Plasma 
Surface Treatment System operating at 100 W with N2 as the process gas, at a flow rate of 8 SCCM. 
N2 plasma treated PDMS was suspended in dichloromethane (DCM) (50 mL) for 2 minutes followed 
by submersion in a solution of Boc-Lys(Z)-OH in DCM (50 mL, 14.34 mM). N,N’-
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dicyclohexylcarbodiimide (147.9 mg, 0.72 mmol) was then added, and the coupling reaction was 
allowed to proceed for two hours, followed by the removal of the disks from the solution and 
submersion in DCM (50 mL). The PDMS sheeting was suspended in 1,4-dioxane (50 mL) for 2 
minutes, removed and suspended in 4 N HCl-dioxane for 30 minutes to achieve tert-butyloxycarbonyl 
(Boc) group removal. Again, the sheeting was suspended in 1,4-dioxane (50 mL) for cleaning purposes, 
before submersion in HBr in acetic acid (33 %) for removal of the carboxybenzyl (Z) protecting group. 
It was noted that the PDMS substrate disintegrated upon submersion in both 4 N HCl-dioxane and HBr 
in acetic acid therefore both the Boc and Z protecting groups were not removed. Samples were subject 
to ATR-FTIR, and XPS analysis as described in Sections 2.2.1.4 and 2.2.1.5, respectively. Further, the 
reaction was repeated, substituting DCM for EtOH.  
A small permeation study was performed, endeavouring to observe the effect of the exposure of plasma 
treated PDMS to the permeation of a pharmaceutical compound, namely lidocaine. The study was 
performed according to the protocol outlined in Section 2.2.1.6, employing a donor solution of 
lidocaine in pH 7.4 phosphate buffered saline (0.15 M NaCl) at a concentration of 3000 μg mL-1. PDMS 
was plasma treated according to Section 2.2.2.1, and immediately stored in 50 mL of dichloromethane, 
ethyl acetate, ethanol, or ultrapure water, for a duration of two hours. The membranes were blotted dry, 
and subsequently dried under vacuum at 70 °C for 15 minutes prior to mounting in the Franz cell. 
2.2.3.2 Lysine attachment to alkoxysilane functionalised PDMS using N,N'-
dicyclohexylcarbodiimide (PDMS-APTMS-Lys) 
PDMS sheeting was cut to an appropriately sized square (4 cm x 4 cm) and was subject to plasma 
treatment for 90 seconds, on one side of the membrane, using a Henniker Plasma HPT-100 Plasma 
Surface Treatment System operating at 100 W with air as the process gas, at a flow rate of 8 SCCM. 
Alkoxysilane layer formation was performed as reported in other work (Pakstis et al., 2010). 
Immediately after treatment, the PDMS sheeting was suspended in a solution of (3-
aminopropyl)trimethoxylsilane (APTMS) in absolute ethanol (1 % v/v, 50 mL) followed by the 
addition of 5 % v/v water. Samples were then incubated at 70 °C for 10 minutes, and then washed with 
  
Materials and Methods 
59 
 
ethanol in deionised water (70 % v/v, 10 mL), and a further three times with deionised water (3 x 10 
mL). 
APTMS functionalised PDMS disks were suspended in DCM (50 mL) for 2 minutes followed by 
submersion in a solution of Boc-Lys(Z)-OH in DCM (50 mL, 14.34 mM). N,N’-
dicyclohexylcarbodiimide (147.9 mg, 0.72 mmol) was then added, and the coupling reaction was 
allowed to proceed for 2 hours, followed by the removal of the disks from the solution and submersion 
in DCM (50 mL). Samples were subject to SEM, ATR-FTIR, and XPS analysis as described in Sections 
2.2.1.3, 2.2.1.4 and 2.2.1.5, respectively.  
2.2.3.3 Lysine attachment to PDMS using glutaraldehyde linker (PDMS-APTES-GA-Lys) 
PDMS sheeting was cut to an appropriately sized square (4 cm x 4 cm) and was subject to plasma 
treatment for 90 seconds, on one side of the membrane, using a Henniker Plasma HPT-100 Plasma 
Surface Treatment System operating at 100 W with air as the process gas, at a flow rate of 8 SCCM. 
PDMS functionalisation with glutaraldehyde was performed according to reported methods (Farrell et 
al., 2010; Kuddannaya et al., 2013; Wipff et al., 2009). The plasma pre-treated PDMS sheeting was 
submerged in a solution of (3-aminopropyl)triethoxysilane (APTES) (5 % v/v, 1.25 mL) in aqueous 
EtOH (94.7 % v/v, 23.75 mL). The solutions were maintained at 30 °C and gently agitated using a 
shaking water bath for one hour. The PDMS was then removed and washed with aqueous ethanol (94.7 
% v/v, 10 mL) and cured at 60 °C for one hour. The PDMS was washed with pH 7.4 phosphate buffered 
saline (10 mL) and subsequently submerged in a solution of glutaraldehyde in pH 7.4 phosphate 
buffered saline (3 % v/v, 12.5 mL), and left for one hour at room temperature. Upon removal, the 
PDMS sheeting was washed with pH 7.4 phosphate buffered saline (10 mL). The PDMS sheeting was 
then submerged in a solution of Nα-Boc-L-lysine (0.397 M, 10 mL) over night at room temperature. 
Samples were subject to SEM, ATR-FTIR, and XPS analysis as described in Sections 2.2.1.3, 2.2.1.4 
and 2.2.1.5, respectively. 
2.2.3.4 Lysine-functionalised PDMS Permeation Studies 
The permeability of PDMS-APTMS-Lys (Section 2.2.3.2) and PDMS-APTES-GA-Lys (Section 
2.2.3.3) was investigated using the flow through type system, as described in Section 2.2.2.3. Four 
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model pharmaceutical compounds were employed namely butyl paraben, methyl 4-aminobenzoate, 
lidocaine, and benzoic acid, to encompass a range of physicochemical parameters.  
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Chapter 3 The Effect of Air Plasma Treatment on the 
Permeation of Pharmaceutical Compounds through 
Poly(dimethylsiloxane) 
3.1. Introduction 
The oxidation of poly(dimethylsiloxane), typically performed using O2 plasma treatment, is widely 
reported in literature for a plethora of applications, ranging from microfluidic device formation, to the 
formation of suitable substrates for cell culture applications (Gunda et al., 2014; Kuddannaya et al., 
2013).  The use of air as a process gas in plasma treatments aiming to generate surface silanol groups, 
and subsequent enhanced wettability and chemical reactivity, provides an alternative to O2 based 
treatments, and offers financial advantages, along with more basic experimental setups. As such, it has 
received considerable attention. For instance, air plasma oxidation of PDMS has been used as a 
prerequisite to forming poly(vinyl alcohol) coatings, which have been shown to display enhanced 
stability of surface hydrophilicity  (Li et al., 2012), and have found use in the construction of 
microfluidic devices (Sharma et al., 2007). Additionally, air plasma treatments have found use in tissue 
engineering, enabling heightened cell migration, which may assist complex tissue formation (Leclerc 
et al., 2009), along with biomolecule immobilisation (Hu et al., 2014), and more recently, in the support 
of lipid bilayers (Faysal et al., 2017).  
To date, the superior interactions between air plasma modified PDMS and biomolecules have not been 
capitalised for use in the production of artificial skin mimics for in vitro permeation studies. More 
simply, the enhanced properties of oxidised PDMS alone have not been considered with regards to 
such studies. For example, hydrogen bonding between penetrants and the polar head groups of fatty 
acids and ceramides in the intercellular lipid lamellae has long been known to be a determinant in the 
extent of percutaneous adsorption (Du Plessis et al., 2002b). Work by Du Plessis et al. simulated 
hydrogen bonding effects in silicone membranes by membrane impregnation with solvents to 
maximise, and minimise, hydrogen bonding. Reductions in the diffusion coefficient of phenolic 
compounds were observed with increases in the number of hydrogen bonding groups in the penetrant, 
when the membrane was saturated with octanol. The authors noted that decreases in the diffusion 
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coefficient were likely to be as a result of membrane-penetrant hydrogen bonding, and were 
comparable to those observed in studies employing biological tissue. No such effect was observed 
when the membrane was impregnated with toluene and hydrogen bonding was minimised (Du Plessis 
et al., 2001). The work emphasises the role of hydrogen bonding in the permeation of xenobiotics 
through biological tissue, and how polymeric skin mimics can be chemically adapted to enhance their 
performance in biomimetic systems. Nonetheless, since its publication, limited attempts have been 
made to incorporate such groups into the structure of PDMS more permanently, in order to enhance in 
vitro-in vivo correlation in skin permeability studies. Moreover, to date, only one body of work has 
been published aiming to imitate the crystalline nature of the stratum corneum intercellular lipids, by 
inclusion of more rigid, glassy domains within a  polymeric skin mimic (Feldstein et al., 1998). The 
use of plasma treatments is known to result in the formation of crystalline layers of SiOx species 
(Bartalena et al., 2012), thus, plasma treatments may be a promising tool in the development of 
appropriate skin mimics.  
This chapter investigates the hypothesis that the air plasma treatment of PDMS membrane produces a 
barrier to permeation which is more similar to that of the intercellular lipid lamellae on the basis of its 
heteropolarity, crystallinity, and tortuosity (Figure 3.1). 
 
Figure 3.1 Intercellular lipid lamellae, taken from Benson et al. (Benson et al., 2011), modelled using 
plasma treated PDMS. 
In this chapter, the effect of the air plasma treatment of PDMS on the permeation of pharmaceutical 
compounds was evaluated using various compounds representing a wide range of therapeutic classes. 
 
 
Hydrophobic bulk PDMS 
Hydrophilic SiOx layer 
Hydrophilic SiOx layer 
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The correlation between differences in permeation through native and plasma treated PDMS, and 
physicochemical properties of the permeant were investigated. Further, the permeability coefficients 
of eighteen compounds through both native and plasma treated PDMS were obtained from steady-state 
diffusion profiles, obtained under infinite dose conditions, and compared with a database of Kp values 
extracted from literature, whereby data had been collected under similar experimental conditions.  
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3.2. Results and Discussion 
3.2.1. Membrane Characterisation  
3.2.1.1. Water Contact Angle Analysis 
The static water contact angle of PDMS pre and post modification was obtained in order to evaluate 
changes in surface hydrophilicity (Table 3.1). Native PDMS was found to display a static water contact 
angle of 112.26 º ± 0.88 (mean ± standard deviation), characteristic of a hydrophobic substrate, and in 
line with reported data (Da Silva et al., 2017; Maheshwari et al., 2010; Mata et al., 2005). The water 
contact angle of PDMS following a 90 second plasma treatment was found to be 60.74 º ± 5.09, 
indicative of a surface energy increase, in line with reported data (Mata et al., 2005). The data confirms 
the formation of an overlying hydrophilic layer, and an underlying hydrophobic bulk substrate, or a 
‘lamellar’ type structure of lipophilic native polymer and hydrophilic, oxidised polymer.  
Table 3.1 Water contact angle analysis of native PDMS and PDMS following air plasma treatment. 
Membrane 
Mean water contact angle 
(°) 
Standard deviation 
Native PDMS 112.26 0.88 
Plasma treated PDMS 60.74 5.09 
 
3.2.1.2. Attenuated Total Reflectance – Fourier Transform Infrared Spectroscopy (ATR-FTIR) 
ATR-FTIR analysis was performed in order to confirm the surface chemical composition pre and post 
air plasma treatment (Table 3.2). The presence of surface methyl groups is confirmed by a symmetrical 
stretching vibration of the CH3 group at 2962 cm-1, and the asymmetric and symmetric deformation of 
the CH3 group at 1413 and 1258 cm-1, respectively, in the spectra of both native and air plasma treated 
PDMS. The Si-O-Si stretching vibration is observed in spectra of both membranes at 1006 cm-1, along 
with absorptions at 786 and 701 cm-1, confirming the presence of the O-SiCH3 and C-SiCH3 groups, 
respectively.  The absence of the absorbance at 3300 cm-1, indicative of the presence of hydroxyl 
groups, should be noted, and may be explained by the sampling depth of the spectroscopic technique. 
The penetration depth of the evanescent wave ranges from 700 nm to greater than 1 μm, orders of 
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magnitude greater than alternative techniques such as energy dispersive X-ray spectroscopy (EDX), 
X-ray photoelectron spectroscopy (XPS), secondary ion mass spectroscopy (SIMS) and ion scattering 
spectroscopy (ISS) (Vladkova, 2013), rendering the spectrum representative of the surface chemical 
composition of both the surface and underlying bulk substrate. For this reason, ATR-FTIR data is 
presented in this thesis supported by analysis from alternative surface characterisation methods.   
Table 3.2 ATR-FTIR of native PDMS and PDMS following air plasma treatment. 
Assignment 
νmax (cm-1) 
Native PDMS Plasma treated PDMS 
νs(CH3) 2962.3 2962.3 
δas(CH3) 1412.6 1413.4 
δs(CH3) 1258.2 1258.2 
Si-O-Si 1006.3 1006.4 
O-SiCH3 786.2 785.8 
C-SiCH3 701.4 701.1 
 
3.2.1.3. X-ray Photoelectron Spectroscopy (XPS) 
Quantitative elemental composition of the PDMS surface pre- and post-modification was determined 
using XPS survey scans (Figure 3.2 and Figure 3.3), with data subsequently presented in the form of 
atomic percent (%) (Table 3.3). The O 1s, C 1s and Si 2p orbitals were identified at binding energies 
circa 530 eV, 282 eV and 100 eV, respectively, in both native PDMS and PDMS following 90 seconds 
plasma treatment, with an additional emission at a binding energy of 399 eV associated with the N 1s 
orbital in plasma treated PDMS.  A carbon: oxygen: silicon atomic ratio of 2.1: 1.0: 1.2 was obtained 
for native PDMS, consistent with the theoretical ratio of 2: 1: 1, based on the chemical composition of 
the monomer unit. An increase in the atomic percent of oxygen post plasma treatment yields a C: O: 
Si atomic ratio of 1.0: 1.9: 1.4, and is consistent with the oxidative nature of air plasma treatments, and 
suggests up to 50 % conversion of surface methyl groups to silanol and carbonyl containing groups. 
The presence of ~ 0.6 % of nitrogen at the surface post plasma treatment, in comparison to < 0.1 % 
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pre-treatment, is unsurprising taking into account the chemical composition of air, i.e. 78 % nitrogen 
(Pandit et al., 2010), and the reported use of nitrogen plasma treatments to obtain amine and imine 
functionalities (Hirata et al., 2008; Vesel et al., 2008; Wu et al., 2011; Yang et al., 2016). 
 
Figure 3.2 XPS survey scan of native PDMS. 
 
Figure 3.3 XPS survey scan of PDMS following a 90 second air plasma treatment. 
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Table 3.3 Atomic (%) of oxygen, nitrogen, carbon and silicon taken from XPS survey scans of native 
PDMS and PDMS following air plasma treatment. 
Membrane Sample 
Atomic percent (%) 
O N C Si 
Native PDMS 
1 23.17 < 0.10 47.83 29.00 
2 22.79 < 0.10 48.92 28.28 
Plasma treated 
PDMS 
1 44.80 0.56 23.22 31.42 
2 44.11 0.61 24.49 30.79 
 
High resolution spectra of the Si 2p, C 1s and N 1s peak were obtained prior to and following air 
plasma treatment (Figure 3.4 - Figure 3.9). The Si 2p peak can be deconvoluted by curve fitting into 
siloxane units containing one (mono), two (di), three (tri) or four (quaternary) oxygen atoms, and are 
given the notation M, D, T and Q respectively.  An increase in binding energy of ~ 0.65 eV is expected 
for the substitution of a methyl group with an oxygen atom in a siloxy unit, however, curve fitting the 
Si 2p level is made more complex by the existence of two electron spin states (Si 2p3/2 and Si 2p1/2), 
resulting in the occurrence of two symmetrical peaks per chemical state with a peak area ratio of 0.5 
(Owen et al., 2012). The peak at binding energy 102.32 eV and 102.41 in native and plasma treated 
PDMS, respectively, can be assigned to di siloxy units, supported by the 2.1: 1.0: 1.2 atomic ratio 
obtained in the survey scan. A decrease in the percent area of this peak, from 60.56 % in native PDMS, 
to 20.60 % following plasma treatment, can be attributed to a depletion in concentration of this siloxy 
unit in the top 10 nm of the substrate. This is further supported by an increase in the percent area of the 
emission at a binding energy ca.103.7 eV, which can be assigned to Q siloxy units, from 6.11 % in 
native PDMS to 46.08 % in plasma treated PDMS. The presence of a small percentage (6.11 %) of Q 
siloxane units in native PDMS is unsurprising since other work in the Waters research group has 
confirmed the basic nature of the native surface (Waters et al., 2016).    
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Figure 3.4. High resolution XPS spectrum of the Si 2p orbital in native PDMS. 
 
Figure 3.5. High resolution XPS spectrum of the Si 2p orbital in plasma treated PDMS. 
 
Existing literature reports the deconvolution of C 1s spectra into alkyl carbon, amine, imine and nitrile, 
alcohol and ether, and carboxylic acid and ester groups (Wolf, 2012; Wu et al., 2011). Expectedly, the 
high resolution XPS spectrum of the C 1s peak in native PDMS (Figure 3.6) contains one peak at 285 
eV, corresponding to that of C-H groups. The XPS spectrum of the C 1s peak in plasma modified 
PDMS (Figure 3.7) contains two further peaks at 286.7 eV and 288.5 eV, with the former matching 
most closely those reported for alcohol, amine, and nitrile groups, and the latter matching most closely 
those reported for amide and carbonyl groups (Williams et al., 2004; Wu et al., 2011; Yang et al., 
2016).  
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Figure 3.6. High resolution XPS spectrum of the C 1s orbital in native PDMS. 
  
Figure 3.7. High resolution XPS spectrum of the C 1s orbital in plasma treated PDMS. 
 
Given that carbon atoms represent ~ 24 % of the surface of PDMS post plasma treatment, 8.60 % of 
which are present as either alcohol, amine, or nitrile groups (> 2% of atoms overall), the peak at 286.7 
eV cannot be accounted for entirely by amine or nitrile species, since this would necessitate a 
stoichiometric atomic percent of nitrogen, i.e. > 2 %. The lack of a peak in the high resolution XPS 
spectrum of the N 1s orbital in native PDMS is expected (Figure 3.8), and the presence of only one 
peak in the high resolution spectrum of the N 1s orbital at 400.79 eV (Figure 3.9) suggests that all 
nitrogen atoms are present in one chemical state i.e. amide groups. This is further supported by the 
peak at 288.50 eV in the high resolution spectrum of the C 1s orbital in plasma treated PDMS 
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representing 0.59 – 0.71 % of overall surface atoms (2.41 % and 3.07 % of carbon atoms in samples 1 
and 2 respectively), and the presence of a stoichiometric percent of nitrogen (0.56 - 0.61 %).  Only ~ 
11 % of carbon atoms, comprising only 24 atomic % of the surface, i.e. 2.6 % overall, are in the 
oxidised state, suggesting that the majority of oxygen containing groups at the surface are present as 
silanol groups, more specifically, Q siloxane units.  
 
Figure 3.8. High resolution XPS spectrum of the N 1s orbital in native PDMS. 
 
Figure 3.9. High resolution XPS spectrum of the N 1s orbital in plasma treated PDMS. 
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3.2.1.4. Scanning Electron Microscopy 
Changes in surface morphology of PDMS upon plasma treatment, which may subsequently affect 
polymer permeability, were monitored using scanning electron microscopy, the general findings of 
which are presented in Figure 3.10. 
 
Figure 3.10 Scanning Electron Microscopy images of native PDMS (A-C, 500 X, 1000 X, and 1500 
X magnification, respectively) and PDMS following 90 seconds plasma treatment (D-F, 500 X, 1000 
X and 1500 X magnification, respectively).   
A 
B 
C 
D 
E 
F 
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Notably, an increase in wrinkling and cracking of the surface was observed following plasma treatment 
compared with native PDMS, in line with literature reports (Kaczorowski et al., 2015). These 
phenomena can be correlated to the formation of an oxidised, silica-like surface following plasma 
oxidation, and the subsequent brittle nature of the surface, resulting in a contrast in elasticity and 
increased mechanical strain between the surface and the bulk (Cordeiro et al., 2009; Lee et al., 2017; 
Nania et al., 2015). 
3.2.2. Permeability Studies 
3.2.2.1. Finite Dose Studies 
The effect of plasma treatment time on the permeability of PDMS was investigated using the model 
drug ibuprofen (IBU). Three treatment times of 90, 120 and 150 seconds were employed, and the mean 
percent reduction in mass permeated was calculated, relative to permeation through native PDMS 
(Table 3.4).  
Table 3.4 Effect of plasma treatment time on the permeation of the model drug ibuprofen 
 (mean ± standard deviation). 
Compound 
Treatment time 
(seconds) 
Cumulative mass 
permeated after 6 
hours (µg) 
Mean percent 
reduction in mass 
permeated 
(%) 
IBU 
0 63.22 ± 2.23 N/A 
90 53.22 ± 3.10 15.82 
120 39.60 ±  15.52 37.36 
150 39.71 ± 6.78 37.19 
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An overall statistically significant difference in the cumulative mass of IBU permeated after 6 hours 
was observed (F(3,4.05) = 12.43, p = 0.017). Levene’s test for homogeneity of variance revealed data 
heteroscedasticity (F(3,8) = 6.109, p = 0.018); thus, a post hoc Games-Howell test was used to perform 
pairwise comparisons.  A 15.82 % reduction in the cumulative mass of IBU permeating the membrane 
was observed upon employment of a 90 second air plasma pre-treatment (p = 0.042). A further 21.54 
% mean decrease in permeation was observed upon a 30 second extension in treatment time, suggesting 
a greater extent of surface oxidation.  However, an increase in the relative standard deviation (39.19 % 
for PDMS following 120 seconds plasma treatment compared with 3.54 % and 5.82 % for native PDMS 
and PDMS following a 90 second plasma treatment, respectively) suggests an increase in surface 
heterogeneity. Thus, a statistically insignificant difference in permeation was observed (p = 0.560). An 
additional 30 second increase in plasma treatment time yielded a statistically insignificant difference 
in the percent reduction in mass permeated when compared with the previous treatment time (p = 1.00). 
This may be explained by either the occurrence of complete surface oxidation at 120 seconds exposure 
time, or further oxidation occurring at prolonged treatment times, accompanied by phenomena which 
may increase permeability, such as cracking, observed previously (Figure 3.10).   
In order to determine the effect of the properties of the permeant on the cumulative mass permeated 
after 6 hours, the permeation of five further compounds through native and plasma treated PDMS was 
investigated (Table 3.5). The five permeants cover a molecular weight range of 119.12 - 234.34 g mol-
1, a log10 P range of -0.13 - 3.72, and represent both cationic and anionic charged states. A treatment 
time of 90 seconds was selected, according to preliminary data. A donor solution  pH value of 7.4 was 
utilised for all compounds, in order to minimise pH gradients across the membrane, in line with that 
reported by other authors (Uchida et al., 2015; Zhang et al., 2012). Two pH values were selected in 
the case of one anionic compound, namely ibuprofen (IBU) and one cationic compound, namely 
lidocaine (LID), in order to investigate the effect of extent of ionisation on the change in cumulative 
mass observed following plasma treatment. A pH value of 6.0 was selected on the basis of the 
significant change in the extent of ionisation of each compound observed and its biological relevance 
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i.e the pH of skin has been shown to be depth-dependent and  within the range of 5.5 – 8 (Wagner et 
al., 2003). 
Table 3.5 Cumulative mass of ibuprofen (IBU), lidocaine (LID), caffeine (CAF), benzocaine (EAB), 
benzoic acid (BA), and benzotriazole (BTA) permeated through native PDMS and PDMS following 
air plasma treatment (mean ± standard deviation, 4 sig.fig., n = 3). 
Compound pH Cumulative mass permeated after 6 hours (μg) 
Native PDMS Plasma treated PDMS 
IBU 7.4 63.22 ± 2.24 53.22 ± 3.10 
6.0 449.8 ± 18.8 138.2 ± 26.96 
LID 7.4 348.9 ± 20.8 95.07 ± 7.93 
6.0 68.41 ± 5.16 28.92 ± 15.21 
CAF 7.4 6.959 ± 0.824 
5.323 ± 0.688 a 
5.647 ± 0.154 
5.054 ± 1.046 a 
EAB 7.4 819.3 ± 12.8 526.9 ± 15.8 
BA 7.4 19.27 ± 1.47 17.09 ± 1.38 
BTA 7.4 37.04 ± 3.58 29.30 ± 3.95 
a. Recalculated at 5 hours 15 minutes. 
 
Statistically significant differences in the cumulative mass permeated through PDMS following plasma 
treatment were observed for three of the six compounds tested i.e. ibuprofen (IBU), lidocaine (LID) 
and benzocaine (EAB). For LID, a 72.75 % reduction in permeation was observed following plasma 
treatment (t(4) = 19.76, p < 0.001) at pH 7.4, and a 57.73 % reduction in permeation was observed at 
pH 6.0 (t(2.46) = 4.26, p = 0.035). For IBU, a 70.99 % reduction in permeation was observed following 
plasma treatment (t(4) = 16.43,  p < 0.001) at  pH 6.0, and a 15.82 % reduction in permeation was 
observed (t(4) = 4.54, p = 0.01)  at pH 7.4. For EAB, a 35.69 % reduction in mass permeated was 
observed following plasma treatment (t(4) = 24.94,  p < 0.001).  
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In the case of, caffeine (CAF), a statistically significant reduction in permeation was observed after 6 
hours, however, the final sampling interval represented only 1 of 8 for which permeation through native 
PDMS was higher than that through plasma treated PDMS, and was influenced by higher permeation 
in only one of three diffusion cells. This value was eliminated from the analysis, suspected of being 
erroneous. Values were recalculated based on the previous sampling interval, and no statistically 
significant differences in the cumulative mass permeated were observed (t(4) = 0.374,  p = 0.728).  
Further, no statistically significant differences in permeation were observed for benzoic acid (BA) (t(4) 
= 1.874, p = 0.134) and benzotriazole (BTA) (t(4) = 2.516, p = 0.066). Notably, no statistically 
significant increases in permeation following plasma treatment were observed. 
The three compounds displaying statistically significant differences in permeation through PDMS 
following plasma treatment were found to be those with the greatest cumulative mass permeated 
through native PDMS after 6 hours. Therefore, it may be inferred that properties which govern 
permeation through silicone membranes, such as log10 KO/W (log10 P) (Miki et al., 2015), and the extent 
of ionisation (Waters et al., 2016), may also influence the reduction in permeation observed following 
plasma treatment.  
IBU, LID, and EAB represent the three compounds with the highest log10 P values i.e. 3.72, 3.63 and 
1.95, respectively. CAF, BTA, and BA represent the three compounds with the lowest log10 P values 
i.e. -0.13, 1.34, and 1.89, respectively. It is widely accepted that the log10 P, or log10 KO/W, of a 
compound influences the compounds ability to partition into both the stratum corneum i.e. the stratum 
corneum partition coefficient, K, (Section 1.5) (Moss et al., 2015), and alternative lipophilic 
membranes (Waters et al., 2016). Thus, the data may suggest that the oxidation of PDMS may exhibit 
some effect on the partitioning of the tested compounds on the ability of the permeant to partition into 
the membrane. The reduction in WCA observed following plasma treatment (Table 3.1) indicates the 
formation of a hydrophilic layer, and may suggest reduced solubility of lipophilic compounds in the 
superficial layer, reducing membrane partitioning. 
Many active pharmaceutical ingredients (APIs) are known to be weak acids or bases. Increases in 
ionisation are known to significantly decrease the permeation of compounds through lipophilic 
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membranes, described by pH-partition theory (Baba et al., 2017; Charifson et al., 2014; Zhang et al., 
2017). Subsequently, studies aiming to determine the physicochemical parameters which may 
influence topical and transdermal delivery have considered the distribution coefficient, log10 D, as a 
suitable descriptor of membrane partitioning (Avdeef, 2012; Baba et al., 2017; Lee et al., 2010). The 
effect of pH on the reduction in mass permeated following plasma treatment was investigated using 
LID and IBU.  In the case of both compounds, the percent reduction was greatest at the pH at which 
the compound is least ionised i.e. pH 6.0 for IBU and pH 7.4 for LID, supporting the hypothesis that it 
is the permeation of the lipophilic, unionised form of the compound, that is most hindered following 
the plasma oxidation of PDMS. In neither case, an increase in ionisation resulted in an increase in the 
extent of permeation.  
The treatment of PDMS with air plasma has been shown to primarily result in the formation of silanol 
groups, using X-ray photoelectron spectroscopy (Figure 3.2 - Figure 3.9). Silanol groups are known to 
be weakly acidic, with a of ~ 4 (Owen et al., 2012). The Henderson-Hasselbalch equation can be used 
to determine the percent ionisation of weak acids, with known pKa values at a determined pH, as 
follows: 
pH = pK
a
+ log10 (
[A-]
[HA]
)                                      Equation 3.1 
Taking a pKa value of 4, at pH values of 7.4 and 6.0, > 99 % of surface silanol groups are deprotonated. 
Hence, in both cases, the surface charge is primarily anionic. LID is a weak base, and is 79.92 % 
ionised at pH 7.4 with a log10 D of 1.66. At pH 6.0, LID is 98.76 % ionised, with a log10 D of 0.40. 
IBU is a weak acid and is 99.92 % ionised at pH 7.4, and 98.04 % ionised at pH 6.0, displaying log10 
D values of 0.58 and 1.93, respectively (ACD/I-Lab). In both cases, the largest reduction in permeation 
was observed at the pH at which each compound displayed the greatest log10 D. The difference in 
percent reduction across the pH ranges tested for each compound varies. The percent reduction in IBU 
permeation observed following plasma treatment increased by 55.17 % over the pH range tested (from 
15.82 % at pH 7.4, to 70.99 % at pH 6.0). The percent reduction in LID permeation observed following 
plasma treatment increased by 15.02 % over the pH range tested (from 57.73 % at pH 6.0, to 70.75 % 
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at pH 7.4). Despite this, similar changes in log10 D are observed over the pH range tested i.e. 1.26 units 
for LID, and 1.35 units for IBU. Assuming a relationship between the log10 D of the penetrant and the 
percent reduction in permeation observed following plasma treatment, the percent reduction in 
permeation of LID is high (57.73 %) at a log10 D of just 0.40, compared with a percent reduction of 
just 15.82 % at a similar log10 D of 0.58 in the case of IBU.  LID is known to readily form ion pairs in 
solution, thus, the log10 D of primarily cationic LID may be a poor descriptor for the distribution of ion 
pairs (Wood et al., 2012). 
It is conceivable that the mechanism by which plasma oxidation of PDMS reduces the permeation  of 
pharmaceutical compounds is complex and varies for each compound, similar to the multitude of 
complex interactions between xenobiotics and ionogenic groups in the stratum corneum (Du Plessis et 
al., 2002a, 2002b). For example, in the case of anionic compounds, electrostatic repulsion between the 
surface and permeant may prevent membrane partitioning, as hypothesised in earlier work (Bhuiyan et 
al., 2017; Waters et al., 2013). On the contrary, electrostatic attraction between cationic permeants and 
the anionic PDMS surface may result in boundary layer formation, reduced partitioning, and 
retardation of diffusion.  Importantly, following oxidation, PDMS appears to maintain its general 
impermeability towards ionised species, i.e. permeation through oxidised PDMS was reduced 
following increases in permeant ionisation. This is analogous to similar relationships observed with 
the stratum corneum (Baba et al., 2017).  
In any case, plasma treatment appears a promising method of reducing the permeation of 
pharmaceutical compounds through silicone skin mimics, the use of which often results in 
overestimations of the extent of percutaneous absorption that may be observed in vivo. In order to 
further characterise the complex interactions occurring, and evaluate the effect of plasma treatment on 
endpoints more broadly used in in vitro studies i.e. steady-state flux and the permeability coefficient, 
further studies using a more extensive body of compounds at an alternative dosing level were then 
performed.  
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3.2.2.2. Infinite Dose Studies 
Diffusion cell experiments were performed under infinite dose conditions in order to acquire the 
steady-state flux (Jss) of the compounds selected, and to facilitate calculation of the permeability 
coefficient (Kp) for each compound. The extensive use of Kp as a descriptor for skin permeation 
conveniently permits comparison of permeability data obtained using synthetic skin models with 
permeability data from literature obtained using human epidermal tissue, and is a useful measure for 
evaluating the predictive capability of in vitro models (Baba et al., 2017; Miki et al., 2015; Uchida et 
al., 2015).  
The body of compounds selected represents a range of therapeutic classes, namely antifungals, 
keratolytic agents, non-steroidal anti-inflammatories, analgesics, antipyretics and anaesthetics. 
Further, the data set represents a wide range of functionalities, including carboxyl, amide, amine, ester, 
phenyl, hydroxyl, imidazole and ketone groups, and contains two homologous series. The molecular 
weight of the compounds varies greater than 2 fold (138.12 - 296.15 g mol-1), and the log10 P of the 
compounds selected varies from -0.13 - 4.11; properties which have both been shown to heavily 
influence skin permeation (Potts et al., 1992).   
The steady-state flux (Jss) values for all 18 compounds are presented in Table 3.6. Statistically 
significant differences in Jss were found for all compounds in the dataset, with the exception of caffeine 
(CAF), acetyl salicylic acid (ASA), benzocaine (EAB) and risocaine (PAB) (p > 0.05, α = 0.05). 
Markedly significant differences in Jss were observed for benzoic acid (BA), lidocaine (LID) and 
ibuprofen (IBU) (Figure 3.11-Figure 3.13) (p < 0.001, α = 0.05). 
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Table 3.6 Steady-state flux (Jss) of ibuprofen (IBU), flurbiprofen (FLP), ketoprofen (KTP), caffeine 
(CAF), lidocaine (LID), benzoic acid (BA), salicylic acid (SA), acetyl salicylic acid (ASA) 
aminopyrine (AMP), methyl paraben (MP), ethyl paraben (EP), propyl paraben (PP), butyl paraben 
(BP), methyl 4-aminobenzoate (MAB), benzocaine (EAB), risocaine (PAB), butamben (BAB) and 
diclofenac (DF) through native PDMS and PDMS following air plasma treatment (mean ± standard 
deviation, 4 sig.fig, n = 3). 
Compound Jss (µg cm-2 min-1) p-value 
 
Native Plasma 
IBU 5.461 ± 0.284 2.491 ± 0.272 < 0.001 
FLP 0.9748 ± 0.0307 0.7940 ± 0.0650 0.012 
KTP 0.3308 ± 0.0204 0.2737 ± 0.0131 0.015 
CAF 0.1908 ± 0.0107 0.2215 ± 0.0299 0.169 
LID 13.34 ± 0.64 8.487 ± 0.456 < 0.001 
BA 9.813 ± 0.399 5.379 ± 0.427 < 0.001 
SA 5.052 ± 0.317 3.972 ± 0.123 0.005 
ASA 1.584 ± 0.068 1.239 ± 0.100 0.08 
AMP 9.295 ± 0.549 4.978 ± 0.736 0.001 
MP 2.191 ± 0.066 1.760 ± 0.091 0.003 
EP 2.223 ± 0.031 1.813 ± 0.135 0.007 
PP 1.907 ± 0.022 1.266 ± 0.091 0.005 
BP 2.211 ± 0.117 1.892 ± 0.140 0.039 
MAB 6.577 ± 0.525 5.015 ± 0.478 0.019 
EAB 4.257 ± 0.156 4.392 ± 0.093 0.267 
PAB 4.121 ± 0.143 4.142 ± 0.190 0.889 
BAB 2.480 ± 0.150 2.012 ± 0.200 0.032 
DF 0.1181 ± 0.0064 0.1088 ± 0.0054 0.125 
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Figure 3.11 Steady-state flux of benzoic acid through native PDMS and PDMS following air plasma 
treatment (mean ± standard deviation, n = 3). 
 
Figure 3.12 Steady-state flux of lidocaine through native PDMS and PDMS following air plasma 
treatment (mean ± standard deviation, n = 3). 
  
0
500
1000
1500
2000
2500
3000
3500
4000
0 50 100 150 200 250 300 350 400
C
u
m
u
la
ti
v
e 
am
o
u
n
t 
p
er
m
ea
te
d
 (
μ
g
 c
m
-2
)
Time (minutes)
Permeation of BA through native and air plasma treated PDMS
Native PDMS
Plasma treated
PDMS
0
1000
2000
3000
4000
5000
6000
0 50 100 150 200 250 300 350 400
C
u
m
u
la
ti
v
e 
am
o
u
n
t 
p
er
m
ea
te
d
 (
μ
g
 c
m
-2
)
Time (minutes)
Permeation of LID through native and air plasma treated PDMS
Plasma treated
PDMS
Native PDMS
  
The Effect of Air Plasma Treatment on the Permeation of Pharmaceutical Compounds through 
Poly(dimethylsiloxane) 
 
82 
 
 
Figure 3.13 Steady-state flux of ibuprofen through native PDMS and PDMS following air plasma 
treatment (mean ± standard deviation, n = 3). 
The concentration of permeant in the donor chamber was determined as described in Section 2.2.1.7, 
and is presented in Table 3.7. Since PDMS is in many cases more permeable than human epidermal 
tissue, receptor chamber concentrations are often much higher during static permeation experiments 
using the synthetic substitute than those using isolated biological tissue. This can be particularly 
problematic with high log10 P compounds, for which aqueous solubility is very low, but permeability 
through a lipophilic barrier is high. It can be seen in Table 3.7 such an effect was observed with butyl 
paraben (BP), benzocaine (EAB), risocaine (PAB) and butamben (BAB). This is somewhat 
unsurprising since these compounds are amongst the highest log10 P, and lowest percent ionised of the 
compounds tested, parameters both known to influence permeation through lipophilic, non-porous 
membranes, and limit solubility in physiologically conducive receptor solutions.   The linearity of the 
permeation profiles for these compounds was inspected, and R2 ≥ 0.99 for all four compounds, 
indicating maintenance of steady-state conditions. Thus, steady-state fluxes (Jss) (Table 3.6) and 
permeability coefficients (Kp) (Table 3.8) were calculated for all compounds in this dataset. Such data 
treatment may be appropriate for intra-dataset comparative purposes, however, caution must be 
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exercised when correlating this data with external datasets, such as literature Kp values, for which sink 
conditions were maintained throughout the course of the study. 
Table 3.7 Concentration of ibuprofen (IBU), flurbiprofen (FLP), ketoprofen (KTP), caffeine (CAF), 
lidocaine (LID), benzoic acid (BA), salicylic acid (SA), acetyl salicylic acid (ASA) aminopyrine 
(AMP), methyl paraben (MP), ethyl paraben (EP), propyl paraben (PP), butyl paraben (BP), methyl 
4-aminobenzoate (MAB), benzocaine (EAB), risocaine (PAB), butamben (BAB) and diclofenac (DF) 
in the donor chamber (Cdonor), and receptor chamber after 6 hours (Creceptor) quoted to 4 significant 
figures (mean ± standard deviation, 4 sig.fig., n = 3), and the time at which the receptor chamber 
exceeded 10 % saturation. 
Compound Membrane Cdonor  (mg mL-1) 
Creceptor 
( µg mL-1) 
t10% (mins) 
LID 
Native 
3.694 ± 0.039 
365.6 ± 3.2 > 360 
Plasma 241.7 ± 26.4 > 360 
IBU 
Native 
4.585 ± 0.025 
150.6 ± 12.4 > 360 
Plasma 70.86 ± 8.04 > 360 
BA 
Native 
8.625 ± 0.008 
253.0 ± 9.7 > 360 
Plasma 147.7 ± 12.9 > 360 
SA 
Native 
7.703 ± 0.053 
148.0 ± 9.0 > 360 
Plasma 112.9 ± 1.8 > 360 
ASA 
Native 
12.62 ± 0.26 
41.76 ± 3.08 > 360 
Plasma 33.54 ± 3.22 > 360 
AMP 
Native 
46.32 ± 0.72 
262.1 ± 10.1 > 360 
Plasma 146.4 ± 22.2 > 360 
CAF 
Native 
21.59 ± 0.28 
5.036 ± 0.125 >360 
Plasma 5.933 ± 0.229 > 360 
DF 
Native 
1.938 ± 0.048 
3.007 ± 0.384 > 360 
Plasma 2.860 ± 0.038 > 360 
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Table 3.7 continued. 
Compound Membrane Cdonor  (mg mL-1) 
Creceptor 
( µg mL-1) 
t10% (mins) 
FLP 
Native 
4.494 ± 0.051 
25.99 ± 1.44 > 360 
Plasma 22.16 ± 1.37 > 360 
KTP 
Native 
9.301 ± 0.119 
9.319 ± 0.600 > 360 
Plasma 8.033 ± 0.608 > 360 
MP 
Native 
3.094 ± 0.154 
59.55 ± 1.33 > 360 
Plasma 43.60 ± 1.65 > 360 
EP 
Native 
1.209 ± 0.031 
57.06 ± 1.17 > 360 
Plasma 50.78 ± 2.00 > 360 
PP 
Native 
0.4839 ± 0.0068 
50.13 ± 2.59    300 
Plasma 34.69 ± 4.92 > 360 
BP 
Native 
0.3105 ± 0.0020 
57.03 ± 2.25   102 
Plasma 52.96 ± 4.58   181 
MAB 
Native 
1.804 ± 0.018 
167.3 ± 16.0 > 360 
Plasma 139.9 ± 8.3 > 360 
EAB 
Native 
0.8901 ± 0.0076 
112.6 ± 5.9   162 
Plasma 121.4 ± 4.1   191 
PAB 
Native 
0.7489 ± 0.0091 
106.3 ± 1.6   123 
Plasma 98.47 ± 12.2   250 
BAB 
Native 
0.2256 ± 0.0005 
67.63 ± 5.11 59 
Plasma 55.42 ± 3.54 86 
 
Kp values were calculated by the normalisation of Jss (Table 3.6) with Cdonor (Table 3.7), according to 
Equation 1.5, and the resultant values are presented in Table 3.8. Further, the mean percentage 
reduction in Kp was calculated according to Equation 3.2: 
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Mean percent reduction in Kp= (
(Kp
native - Kp
plasma
)
Kp
native )  x 100                          Equation 3.2 
To assist in the understanding of the varying effect of plasma treatment on different compounds, 
bivariate correlation analysis was performed, endeavouring to evaluate the relationship between the 
mean percent reduction in Kp with physicochemical parameters of the penetrant. Physicochemical 
parameters known to influence the extent of permeation through synthetic lipophilic membranes and 
epidermal tissue i.e. log10 P, molecular weight, log10 D, polar surface area (PSA), the extent of 
ionisation, and hydrogen bond donor (HBD) and acceptor (HBA) count, and hydrogen bond donor 
acidity (HBacid) and basicity (HBbasic) were compiled and are summarised in Table 3.9 (Baba et al., 
2017; Cronin et al., 1998; Lee et al., 2010; Potts et al., 1992; Pranitha et al., 2014; Zhang et al., 2017). 
It was noted that the buffer failed to control pH upon saturation with permeant, therefore the pH was 
recorded (Appendix 11) to enable the accurate determination of various parameters i.e. log10 D and 
percent ionisation.  
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Table 3.8 Kp values of ibuprofen (IBU), flurbiprofen (FLP), ketoprofen (KTP), caffeine (CAF), 
lidocaine (LID), benzoic acid (BA), salicylic acid (SA), acetyl salicylic acid (ASA) aminopyrine 
(AMP), methyl paraben (MP), ethyl paraben (EP), propyl paraben (PP), butyl paraben (BP), methyl 
4-aminobenzoate (MAB), benzocaine (EAB), risocaine (PAB), butamben (BAB) and diclofenac (DF) 
obtained with native (Kpnative) and air plasma (Kpplasma) treated PDMS.  (mean ± standard deviation, 
n = 3). 
Compound Kpnative  
(x 10-4 cm min-1) 
Kpplasma 
(x 10-4 cm min-1) 
Mean reduction in Kp  
(%) 
IBU 11.91 ± 0.54 5.432 ± 0.514 54.39 
FLP 2.169 ± 0.063 1.767 ± 0.1264 18.53 
KTP 0.3557 ± 0.0193 0.2944 ± 0.0126 17.23 
CAF 0.0884 ± 0.0044 0.1026 ± 0.0120 -28.25 
LID 36.11 ± 1.54 22.98 ± 1.09 36.36 
BA 11.38  ± 0.40 6.236 ± 0.428 45.20 
SA 6.560 ± 0.359 5.158 ± 0.142 21.37 
ASA 1.255 ± 0.051 0.9821 ± 0.0709 21.75 
AMP 2.007 ± 0.106 1.075 ± 0.139 46.44 
MP 7.092 ± 0.363 5.698 ± 0.359 19.66 
EP 18.40 ± 0.47 15.00 ± 1.03 18.48 
PP 39.43 ± 0.62 26.17 ± 1.65 33.63 
BP 71.21 ± 3.28 60.94 ± 3.91 14.42 
MAB 36.45 ± 2.54 27.80 ± 2.31 23.73 
EAB 47.83 ± 1.56 49.35 ± 0.98 -3.18 
PAB 55.04 ± 1.75 55.31 ± 2.27 -0.49 
BAB 109.9 ± 5.8 89.21 ± 7.67 18.83 
DF 0.6099 ± 0.0316 0.5618 ± 0.0272 7.89 
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Table 3.9 Percent ionised, polar surface area (PSA), log10 D, and log10 P, hydrogen bond donor (HBD) 
and acceptor (HBA) count, and hydrogen bond acidity (HBacid), and basicity (HBbasic) of ibuprofen 
(IBU), flurbiprofen (FLP), ketoprofen (KTP), caffeine (CAF), lidocaine (LID), benzoic acid (BA), 
salicylic acid (SA), acetyl salicylic acid (ASA) aminopyrine (AMP), methyl paraben (MP), ethyl 
paraben (EP), propyl paraben (PP), butyl paraben (BP), methyl 4-aminobenzoate (MAB), benzocaine 
(EAB), risocaine (PAB), butamben (BAB) and diclofenac (DF). 
Compound Percent 
ionised 
(%) (i) 
PSA 
(Å2)  
(ii) 
log10 D 
 
(i) 
log10 P 
 
(ii) 
HBD 
 
(ii) 
HBA 
 
(ii) 
HBacid 
 
(iii) 
HBbasic 
 
(iii) 
LID 28.47 36 2.10 3.63 1 3 0.07 1.24 
IBU 99.37 37 1.44 3.72 1 2 0.08 3.31 
BA 55.73 37 1.40 1.89 1 2 0.02 2.75 
SA 66.61 58 1.95 2.06 2 3 0.08 2.74 
ASA 50.00 64 1.09 1.19 1 4 0.71 0.67 
AMP 0.25 27 -0.52 0.76 0 4 0.00 1.60 
CAF 0.00 58 0.11 -0.13 0 6 0.08 1.25 
DF 99.89 49 1.85 4.06 2 3 0.03 3.35 
FLP 99.66 37 1.48 4.11 1 2 0.07 3.36 
KTP 98.84 54 1.00 2.81 1 3 0.01 3.39 
MP 5.94 47 1.93 1.87 1 3 0.71 0.46 
EP 7.36 47 2.33 2.40 1 3 0.66 a 0.72 a 
PP 5.94 47 2.85 2.93 1 3 0.74 0.43 
BP 7.36 47 3.18 3.46 1 3 0.74 0.43 
MAB 0.00 52 1.39 1.41 2 3 0.30 0.72 
EAB 0.00 52 1.79 1.95 2 3 0.31 0.69 
PAB 0.00 52 2.21 2.48 2 3 0.23 a 0.77 a 
BAB 0.00 52 2.50 3.01 2 3 0.30 0.68 
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(i) ACD/I-Lab. Calculated at the pH of the donor solution (Appendix 11). 
(ii) Chemspider 
(iii) Zhang et al., 2017. Where available, data was taken for the macrospecies, based on the percent ionisation at 
the donor solution pH. Values marked with a were unavailable, and were calculated using ACD/I-Lab Absolv 
module. 
 
The most extensive correlation was found between the mean reduction in Kp (%) and PSA, and is 
demonstrated in Figure 3.14. Pearson’s correlation coefficient (r = -0.652, p = 0.003, [-0.847, -0.374]) 
indicated a large effect of PSA on the reduction in Kp observed, significant at both the α = 0.05 and α 
= 0.01 level. Further, 42.3 % of the variance in the mean reduction in Kp (%) can be accounted for by 
PSA (R2 = 0.423).  
Figure 3.14 Plot of percent reduction in Kp (%) versus polar surface 
area (PSA) (R2= 0.423, n = 18). 
The correlation indicates that, in general, the introduction of silanol groups to the surface of PDMS 
had the greatest effect on compounds with the lowest polar surface area (PSA), and the smallest effect 
on compounds with the greatest polar surface area. The introduction of Si-OH groups at the surface of 
PDMS, thus, hinders the permeation of pharmaceutical compounds with the lowest surface area of 
polar functionalities, such as nitrogen-, oxygen-containing groups. Similar dependences on PSA have 
been observed with epithelial barriers; Shanmugasundaram et al. report a negative correlation between 
PSA and the human skin permeability coefficients of 61 compounds (R2 = 0.46) (Lee et al., 2010), and 
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work by Palm et al. highlighted the dependence of fraction absorbed (FA) in humans, following oral 
administration, on PSA (Palm et al., 1997).   
The presence of hydrophilic groups at the surface of PDMS, introduced via physical adsorption, has 
previously been shown to reduce the permeation of pharmaceutical compounds, hypothesised to be a 
consequence of reduced partitioning of the permeant into the membrane (Bhuiyan et al., 2017; Waters 
et al., 2013).  Based on the above findings, the partitioning of compounds with a high polar surface 
area, therefore, may be less affected by the introduction of polar functionalities to the surface of PDMS. 
Conversely, compounds with a low polar surface area may display low partitioning into the outermost, 
hydrophilic polymer layers. One explanation for the lack of permeability increases is that the diffusion 
of compounds with high PSAs that may display enhanced partitioning into the outer layers, may be 
limited by diffusion through the underlying, hydrophobic bulk. 
No statistically significant bivariate correlations were found for log10 D (r = -0.001, p = 0.996, [-0.614, 
0.578]), log10 P (r = 0.287, p = 0.248, [-0.455,0.726]), percent ionised (r = 0.269, p = 0.281 [-0.185, 
0.608]), MW (r = -0.043, p = 0.866, [-0.401, 0.415]), HBD (r = -0.147, p = 0.561, [-0.796, 0.458]), 
and HBA (r = -0.498, p = 0.035, [-0.850, 0.451]), HBacid (r = -0.071, p = 0.781, [-0.465, 0.357]) and 
HBbasic (r = 0.251, p = 0.315, [-0.149, 0.608]) 
3.2.3. Comparison with Human Skin Data 
The Kp values obtained using both synthetic membranes i.e. native and plasma treated, were compared 
with a library of Kp values collated from permeability studies reported in literature employing excised 
skin. Appropriate Kp values were identified on the basis of experimental setup, and the data were 
scrutinised according to the following factors: tissue type, experimental temperature, dose, receptor 
solution composition, and donor solution composition. The resultant library is presented in Appendix 
14, and the Kp values selected for comparison are summarised in Table 3.10. 
 Multiple authors have reported the lack of standardised permeability data in literature, and emphasised 
the importance of performing comparisons made with literature permeability coefficients on smaller 
datasets, which are more standardised in terms of experimental procedures, and human skin source and 
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preparation technique (Provin et al., 2015; Sinkó et al., 2012). Exceptions to this were made where 
appropriate; For example, data for LID was available from Uchida et al. (Uchida et al., 2015), however, 
the authors report obtaining the hydrochloride salt, thus this data was substituted with data from  
another  source reporting use of the free base (Miki et al., 2015).    
All donor solutions were aqueous (either buffers or purified/deionised water) in order to exclude the 
possibility of excipients altering the barrier function of the skin. Where possible, Kp values were 
selected whereby the author had reported no pH adjustment to the donor phase, and the donor and 
receptor phase matched that of permeation studies employing synthetic substitutes i.e. pH 7.4 
phosphate buffered saline.  The Kp value of a compound is known to be heavily influenced by pH, and 
the subsequent extent of ionisation. The overall Kp of a compound is known to be a sum of the 
permeability coefficients of  the macro- and microspecies present  (Zhang et al., 2017): 
Kp
total= (Kp
unionx Funion) + (Kp
ion x Fion)                            Equation 3.3 
Where Kpunion and Funion are the permeability coefficient of the unionised species and the fraction 
unionised, respectively, and Kpion and Fion are the corresponding values for the ionised species.  
Given that the stratum corneum is orders of magnitude less permeable to the ionised form of a 
compound, it is clear that variations in the pH of the vehicle may have a profound effect on the observed 
permeability coefficient (Bartosova et al., 2012). Similar relationships have also been observed in 
silicone membranes (Waters et al., 2016).  The influence of vehicle pH was considered particularly 
important for compounds at pH values considerably close to the pKa, or for which significant fraction 
was known to be ionised. For example, BA has a pKa of 4.1, and is 55.73 % ionised at a donor solution 
pH of 4.2 (ACD/I-Lab).  Zhang et al. report a similar donor solution pH of 4.0. Adjustment to a pH of 
7.4 would yield a percent ionisation of 99.95 % (ACD/I-Lab). Deviations from the buffer pH for the 
remaining compounds for which Kp values were abstracted from the same source were comparable to 
those obtained in this study, thus were deemed more suitable than those published by Miki et al (Miki 
et al., 2015).   
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Two compounds were removed from the data set on the basis of insufficient data for comparison with 
external datasets. A minimum of four data points prior to the receptor solution concentration exceeding 
10 % that of the donor was considered adequate to ensure steady-state conditions were attained, and to 
enable calculation of Kp. In the case of butamben (BAB) and butyl paraben (BP), only two and three 
data points, respectively, were obtained. As such, Kp values for these compounds were not correlated 
with those from literature, whereby sink conditions were reported.  
Table 3.10 Permeability coefficients extracted from literature for lidocaine (LID), ibuprofen (IBU), 
benzoic acid (BA), salicyclic acid (SA), acetylsalicylic acid (ASA), aminopyrine (AMP), caffeine 
(CAF), diclofenac (DF), flurbiprofen (FLP), ketoprofen (KTP), methyl paraben (MP), ethyl paraben 
(EP), propyl paraben (PP) methyl 4-aminobenzoate (MAB), benzocaine (EAB) and risocaine (PAB). 
Compound 
Permeability Coefficient 
( x 10-4 cm min-1) 
Source 
LID 4.209 (Miki et al., 2015) 
IBU 0.560 (Zhang et al., 2012) 
BA 2.940 (Zhang et al., 2012) 
SA 2.301 (Degim et al., 1998) 
ASA 0.085 (Walker et al., 1997) 
AMP 0.198 (Uchida et al., 2015) 
CAF 0.108 (Uchida et al., 2015) 
DF 0.167 (Degim et al., 1998) 
FLP 0.379 (Zhang et al., 2012) 
KTP 1.17 (Zhang et al., 2012) 
MP 1.49 (Uchida et al., 2015) 
EP 2.32 (Uchida et al., 2015) 
PP 2.18 (Uchida et al., 2015) 
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Table 3.10 continued. 
Compound 
Permeability Coefficient 
( x 10-4 cm min-1) 
Source 
MAB 11.0 (Uchida et al., 2015) 
EAB 12.1 (Uchida et al., 2015) 
PAB 13.4 (Uchida et al., 2015) 
 
Bivariate correlation analysis and simple linear regression was performed in order to evaluate the 
extent of correlation between Kphunan and Kpnative, and Kphuman and Kpplasma. Pearson’s correlation 
coefficient revealed a large effect size and a statistically significant correlation between Kphuman and 
Kpnative  (r = 0.869, p = < 0.001, [0.621, 0.988])  (Figure 3.15). 
Figure 3.15 Plot of permeability coefficients through native PDMS (Kpnative) versus human skin 
(Kphuman) (R2 = 0.75, n = 16). 
  
Human Skin Permeability Coefficient (Kphuman)  
(x 10-4 cm min-1) 
N
at
iv
e 
P
D
M
S
 P
er
m
ea
b
il
it
y
 C
o
ef
fi
ci
en
t 
(K
p
n
at
iv
e )
 
 (
x
 1
0
-4
 c
m
 m
in
-1
) 
  
The Effect of Air Plasma Treatment on the Permeation of Pharmaceutical Compounds through 
Poly(dimethylsiloxane) 
 
93 
 
Bivariate correlation analysis was also performed in order to evaluate the extent of correlation between 
Kphunan and Kpnative for values of Kphuman whereby no correlation was expected, serving as a negative 
control. For example, values of Kphuman for FLP, KTP, and BA taken from Zhang et al. were substituted 
for values reported by other authors (Miki et al in the case of FLP and KTP, and Degim et al in the 
case of BA) whereby the pH of the donor solution differed significantly from that observed for Kpnative, 
or no control of the pH was reported i.e. an aqueous solution was used. Further, the value of Kphuman 
corresponding to LID reported by Miki et al. was substituted with that from Uchida et al. whereby the 
hydrochloride salt was used. Expectedly, Pearson’s correlation coefficient revealed no statistically 
significant correlation between Kphuman and Kpnative  (r = -0.030,  p = < 0.912, -[0.316, 0.914]). 
An increase in correlation was observed between permeability coefficients obtained using human skin, 
and the synthetic skin mimic, following plasma treatment (r = 0.925, p = < 0.001, [0.750, 0.990], 
indicating an increase in predictive capability of the skin mimic (Figure 3.16). 
Figure 3.16 Plot of permeability coefficients through plasma treated PDMS (Kpplasma) versus human 
skin (Kphuman) (R2 = 0.86, n = 16). 
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Bivariate correlation analysis was also performed in order to compare physicochemical properties 
which may influence permeation through both synthetic systems and human skin. A statistically 
significant relationship was observed between Kpnative and log10 D (r = 0.553, p = 0.026, [0.226, 0.794]), 
and Kpnative and percent ionisation (r = -0.550, p = 0.027, [-0.862, -0.191]). Similar relationships were 
observed between Kpplasma and percent ionisation (r = -0.549, p = 0.027, [-0.797, -0.283]), and Kpplasma 
and log10 D (r = 0.486, p = 0.056, [0.156, 0.813], the latter of which was marginally insignificant at 
the α = 0.05 level. The negative value of Pearson’s correlation coefficient with regards to the 
relationship between permeation through both synthetic systems and the extent of ionisation indicates 
the negative effect of ionisation on permeation through the two synthetic substitutes, and has been 
shown previously (Waters et al., 2016). A similar relationship was observed between Kphuman and 
percent ionisation, however, was insignificant at the α = 0.05 level (r = -0.415, p = 0.110, [-0.885, 
0.302]). The limited correlation may indicate greater sensitivity of silicone based skin mimics to 
ionisation compared with human skin, as a result of the presence of more continuous hydrophilic routes 
through the stratum corneum, such as the polar head groups of the stratum corneum intercellular lipid 
lamellae. Conversely, it may indicate that the percent ionisation values presented in Table 3.9 are a 
poorer representation of the extent of ionisation observed in literature studies employing human skin 
tissue. The percent ionisation values were corrected for compounds which the authors noted significant 
deviations in donor solution pH, and no increase in correlation was observed (r = -0.406, p = 0.118, [-
0.847, 0.254]), supporting the hypothesis that silicone membranes are more sensitive to permeant 
ionisation. A similar dependence of the permeability coefficient on log10 D was observed with data 
obtained using human skin (r = 0.518, p = 0.040, [0.121, 0.765]). Correction of log10 D for reported 
pH values yielded a similar relationship (r = 0.518, p = 0.040, [-0.008, 0.831]).  
Statistically significant correlations between Kp and HBbasic were observed for native PDMS (r = -
0.568, p = 0.022, [-0.832, -0.278]) and plasma treated PDMS (r = -0.553, p = 0.026, [-0.755, -0.351]). 
No statistically significant correlations were observed between Kp and HBacid for native PDMS (r = 
0.244, p = 0.363, [-0.148, 0.702]), or plasma treated PDMS (r = 0.215, p = 0.425, [-0.220, 0.845]). 
Values for HBacid and HBbasic were corrected for any changes in the macrospecies present based on the 
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reported donor solution pH i.e. for LID and BA, the values were substituted for those for the ionised 
and neutral species, respectively, from Zhang et al.(Zhang et al., 2017). No statistically significant 
correlations were observed between Kp and HBbasic (r = -0.419, p = 0.106, [-0.695, 0.006]) or HBacid (r 
= 0.388, p = 0.137, [-0.140, 0.727]), in the case of human skin.  
Two homologous series’ were included in the dataset presented in this work, analogous to other studies 
aiming to quantify the effect of various physicochemical properties of permeation through human skin 
and alternative models (Baba et al., 2017; Du Plessis et al., 2002b; Uchida et al., 2015). The inclusion 
of homologous series provides a useful method of observing the effects of parameters such as log10 P 
and molecular weight, on skin permeation, in the absence of more complex interactions arising from 
the inclusion of alternative functional groups, such as hydrogen bond acidity and basicity. In this work, 
this was performed using two series of alkyl benzoate based compounds. In general, the permeability 
coefficients of alkyl 4-aminobenzoates through native PDMS were greater than alkyl 4-
hydroxybenzoates. A similar relationship was observed in human skin, and is represented graphically 
in Figure 3.17. 
Figure 3.17 Permeability coefficients of alkyl 4-amino- and 4-hydroxy- benzoates as a function of 
carbon chain length.  
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The permeability coefficients of compounds through native PDMS increased with increases in carbon 
chain length, within each series. Increasing carbon chain length represents an increase in log10 P and 
molecular weight. Increases in log10 P are known to be concomitant with increases in the permeability 
coefficient, and increases in molecular weight, or molecular volume, are known to contribute 
negatively to the permeability coefficient, described in pioneering work by Potts and Guy (Potts et al., 
1992). In this work, decreases in Kp, as a result of increases in molecular volume, appear to be largely 
offset by increases in log10 P. This is also represented mathematically in the Potts and Guy model by 
the varying magnitude of the coefficients associated with each parameter i.e. 0.71 for log10 KO/W, and -
0.0061 for molecular weight (Potts et al., 1992). The magnitude of the increase in Kp associated with 
the extension of the carbon chain length appears to be larger at longer chain lengths, particularly with 
regards to permeation through PDMS. This effect is particularly evident between a chain length of 
three and four carbons in the alkyl 4-aminobenzoate series. It must also be considered that a loss of 
sink conditions in the experiment employing butyl 4-aminobenzoate may have resulted in boundary 
layer control and an underestimation of Kp. It is, therefore, plausible that this effect is more prominent 
than that displayed in Figure 3.17. This effect is somewhat unsurprising, given the lack of hydrophilic 
domains within the native PDMS structure, in contrast to the stratum corneum, noted previously by 
Cronin et al. Interestingly, the author notes that polymeric systems containing ‘alternating hydrophobic 
and hydrophilic layers’ may provide skin mimics of greater mechanistic relevance (Cronin et al., 1998).   
In any case, a similar relationship has been observed previously with the permeation of alkyl 4-
aminobenzoates through silicone membranes by Addicks et al. (Addicks et al., 1987). 
The permeability coefficients of compounds from both series displayed similar trends through plasma 
treated PDMS, and are represented graphically in Figure 3.18. As previously, alkyl 4-aminobenzoates 
show greater permeability coefficients than alkyl 4-hydroxybenzoates, and the permeability coefficient 
increases with increasing chain length.  
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The effect of plasma treatment on the permeation of alkyl benzoate based compounds appears to be 
somewhat variable. The mean percent reduction in Kp following plasma treatment in the case of methyl 
4-hydroxybenzoate (MP), ethyl 4-hydroxybenzoate (EP), methyl 4-aminobenzoate (MAB) and butyl 
4-aminobenzoate (BAB) were similar, with values of 19.66 %, 18.48 %, 23.73 %, and 18.83 %, 
respectively. The mean percent reduction in Kp with respect to butyl 4-hydroxybenzoate (BP) was 
marginally lower, displaying a value of 14.42 %. The greatest mean percent reduction was observed 
with propyl 4-hydroxybenzoate, with a value of 33.63 %. No statistically significant reductions were 
observed in the case of ethyl 4-aminobenzoate and propyl 4-aminobenzoate (Table 3.6).  Despite the 
variable degree of reduction in Kp observed, all eight compounds display similar values of PSA, shown 
previously to correlate well with the extent of reduction in value of Kp (Figure 3.14).  Limited 
correlation with other physicochemical parameters found previously, which vary within the 
homologous series, such as MW, HBacid, HBbasic and log10 P, may indicate the source of variability is 
the plasma process. For example, alterations in the composition of the process gas in the case of air 
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plasma, such as increases or decreases in the amount of water vapour present, may limit the 
reproducibility of the PDMS surfaces obtained (Chau et al., 2011).  It is therefore, a logical progression 
of the work presented in this thesis to evaluate the effect of administering greater control of the 
composition of the plasma process gas by use of well-defined process gases, such as those provided by 
commercially obtained cylinders.  
3.3. Conclusions 
Despite the multitude of advantages associated with the replacement of biological tissue with silicone 
based skin mimics in in vitro permeation studies, such as limited ethical criticism, legal status, 
heightened availability, greater reproducibility, and the consequent ease of data deconvolution, the 
overestimation in percutaneous absorption observed with such systems continues to be a drawback. 
Therefore, a major aim of the work presented in this chapter was to determine a suitable method of 
chemically modifying the structure of PDMS, in order to reduce the permeation of pharmaceutical 
compounds, and subsequently reduce, or eliminate, overestimations of percutaneous absorption.  
Statistically significant reductions in the steady-state flux, Jss, of fourteen pharmaceutical compounds 
were observed, for thirteen of which overestimations in percutaneous adsorption had been observed 
upon comparison with suitable data from literature. No statistically significant increases in permeation 
were observed following plasma treatment, deeming the method compatible with permeation studies. 
Further, the work endeavoured to produce a mechanistically substantiated model of the stratum 
corneum, based on the heteropolar structure of the intercellular lipid lamellae and surrounding 
corneocytes. Physical and chemical characterisation, using water contact angle analysis, X-ray 
photoelectron spectroscopy, attenuated total reflectance-Fourier transform infrared spectroscopy, and 
scanning electron microscopy was performed in order to confirm the presence of polar, silanol species 
into the overall apolar structure of the PDMS bulk. Thus, the resultant membrane may provide a more 
tortuous barrier to permeation, analogous to the stratum corneum. 
Bivariate correlation analysis was performed in order to evaluate the predicting capability of both the 
native and modified PDMS skin mimic. A library of ex vivo human skin permeability data was collated 
from literature, and refined according to the reported experimental procedure. An increase in 
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correlation was observed between permeability coefficients extracted from literature (Kphuman), and 
experimentally determined permeability coefficients using the plasma modified membrane (Kpplasma) 
(R2 = 0.86), compared with the native PDMS membrane (R2 = 0.75). Various physicochemical 
properties of the compounds in the data set were considered, and it was found that the percent reduction 
in Kp observed was heavily influenced by polar surface area (PSA) (r = -0.652, p = 0.003 [-0.847, -
0.374]).  
Furthermore, the compatibility of the plasma modification method used in this work with permeation 
studies, and the increased chemical reactivity of plasma treated PDMS, renders the work an appropriate 
platform for the production of more biorelevant surfaces via subsequent wet chemical methods. 
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Chapter 4 The Effect of Nitrogen Plasma Treatment on the 
Permeation of Pharmaceutical Compounds through 
Poly(dimethylsiloxane)  
4.1. Introduction 
The suitability of poly(dimethylsiloxane) (PDMS) substrates in cell culture applications and tissue 
engineering has generated significant interest in plasma technologies and modification, with benefits 
ranging from increased cell adhesion, to controlled differentiation in three-dimensional tissues. 
Nitrogen-containing plasmas are of particular interest to such studies, providing a simple route to 
aminated surfaces which previously may display poor reactivity to biomolecules. The use of nitrogen-
containing plasmas simultaneously allows for the introduction of functional groups typical of proteins 
(Salerno et al., 2009), along with groups suitable for covalent coupling with peptides, or extracellular 
matrix proteins such as collagen, resulting in a more accurate representation of the micro-environment 
in vivo (Xu et al., 2011). 
Work by Yang et al. used an N2 plasma treatment to enhance the reactivity of PDMS towards an epoxy 
group-containing photoresist for use in microfluidic channels. The group confirmed successful PDMS 
amination using ATR-FTIR and X-ray photoelectron spectroscopy (XPS). A peak at 399.7 eV in the 
high resolution N 1s XPS spectrum of N2 plasma treated PDMS was attributed to surface amine 
functionalities. A peak at 286.4 eV in the high resolution C 1s spectra, along with a signal at 1100 – 
1040 cm-1 in the ATR-FTIR spectrum, led the group to conclude that amine functionalisation had 
occurred at carbon atoms in the polysiloxane structure (Yang et al., 2016). Williams et al. performed 
similar work, aiming to control the thrombogenicity of PDMS-based medical devices. The authors 
compared the surface chemistry of medical grade PDMS following plasma treatments performed using 
O2, Ar, N2, and NH3 process gases. Regarding both the N2 and NH3 plasma treatments, four new binding 
energies were observed in the C 1s spectra compared with the untreated polymer, indicating the 
presence of similar surface functionalities. In both cases, the signal consisting of the greatest atomic 
percent was that at a binding energy of 286 eV, which the authors assigned as either primary, or 
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secondary, amine groups. Of interest to this project, the group stored the membranes in phosphate 
buffered saline for one month and noted the presence of all four binding energies observed previously, 
with around three-quarters of the surface amine groups still present (Williams et al., 2004). 
Nitrogen containing plasmas are of particular interest to this project, since such processes are known 
to introduce amine groups, which are highly abundant in the stratum corneum proteinaceous 
environment, and may provide suitable sites for the covalent coupling of biomolecules.  In the previous 
chapter, the introduction of primarily silanol groups to the surface of PDMS via an air plasma treatment 
was found to reduce the permeation of pharmaceutical compounds. Upon the employment of the 
resultant membrane as a skin mimic in permeation studies, an increase correlation with a self-collated 
library of literature permeability coefficients obtained using excised human skin was observed. In this 
chapter, similar plasma treatments using an N2 process gas have been performed in order to observe 
the effect of N2 plasma treatments on the permeation of pharmaceutical compounds.  
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4.2. Results and Discussion 
4.2.1. Membrane Characterisation 
4.2.1.1.  Attenuated Total Reflectance-Fourier Transform Infrared Spectrocopy (ATR-FTIR) 
ATR-FTIR analysis was performed, in order to confirm the surface chemical composition of PDMS 
following N2 plasma treatment, and permit comparison with both native PDMS, and PDMS following 
air plasma treatment. Data corresponding to N2 plasma treated PDMS is presented in Table 4.1, along 
with data corresponding to native PDMS, as presented previously (Table 3.2).  
Table 4.1 ATR-FTIR of native PDMS and PDMS following N2 plasma treatment. 
Assignment 
νmax (cm-1) 
Native PDMS N2 plasma treated PDMS 
νs(CH3) 2962.3 2962.1 
δas(CH3) 1412.6 1412.4 
δs(CH3) 1258.2 1258.2 
Si-O-Si 1006.3 1005.7 
O-SiCH3 786.2 785.1 
C-SiCH3 701.4 701.2 
 
The presence of surface methyl groups is confirmed by a symmetrical stretching vibration of the CH3 
group at 2962.1 cm-1, and the asymmetric and symmetric deformation of the CH3 group at 1412.4 and 
1258.2 cm-1, respectively. The Si-O-Si stretching vibration is observed at 1005.7 cm-1, along with 
absorptions at 785.1 and 701.2 cm-1, confirming the presence of the O-SiCH3 and C-SiCH3 groups, 
respectively.  As found previously, no additional adsorptions were observed associated with the surface 
functionalisation of PDMS, thus, the data was further supplemented with that obtained using X-ray 
photoelectron spectroscopy. 
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4.2.1.2.  X-ray Photoelectron Spectroscopy (XPS) 
As discussed previously (Section 3.2.1.3), quantitative elemental composition of the PDMS surface 
pre- and post-modification was determined using XPS survey scans (Figure 4.1). The O 1s, C 1s, Si 
2p, and N 1s orbitals were identified at binding energies circa 530 eV, 282 eV, 100 eV, and 399 eV, 
respectively, with data subsequently presented in the form of atomic percent (%) (Table 4.2). Data 
corresponding to native and air plasma treated PDMS, determined previously (Table 3.3), is also 
summarised in Table 4.2 to enable facile comparison with previous data. 
 
Figure 4.1 XPS survey scan of N2 plasma treated PDMS. 
Table 4.2 Atomic percent (%) of oxygen, nitrogen, carbon, and silicon at the surface of native, air 
plasma treated, and N2 plasma treated PDMS taken from XPS survey scans. 
Membrane Sample 
Atomic percent (%) 
O N C Si 
Native PDMS 
1 23.17 < 0.1 47.83 29.00 
2 22.79 < 0.1 48.92 28.28 
  
CasaXP S (Thi s st ring can be edit ed in CasaXPS.DEF/P rintFootNote.txt)
Survey/5
Name
O1s
N1s
Ca2p
C1s
Si2p
Pos.
530.50
397.00
345.00
282.50
101.00
FWHM
2.54
3.63
2.17
2.34
2.81
Area
199.55
2.51
2.61
46.97
43.22
At%
44.20
0.83
0.31
26.21
28.45
5
10
15
20
25
30
35
40
45
50
C
P
S
 x
 1
0
-4
1200 900 600 300 0
Binding Energy (eV)
  
The Effect of Nitrogen Plasma Treatment on the Permeation of Pharmaceutical Compounds through 
Poly(dimethylsiloxane) 
 
107 
 
Table 4.2 continued. 
Membrane Sample 
Atomic percent (%) 
O N C Si 
Air plasma treated PDMS 
1 
44.80 0.56 23.22 31.42 
2 
44.11 0.61 24.49 30.79 
Nitrogen plasma treated 
PDMS 
1 
44.49 0.87 25.86 28.44 
2 
44.20 0.83 26.21 28.45 
 
A decrease in the atomic percent of carbon, from 47.83 – 48.92 % in native PDMS to 25.86 – 26.21 % 
following N2 plasma treatment, is consistent with the nature of plasma treatments and findings 
published in other work (Williams et al., 2004). Unexpectedly, this was accompanied by a considerable 
increase in atomic percent of oxygen, from 22.79 – 23.17 % in native PDMS, to 44.11 – 44.80 % in N2 
treated PDMS, and is similar to that observed following air plasma treatment (44.20 – 44.49 %). A 
small increase in atomic percent of nitrogen present following N2 plasma treatment (0.83 – 0.87 %) 
was observed, in comparison to that observed following air plasma treatment (0.56 – 0.61 %) (Table 
4.2).  
High resolution XPS spectra of the C 1s, N 1s, and Si 2p orbitals were also obtained and are presented 
in Figure 4.2, Figure 4.3, and Figure 4.4, respectively. Three signals were identified in the high 
resolution XPS spectrum on the C 1s orbital in N2 plasma treated PDMS (Figure 4.2), at binding 
energies of 285.00 eV, 286.62 eV, and 288.43 eV, comparable to those obtained following air plasma 
modification of PDMS (Figure 3.7).  As found previously, the signal at 285.00 corresponds to that of 
C-H bonds, and the signal at 288.43 corresponds to carbonyl containing units, i.e. C=O or O-C=O 
(Vesel et al., 2008; Yang et al., 2016). Literature reports the binding energy of the C-N group to occur 
in the range of 285.5-286.4 eV (Vesel et al., 2008; Yang et al., 2016), close to the binding energy 
observed at 286.62 eV in this work. On the basis that multiple authors have observed the formation of 
primary amine groups at the surface of PDMS following N2 plasma treatments, the signal at this binding 
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energy may be attributed to the formation of primary amines (Williams et al., 2004). The binding 
energies of C-O and C=N groups are reported to be markedly similar, at 285.5 eV, and 285.5 eV-286.6 
eV (Vesel et al., 2008; Yang et al., 2016), respectively, and may suggest that the signals associated 
with these functionalities are unresolvable, particularly since nitrogen-containing groups represent, at 
most, 0.87 % of groups at the surface  in this instance.   
 
Figure 4.2 High resolution XPS spectrum of the C 1s orbital in N2 plasma treated PDMS. 
 
Only one signal was observed in the high resolution XPS spectrum of the N 1s orbital in N2 plasma 
treated PDMS (Figure 4.3), similar to spectra of the N 1s orbital obtained following air plasma 
treatment (Figure 3.9). The signal was observed at a lower binding energy of 400.23 eV, compared 
with a binding energy of 400.79 eV observed following air plasma treatment. A reduction in binding 
energy may suggest the presence of fewer electron-withdrawing groups, such as oxygen, attached at 
the neighbouring carbon atom, and is consistent with the presence of amine groups at the surface as 
opposed to amide groups, on par with observations made in other work (Williams et al., 2004).  
The oxidative nature of N2 plasma treatments was somewhat unanticipated given the known 
composition of the process gas i.e. 99.998 % N2 (oxygen free), and numerous reports of N2 plasmas 
resulting in the formation of PDMS surfaces displaying amine group functionality (Vesel et al., 2008; 
Williams et al., 2004; Yang et al., 2016). Other authors note the occurrence of surface oxidation during 
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N2 plasma treatment, and attribute this to the presence of residual air and/or H2O in the plasma chamber, 
or oxygen entrapped within the polymer (Egitto et al., 2006; Owen et al., 1994). The findings in this 
work appear to match those by Owen et al. whom observed a surface atomic percent of oxygen of 48.7 
% following the radiofrequency N2 plasma treatment of PDMS (Owen et al., 1994).   
 
Figure 4.3 High resolution XPS spectum of the N 1s orbital in N2 plasma treated PDMS. 
Four signals were identified in the high resolution XPS spectrum of the Si 2p orbital in N2 plasma 
treated PDMS (Figure 4.4), at binding energies of 102.34 eV, 102.97 eV, 103.61 eV, and 104.24 eV. 
Based on the observed oxidative nature of the N2 plasma treatment performed in this work, the presence 
of two emissions at 103.61 eV and 104.24 eV, with a peak area ratio of 0.5, is unsurprising, and is 
indicative of the presence of quaternary (Q) siloxane units, in line with previous observations (Figure 
3.5).  
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Figure 4.4 High resolution XPS spectrum of the Si 2p orbital in N2 plasma treated PDMS. 
4.2.1.3. Scanning Electron Microscopy 
Scanning electron microscopy images of PDMS post-N2 plasma treatment (Figure 4.5) were collected 
to facilitate the comparison of the surface morphology of PDMS following N2 plasma treatment with 
both native PDMS, and PDMS following air plasma treatment (Figure 3.10). Interestingly, at an N2 
plasma treatment time of 90 seconds, cracking and surface wrinkling is observed to a lesser extent than 
the corresponding treatment employing air plasma. Further, images were collected following three 
exposure times (90, 150 and 300 seconds) in order to evaluate the effect of treatment time on surface 
morphology, and identify any correlation between surface morphology and drug permeation (Figure 
4.5).   
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Figure 4.5 Scanning Electron Microscopy images of PDMS following 90 seconds N2 plasma treatment (A-C, 
500 X, 1000 X and 1500 X magnification, respectively) and 150 seconds N2 plasma treatment (D-F, 500 X, 
1000 X and 1500 X magnification respectively). 
A 
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Changes in the morphological properties of the polymer are particularly evident at an N2 plasma 
treatment time of 300 seconds (Figure 4.6). The polymer surface appears distinctly cracked and 
wrinkled, in contrast to the surface at the previous treatment times (Figure 4.5). Based on data obtained 
previously using X-ray photoelectron spectroscopy (Section 4.2.1.2.), this may be attributed to brittle 
SiOx layer formation, and increased mechanical strain between the surface and the bulk (Cordeiro et 
al., 2009; Lee et al., 2017; Nania et al., 2015). 
 
Figure 4.6 Scanning Electron Microscopy images of PDMS following 300 seconds N2 plasma 
treatment at 500 X (A), 1000 X (B) and 1500 X (C) magnification. 
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4.2.2. Permeation study 
4.2.2.1. Treatment time determination 
Previous work (Chapter Three) demonstrated the potential of air plasma treatments to reduce the 
permeation of pharmaceutical compounds through PDMS, a frequently employed skin mimic with 
which over-estimations of percutaneous absorption are often observed. However, overestimations in 
the permeability coefficient were still observed following air plasma treatment; thus, alternative plasma 
treatments, which may offer the potential to reduce permeation further, and simultaneously introduce 
biorelevant sites, are of considerable interest to this work. Work by Nania et al., investigating the effect 
of various experimental parameters on surface wrinkling of glass-elastomer bilayers formed following 
exposure of PDMS to plasma, found that a plasma process gas consisting of an equimolar mixture of 
nitrogen and oxygen resulted in slower hydrophilic ‘glassy layer’ formation, in comparison to that 
obtained using solely oxygen. The authors attributed this to a reduction in kinetics of the surface 
oxidation reaction, since the concentration of the ‘active species’ was considerably reduced following 
N2 introduction (Nania et al., 2015). Such findings suggest that changes in process gas composition 
may result in a necessity for various plasma treatment times for purposes related to those presented in 
this thesis.  
Initial comparisons between N2 and air plasma treated PDMS were performed employing two 
compounds from the previous compound library, namely lidocaine and caffeine (Table 4.3). The 
former previously displayed a 36.36 % reduction in Kp following plasma treatment, and a 5.5 fold over-
estimation in Kp based on comparison with suitable literature data i.e. Kpplasma/Kphuman. The latter 
displayed no reduction in permeation upon air plasma pre-treatment, and a ratio of 0.95 was observed 
between Kphuman and Kpplasma. 
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Table 4.3 Steady state flux (Jss) of lidocaine (LID) and caffeine (CAF) through N2 plasma treated 
PDMS, at various treatment times. 
Compound Process gas 
Plasma treatment 
time (seconds) 
Jss (µg cm-2 min-1) 
LID 
N/A 0 13.34 ± 0.64 
Air 90 8.487 ± 0.456  
N2 90 10.81 ± 0.56 
N2 150 5.488 ± 1.034 
N2 210 6.172 ± 1.359 
N2 300 11.35 ± 1.61 
CAF 
N/A 0 0.1908 ± 0.0107 
Air 90 0.2215 ± 0.0300 
N2 90 0.2023 ± 0.0294 
N2 150 0.1774 ± 0.0143 
 
A statistically significant difference in the steady state flux (Jss) of lidocaine through PDMS following 
N2 and air plasma treatment was observed (t(4) = -5.573, p = 0.005) (Figure 4.7).  The permeation of 
LID through PDMS appeared to be affected to a lesser extent by an N2 plasma pre-treatment, in 
comparison to an air plasma pre-treatment i.e. Jss values of 10.81 ± 0.56 µg cm-2 min-1 and 8.487 ± 
0.456 µg cm-2 min-1, respectively, were obtained. Since a 5.5 fold overestimation in the permeability 
coefficient of LID was observed previously upon comparison with literature data obtained using 
epidermal tissue, a major objective of the work presented in this chapter was to further reduce the 
permeation of pharmaceutical compounds. Thus, the effect of extended N2 plasma treatment times were 
also investigated (Table 4.3). 
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Figure 4.7 Permeation of lidocaine (LID) through native PDMS,and PDMS following a 90 second air 
and N2 plasma treatment (mean ± standard deviation, n = 3). 
Statistically significant differences in steady state flux (Jss) were observed following alterations in the 
treatment time (F(3,8) = 19.21, p = 0.001).  An increase in N2 plasma treatment time, from 90 to 150 
seconds, resulted in a statistically significant reduction in Jss, from 10.81 ± 0.56 µg cm-2 min-1 to 5.49 
± 1.03 µg cm-2 min-1 (p = 0.003). A further 60 second extension in treatment time to 210 seconds 
resulted in no statistically significant difference in Jss from the previous treatment time i.e. 150 seconds 
(p = 0.898). A further increase in N2 plasma treatment time to 300 seconds resulted in a statistically 
significant increase compared with the previous treatment time, i.e. from 6.17 ± 1.36 µg cm-2 min-1 to 
11.35 ± 1.61 µg cm-2 min-1 (p = 0.003). There was no statistically significant difference in the Jss of 
LID through PDMS following a 300 second N2 plasma treatment, compared with that obtained 
following a 90 second N2 plasma treatment (p = 0.944). 
Permeation data correlate well with the findings of scanning electron microscopy analysis (Figure 4.5 
and Figure 4.6); statistically significant decreases in permeation were observed at intermediate 
treatment times i.e. 90 and 150 seconds, followed by increases in permeation at extended treatment 
times i.e. 300 seconds, consistent with a decrease in integrity of the membrane. These findings are also 
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consistent with findings in previous work regarding SiOx layer formation. Smith et al. noted that the 
uppermost surface of PDMS is subject to the greatest plasma exposure, resulting in a superficial silica-
like layer, which provides protection to the underlying substrate. This superficial protective layer 
results in only a finite modified-layer thickness being achievable, hypothesised to be in the range of 8-
10 nm (Owen et al., 1994). Longer treatment times have also being reported to be accompanied by 
increased cracking, as seen in Figure 4.6 (Juárez-Moreno et al., 2015). Applying these observations to 
the data presented in Table 4.3, it would appear that maximum layer thickness occurs between an N2 
plasma treatment time of 90 and 150 seconds, above which the effect of crack formation on the 
permeation of pharmaceutical compounds supersedes that of hydrophilic layer formation. These 
findings correlate well with data presented previously with a different permeant, namely ibuprofen 
(Table 3.4). Thus, a treatment time of 150 seconds was selected as the most appropriate for this work, 
above which, the permeation of pharmaceutical compounds may become controlled by structural 
damage to the membrane.  
The effect of a 150 second N2 plasma treatment on the permeation of another pharmaceutical 
compound, namely caffeine, was also investigated (Table 4.3). Interestingly, caffeine displays no 
statistically significant differences in Jss, regardless of the duration of plasma treatment (F(2,6) = 1.191, 
p = 0.084). Considering this observation in the context of the plasma modification process, it may be 
taken that the permeation of caffeine is unhindered by hydrophilic layer introduction, independent of 
the hydrophilic layer thickness i.e. the permeation of caffeine is controlled by permeation through the 
underlying hydrophobic bulk substrate. Similar results were also obtained previously following air 
plasma treatment (Table 3.8). In order to further understand these findings, along with the effect of 
further physicochemical properties on the permeation of pharmaceutical compounds, permeation 
studies employing a wider range of penetrants should be performed. 
4.2.2.2. Permeability Coefficient (Kp) Determination 
Permeation experiments were performed on a subset of pharmaceutical compounds employed 
previously. The body of compounds displayed a MW range 121.12 – 234.34 g mol-1, a log10 P range of 
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-0.13 – 3.63, a log10 D range of 0.11 – 3.18, and represented both anionic and cationic charge states. 
The percentage reduction in Kp observed previously, following the air plasma treatment of PDMS, was 
found to correlate well with the polar surface area (PSA) of the penetrant (r = -0.652, p = 0.003 [-
0.847, -0.374]). The percentage reduction in Kp appeared variable for each compound within two 
homologous series’, namely alkyl 4-aminobenzoates and alkyl 4-hydroxybenzoates. It was 
hypothesised that, since the PSA of each compound within each series was similar, this variability may 
be attributed to limited control of the chemical composition of the process gas. Thus, the two 
homologous series’ were included in the body of compounds used for this work. 
It was noted in previous work that the maintenance of sink conditions in the static cell was problematic 
(Table 3.7), in particular for high log10 P and log10 D compounds, for which flux through the lipophilic 
membrane is high, but solubility in aqueous receptor fluids is low. Thus, the static Franz cell type 
system was substituted for a flow-through type system (Figure 2.1). This would also circumvent the 
need for solubility enhancers, such as surfactants, which have been shown to influence permeation 
through silicone membranes (Bhuiyan et al., 2017; Waters et al., 2013), and may introduce artefacts 
to the data.  
Preliminary temperature measurements found the temperature distributions throughout the two cell 
types to vary. It was found that, with the glass, non-jacketed Franz type cells, a water bath temperature 
of 32.9 ± 0.1 °C maintained a membrane temperature of 31.7 ± 0.4 °C, in line with the 
recommendations made by OECD Guideline 428 (32 ± 1 °C). In order to maintain a comparable 
membrane temperature in the flow-through type system (31.5 ± 0.2 °C), a water circulating temperature 
of 35.1 ± 0.5 °C, and a temperature of 34.1 ± 0.1 °C at the point of contact between the cell and the 
heater block was required.  
Further, temperature measurements were performed across the donor chambers. The donor chamber 
temperature varied by up to 1.6 °C from the closest point in contact with the membrane to the furthest 
in the Franz cell, i.e. the height of the donor solution in the chamber, and by 2.4 °C in the flow through 
type system. For this reason, permeation experiments through native PDMS were repeated not only for 
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compounds shown to yield receptor chamber concentrations ≥ 10 % (Table 3.7), but for all compounds 
chosen in this study.  Subsequently, comparisons between native and plasma treated PDMS were only 
performed between data gathered on the same cell system. An international study using quasi-
standardised methods, aiming to identify sources of variation in diffusion cell studies, found a fourfold 
difference in the average flux of methyl paraben through silicone membrane between laboratories. The 
study also identified statistically significant differences in flux values obtained using static and flow-
through cells (α = 0.05). The authors noted that these differences could be attributed to differences in 
the precise membrane temperature, despite general control of the diffusion cell temperature (Chilcott 
et al., 2005). The effect of variation in temperature regulation protocols is demonstrated in Figure 4.8, 
using two pharmaceutical compounds, namely risocaine (PAB) and butyl paraben (BP). ‘Temperature 
unregulated’ refers to the scenario in which the circulating water bath temperature was maintained at 
32.0 °C, i.e. general control of the diffusion cell temperature. ‘Temperature regulated’ refers to the 
scenario in which the membrane temperature was measured using a thermocouple, and the circulating 
water bath temperature was adjusted accordingly to obtain a suitable precise membrane temperature 
i.e. 31.5 ± 0.2 °C.  
 
Figure 4.8 Effect of temperature on the permeation of butyl paraben (BP) and risocaine (PAB) 
through native PDMS.  
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Statistically significant differences in steady state flux (Jss) were obtained for each mode of temperature 
regulation in the case of both risocaine (t(4) = -37.28, p = < 0.001), and butyl paraben (t(4) = -21.11, p 
= < 0.001) i.e. values of Jss were significantly lower when the circulating water temperature was 32 °C, 
in comparison to 35 °C. The data reaffirms remarks made by other authors, advising that data 
comparisons should preferentially be performed using smaller, more standardised bodies of permeation 
data, since the diffusion cell types, dimensions, and  subsequently, temperature distributions, are 
known to vary (Ng et al., 2010; Provin et al., 2015; Sinkó et al., 2012). Values of steady state flux (Jss), 
along with permeability coefficients (Kp) were obtained for a further nine compounds, employing a 
water circulating temperature of 35 °C, and are presented in Table 4.4.  
Table 4.4 Steady state flux (Jss) and permeability coefficient (Kp) of methyl paraben (MP), ethyl 
paraben (EP), propyl paraben (PP), butyl paraben (BP), methyl 4-aminobenzoate (MAB), benzocaine 
(EAB), risocaine (PAB), butamben (BAB), lidocaine (LID), caffeine (CAF) and benzoic acid (BA) 
through native and N2 plasma treated PDMS (mean ± standard deviation, 4 sig.fig., n = 3). 
Compound 
Jss (μg cm-2 min-1) Kp ( x 10-4 cm min-1) 
Native N2 Plasma Native N2 Plasma 
MP 1.355 ± 0.080 0.7565 ± 0.0143 4.646 ± 0.395 2.593 ± 0.290 
EP 1.648 ± 0.033 1.097 ± 0.094 13.49 ± 0.82 8.978 ± 0.849 
PP 1.560 ± 0.054 1.131 ± 0.079 31.25 ± 1.03 22.65 ± 1.40 
BP 1.603 ± 0.015 1.238 ± 0.235 52.34 ± 0.43 40.43 ± 6.64 
MAB 4.585 ± 0.126 4.326 ± 0.028 22.21 ± 0.99 20.95 ± 0.79 
EAB 5.088 ± 0.074 2.462 ± 0.161 42.12 ± 2.81 20.38 ± 1.77 
PAB 3.439 ± 0.037 2.280 ± 0.139 56.64 ± 1.25 37.56 ± 2.12 
BAB 1.819 ± 0.052 0.8424 ± 0.1190 101.9 ± 3.7 84.24 ± 0.12 
LID 16.40 ± 0.42 6.271 ± 0.237 41.75 ± 1.05 15.93 ± 0.54 
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Table 4.4 continued. 
Compound 
Jss (μg cm-2 min-1) Kp ( x 10-4 cm min-1) 
Native N2 Plasma Native N2 Plasma 
CAF 0.2022 ± 0.0044 0.1969 ± 0.0122 0.0906 ± 0.0096 0.0882 ± 0.0104 
BA 8.970 ± 0.695 3.879 ± 0.348 10.48 ± 0.71 4.533 ± 0.356 
 
Kp values through native PDMS using the flow-through type system were found to correlate well with 
those obtained previously using the static, Franz type system (Table 3.8) (r = 0.976, p < 0.001, [0.885, 
0.997]).  The percent reduction in the permeability coefficient (Kp) following N2 plasma treatment was 
calculated according to Equation 3.2, and is presented in Table 4.5, along with the percentage reduction 
in Kp following air plasma treatment, obtained previously (Table 3.8).  
Table 4.5 Percent reduction in the permeability coefficient (Kp) of methyl paraben (MP), ethyl 
paraben (EP), propyl paraben (PP), butyl paraben (BP), methyl 4-aminobenzoate (MAB), benzocaine 
(EAB), risocaine (PAB), butamben (BAB), benzoic acid (BA), lidocaine (LID), and caffeine (CAF)  
following air and N2 plasma treatment. 
Compound 
Mean percent Kp reduction 
following N2 plasma treatment 
(%) 
Mean percent Kp reduction 
following air plasma treatment 
(%) 
MP 44.19 19.66 
EP 33.45 18.48 
PP 27.52 33.63 
BP 22.76 14.42 
MAB 5.67 23.73 
EAB 51.61 -3.18 
PAB 33.69 -0.49 
BAB 17.33 18.83 
LID 61.84 36.36 
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Table 4.5 continued 
Compound 
Mean percent Kp reduction 
following N2 plasma treatment 
(%) 
Mean percent Kp reduction 
following air plasma treatment 
(%) 
CAF 2.88 -28.25 
BA 56.75 45.20 
 
Notable increases in the percent reduction in Kp were observed for seven of the eleven compounds i.e 
methyl paraben (MP), ethyl paraben (EP), butyl paraben (BP), benzocaine (EAB), risocaine (PAB), 
lidocaine (LID) and benzoic acid (BA), with two further compounds displaying reductions on par with 
those observed during air plasma treatment i.e. propyl paraben (PP) and butamben (BAB). Although 
an increase in the percent reduction in Kp  for caffeine (CAF) was observed, no statistically significant 
differences in permeation were observed with regards to either air plasma treatment (Table 3.6), or N2 
plasma treatment (F(2,6) = 1.191, p = 0.084). The most notable reduction in Kp was observed with LID 
(Figure 4.9), for which a 61.84 % reduction in Kp was observed, almost twice that observed following 
air plasma treatment.  
 
Figure 4.9 Permeation of lidocaine (LID) through native PDMS, and PDMS following a 150 second 
N2 plasma treatment (mean ± standard deviation, n = 3). 
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The pH of the donor solution was measured for each compound, as previously (Appendix 11), and was 
found to not differ from that obtained in previous work, with respect to each compound. Thus, the 
physicochemical properties of permeants presented in Table 3.9 were considered suitable descriptors 
for correlation analysis. As previously undertaken, bivariate correlation analysis was performed 
between the percent reduction in Kp, and the physicochemical data presented in Table 3.9. The most 
extensive correlation was found between the mean reduction in Kp (%) and polar surface area (PSA). 
Pearson’s correlation coefficient (r = -0.739, p = 0.009, [-0.973, -0.026]) indicated a large effect of 
PSA on the reduction in Kp observed, significant at both the α = 0.05 and α = 0.01 level. Further, 54.6 
% of the variance in the mean reduction in Kp (%) can be accounted for by PSA (R2 = 0.546). These 
results are somewhat unsurprising, given the previous correlation observed between PSA and the 
percent reduction in Kp (r = -0.652, p = 0.003 [-0.847, -0.374]), and the similarities in the surface 
chemical composition of air plasma treated and N2 plasma treated PDMS (Sections 3.2.1 and 4.2.1). 
The correlation observed here indicates a large, negative dependence of the reduction in Kp on the PSA, 
indicating that the permeation of high PSA compounds through PDMS is less effected by an N2 plasma 
pre-treatment in comparison to that of low PSA compounds.   
In contrast to data obtained using an air plasma treatment, a statistically significant bivariate correlation 
was observed between the percent reduction in Kp and percent ionisation (r = 0.630, p = 0.038, [0.047, 
0.873]). The positive correlation coefficient indicates that greater reductions in Kp were observed with 
compounds displaying a greater extent of ionisation. In this dataset, the most extensively ionised 
compounds were lidocaine (LID) and benzoic acid (BA), displaying percent ionisation values of 28.47 
% and 55.73 %, respectively (Table 3.9). Further, the pH values of the saturated suspensions were 8.32, 
and 4.16, respectively (Appendix 11).  Using the Henderson-Hasselbalch equation (Equation 3.1), and 
taking a pKa of 4.0 (Owen et al., 2012), the percent of surface silanol groups ionised was 100 % and 
55.73 %, when the donor solution consisted of LID and BA, respectively. In these scenarios therefore, 
it may be taken that electrostatic interactions i.e. attraction in the case of cationic LID, and repulsion 
in the case of BA, between penetrants and ionogenic groups in the modified PDMS membrane may 
contribute to a reduction in permeation. These observations, however should be considered in the 
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context of research undertaken. Whilst the range in polar surface area (PSA) of the penetrants used for 
this work is very similar to that observed in previous work, i.e. 36 – 64 in the case of  air plasma, and 
37 – 58 in the case of N2 plasma (Table 3.9), the same conclusion cannot be drawn for the extent of 
ionisation. The compounds in the dataset used in this work displayed a percent ionisation of 0 - 55.73 
%, but the range was twice as large in previous work employing air plasma (0 – 99.89 %) (Table 3.9). 
Thus, caution must be exercised when making broad conclusions regarding the effect of ionisation 
using this dataset.   
As previously found, no statistically significant correlations were observed between the percent 
reduction in Kp and molecular weight (r = -0.045, p = 0.895, [-0.050, 0.442]), hydrogen bond donor 
count (r = 0.096, p = 0.779, [-0.059, 0.369]), hydrogen bond acceptor count (r = -0.557, p = 0.075, [-
0.892, -0.283]), hydrogen bond acidity (r = 0.130, p = 0.702, [-0.581, 0.684]), hydrogen bond basicity 
(r = 0.393, p = 0.232, [0.047, 0.873]) log10 D (r = 0.166, p = 0.625, [-0.821, 0.606]), or log10 P (r = 
0.403, p = 0.219, [-0.072, 0.361]). 
4.2.2.3. Comparison with human skin. 
Permeability coefficients (Kp) through native PDMS obtained using the flow through system correlate 
well with human skin permeability coefficients extracted from literature (Table 3.10) (r = 0.711, p = 
0.014, [0.249, 0.995]). The correlation observed is marginally weaker than that observed between Kp 
values obtained using the static, Franz type diffusion cells, and the same body of literature values (r = 
0.780, p = 0.005, [0.413, 0.997]), which was significant at both the α = 0.05 and the α = 0.01 level. 
Varying degrees of correlation between literature permeability data and the data presented herein may 
be attributed to discrepancies in the experimental protocols employed; for example, all authors (Table 
3.10) report the use of Franz type diffusion cells, as opposed to flow through type systems. 
Furthermore, despite all authors reporting an experimental temperature, no authors report a precise 
membrane temperature. Uchida et al., Walker et al. and Zhang et al. report general control of the cell 
temperature by use of a water bath or incubator maintained at 32 °C, in contrast to Degim et al. whom 
report maintaining a receiver chamber temperature of 37 °C, which has been shown in other work to 
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provide a membrane temperature of 32 °C (Akomeah, 2007; Degim et al., 1998; Miki et al., 2015; 
Uchida et al., 2015; Walker et al., 1997; Zhang et al., 2012). Such subjective interpretation of OECD 
Test Guideline 428, which states that the membrane temperature should be maintained at 32 °C, and 
that to achieve this, different cell designs may require different experimental temperatures, may result 
in variable data. This also highlights a typical problem with QSPR models, and one of numerous 
reasons why these models have failed to completely replace in vitro studies. The models are usually 
developed on older, existing databases of permeation data, collated from multiple authors and sources. 
For example, work published by Baba et al. in 2017, aiming to quantify the effects of ionisation on 
skin permeation, used permeability coefficients extracted from 68 sources, published as early as 1973 
(Baba et al., 2017). Whilst studies have found small, standardised sets of in vitro data to correlate well 
with in vivo data (Mohammed et al., 2014), the effect of the use of multiple experimental procedures 
should be considered when analysing data from numerous authors.  
Although the use of N2 plasma treatment resulted in a percentage reduction in Kp either on par with, or 
greater than, that offered by air plasma treatment (Table 4.5), no increase in correlation with human 
skin data was obtained in comparison to that observed with native PDMS (r =  0.691, p = 0.019, [0.325, 
0.995] (Figure 4.10). 
 
 
 
 
 
 
 
 
 
 
Figure 4.10 Plot of permeability coefficients through N2 plasma treated PDMS (Kpplasma) versus 
human skin (Kphuman) (R2 = 0.48, n = 11). 
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4.3. Conclusion  
The surface of PDMS was modified using an N2 plasma treatment, endeavouring to produce a lamellae 
type polymeric structure containing biorelevant functional groups for use in in vitro skin permeation 
studies. Chemical characterisation of the surface following N2 plasma treatment was performed using 
X-ray photoelectron spectroscopy (XPS) and attenuated total reflectance - Fourier transform infrared 
spectroscopy (ATR-FTIR). N2 plasma treatment was found to primarily result in PDMS surface 
oxidation, as opposed to amination reported by other authors (Williams et al., 2004; Yang et al., 2016). 
This was hypothesised to be a consequence of the presence of residual H2O and oxygen present within 
the plasma chamber and polymer, reported in other work (Egitto et al., 2006; Owen et al., 1994).  
The surface morphology of N2 plasma modified PDMS was analysed using scanning electron 
microscopy, the findings of which were observed to correlate well with preliminary permeation studies 
employing lidocaine (LID), and previous data obtained following air plasma treatment. A statistically 
significant reduction in LID permeation was observed following a 90 second N2 plasma treatment, 
analogous to results obtained previously using an air plasma treatment. An extension in treatment time 
to 150 seconds resulted in a further statistically significant reduction in permeation, greater than that 
obtained previously using an air plasma treatment. A 210 second N2 plasma treatment time was found 
to yield an insignificant difference in LID permeation, followed by a statistically significant increase 
in permeation following a 300 second plasma treatment, compared with the previous treatment time, 
owing to extensive surface cracking, observed during scanning electron microscopy analysis. Thus, 
permeation studies using ten further compounds from the previous dataset, in which PDMS (following 
150 seconds N2 plasma treatment) was used as the barrier to permeation, were performed. Greater 
extents of Kp reduction compared with those obtained following air plasma treatment were observed 
for seven out of eleven compounds, meeting a primary objective of the work presented in this chapter 
i.e. to further reduce the overestimation in permeation observed with PDMS skin mimics. However, 
no increases in correlation were observed following comparison with a library of literature permeability 
coefficients obtained using human epidermal tissue.  
  
The Effect of Nitrogen Plasma Treatment on the Permeation of Pharmaceutical Compounds through 
Poly(dimethylsiloxane) 
 
126 
 
Conversely, a small increase in the atomic percent of nitrogen was observed following N2 plasma 
treatment, which may suggest the presence of a small number of amine group containing surface sites, 
suitable for biomolecule conjugation. These findings may suggest that N2 modified PDMS may provide 
a suitable platform for the production of biorelevant skin mimics, such as those containing protein-
lipid bilayers.   
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Chapter 5 A Comparative Study of Biomolecule Conjugation 
Methods 
5.1 Introduction 
The wet chemical modification of poly(dimethylsiloxane) (PDMS) following plasma-based surface 
activation is used extensively as an approach to tailoring the interactions between the polymer substrate 
and specific biomolecules, looking to enhance biocompatibility and expand the possible applications 
of PDMS, particularly within the field of cytology. For example, various proteins have been 
immobilised at the surface of PDMS, e.g. fibronectin, laminin, and collagen (Kuddannaya et al., 2013; 
Pakstis et al., 2010), resulting in ‘biphasic’ membrane formation, enhanced cell adhesion and 
proliferation, and, in the case of myoglobin, sandwich immunoassay development (Gunda et al., 2014).  
Attempts to produce, and utilise, biphasic systems consisting of polymers and appropriate 
biomolecules are sparsely reported for in vitro skin permeation studies, despite the plethora of literature 
reporting the development of such systems for alternative applications. ‘Biphasic’, or ‘composite’ 
systems consisting entirely of synthetic materials, such as PDMS and poly(2-hydroxyethyl 
methacrylate) (PHEMA) copolymer membranes, have received interest as skin mimics for in vitro 
permeation studies, attributed to their hypothesised ability to represent both the hydrophobic and 
hydrophilic microdomains present in the human stratum corneum (Tomomi et al., 1992; Yamaguchi 
et al., 1997). However, this interest has not been extended to polymer-biomolecule composite systems. 
An example of such limited reports, published by Shumilov et al., evaluated the suitability of 
INTEGRA® regeneration template, an FDA approved membrane for the treatment of burns and use in 
reconstructive surgery, as a surrogate for excised epidermal tissue in permeation studies. The biphasic 
template consists of a lipophilic polysiloxane layer and an underlying hydrophilic collagen layer, and 
following its use in permeation studies employing eight model compounds, good correlation was 
observed between flux through the template and flux through excised epidermal tissue (R2 = 0.8517). 
The authors further noted that the membrane was advantageous in terms of uniformity, reduced safety 
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concerns, and storage. However, the sourcing of collagen from bovine tendon leads to the requirement 
of animal tissue, opposing the ‘Replacement’ principle of the ‘3 R’s’ (Shumilov et al., 2009). 
The stratum corneum has long been known to be the rate limiting barrier to xenobiotic permeation, 
forty percent of which consists of protein, eighty percent of which is known to be keratin (Lee et al., 
2010; Tobin, 2006). To date, a limited body of work has considered the relevance of keratin containing 
membranes for in vitro skin permeation studies. For example, work by Selmin et al., reporting the 
development of a model skin consisting of keratin and ceramides for use in in vitro skin permeation 
studies, considered the permeation of only three penetrants, namely ibuprofen, propranolol, and 
testosterone (Selmin et al., 2012). However, the work highlights an interesting feature of keratin; 
keratin can be obtained from sheep wool using various extraction procedures, and, in contrast to the 
collagen used in the INTEGRA® template, is readily available non-sacrificially. Moreover, arguably 
keratin-containing membranes are more relevant to such studies since eighty percent of the protein 
content of the stratum corneum is known to be keratin (Lee et al., 2010). The authors accredit the 
successful use of the INTEGRA® membrane to the representation of the lipophilic stratum corneum 
and underlying hydrated dermis (Shumilov et al., 2009), however, the stratum corneum is known to be 
the rate limiting barrier to the permeation of most penetrants (Godin et al., 2007). Other interesting 
examples of work with keratin include the laser ablation of keratin membranes endeavouring to 
produce ‘brick and mortar’ patterned surfaces for use in the assessment of moisturising products i.e. 
permeation was not considered (Haq et al., 2015).  
Despite the large number of reported PDMS-biomolecule conjugation protocols, to date no work has 
been published reporting the use of such protocols for the development of suitable skin mimics. 
Further, it was hypothesised that PDMS-protein bilayers may provide a more tortuous pathway for 
permeation, analogous to the stratum corneum (Figure 5.1). For example, whilst the stratum corneum 
is known to be around 20 µm thick, the path length of diffusion is known to be in the range of 300-900 
µm (Lane, 2013).  
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Figure 5.1 Permeation of a xenobiotic through PDMS (left) and PDMS-protein biphasic membrane 
(right). 
In this work, three biomolecule conjugation approaches were compared, whereby lysine was used as a 
model biomolecule, based on its abundance in keratin and its commercial availability (Candi et al., 
1998; Wang et al., 2016). Furthermore, lysine provides the most common covalent binding sites in the 
immobilisation of proteins on polymeric substrates, since lysine residues are typically abundant on the 
exterior structure of protein molecules (Kim et al., 2013; Migneault et al., 2004).    
The first approach involved the generation of an amide linkage between lysine and silanised PDMS by 
use of a carbodiimide coupling reagent, namely N,N′-dicylcohexylcarbodiimide (DCC), according to 
protocols conventionally used in solid phase peptide synthesis (SPPS). DCC has traditionally provided 
an attractive route to the generation of peptides in one-pot systems, since the N,N′-dicyclohexylurea 
side product is poorly soluble, and can be readily eliminated from the reaction by filtration, in contrast 
to those obtained using alternative carbodiimide reagents, such as diisopropyl carbodiimide and 1-
ethyl-3-(3'dimethylamino)carbodiimide hydrochloride (Montalbetti et al., 2005). In this work, a setup 
was chosen analogous to that employed in SPPS whereby the polymeric resin, in this case membrane, 
was amine-functionalised, and the amino acid was ‘anchored’ at the C terminus (Knud J. Jenson, 2013; 
Muttenthaler et al., 2015). The second approach reflected a similar setup, differing only by the method 
of surface amine group generation i.e. N2 plasma was used instead of an alkoxysilane reagent. Finally, 
a more extensively reported method endeavouring to achieve permanent biomolecule adhesion to 
PDMS membranes was evaluated, namely the use of a glutaraldehyde linker molecule, surpassing the 
need for a coupling reagent.  
  
PDMS 
PDMS 
Protein 
Xenobiotic Xenobiotic 
  
A Comparative Study of Biomolecule Conjugation Methods 
 
132 
 
Air plasma -treated 
PDMS 
PDMS PDMS PDMS 
APTMS DCC 
Boc-Lys(Z)-OH 
5.2. Results and Discussion 
5.2.1. Alkoxysilane Layer Formation and N, N′-Dicylcohexylcarbodiimide Coupling to Lysine. 
In this section, an amine terminated alkoxysilane layer was formed, according to reported methods 
(Pakstis et al., 2010), followed by the N,N′-dicylcohexylcarbodiimide (DCC) coupling of lysine 
(Scheme 5.1). In order to prevent peptide formation both the Nα and Nε were protected with tert-
butyloxycarbonyl and carboxybenzyl groups, respectively. 
                                                                    
   
Scheme 5.1 Silanisation and sequential lysine functionalisation of PDMS. 
5.2.1.1. Alkoxysilane Layer Formation  
5.2.1.1.1. Attenuated Total Reflectance - Fourier Transform Infrared Spectroscopy (ATR-
FTIR) 
An amine terminated alkoxysilane self-assembled monolayer (SAM) was generated on the surface of 
PDMS using (3-aminopropyl)trimethoxysilane (APTMS) in order to provide reactive sites for potential 
biomolecule anchoring, according to methods reported previously by other authors (Lin et al., 2010; 
Pakstis et al., 2010). Successful SAM formation was confirmed by the presence of characteristic bands 
in the ATR-FTIR spectrum of APTMS silanised PDMS, summarised in Table 5.1.   
  
PG = tert-butyloxycarboonyl 
R1 = ((CH2)4)NH(PG2), where PG2 is 
carboxybenzyl 
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Table 5.1 Summary of ATR-FTIR spectrum of APTMS silanised PDMS (PDMS-APTMS). 
Assignment νmax (cm-1) 
νas(NH2)  3350.0 
νs(CH3)  2961.9 
δs(NH2) 1567.9 
δs(CH2) 1488.0 
δas(CH3) 1412.2 
δs(CH3) 1258.1 
Si-O-Si 1004.6 
O-SiCH3 784.4 
C-SiCH3 700.0 
 
The presence of surface methyl groups was confirmed, as discussed previously (Sections 3.2.1.2 and 
4.2.1.1), by a symmetrical stretching vibration of the CH3 group at 2961.9 cm-1, and the asymmetric 
and symmetric deformation of the CH3 group at 1412.2 and 1258.1 cm-1, respectively. The Si-O-Si 
stretching vibration was observed at 1004.6 cm-1, along with absorptions at 784.4 and 700.0 cm-1, 
confirming the presence of the O-SiCH3 and C-SiCH3 groups, respectively.  The formation of an N-H 
stretching band at ~ 3350 cm-1, the presence of asymmetric bending deformation of the methylene 
group at 1488.0 cm-1, along with the presence of an in plane deformation vibration of the NH2 group 
of a primary amine at 1567.9 cm-1, is indicative of successful surface functionalisation. The ν(C-N) of 
a primary amine group, expected to appear at 1220-1020 cm-1 was not observed in the ATR-FTIR 
spectrum of APTMS functionalised PDMS, most likely as it is orders of magnitude smaller than the 
Si-CH3 and Si-O-Si bands observed in this region. 
5.2.1.1.2. X-ray Photoelectron Spectroscopy (XPS) 
X-ray photoelectron spectroscopic analysis of APTMS silanised PDMS was performed in order to 
observe changes in the surface chemical composition of PDMS following SAM formation. The surface 
  
A Comparative Study of Biomolecule Conjugation Methods 
 
134 
 
atomic percent of oxygen, nitrogen, carbon, and silicon were obtained from XPS survey scans (Table 
5.2) (Appendix 3). 
Table 5.2 Atomic percent (%) of oxygen, nitrogen, carbon and silicon at the surface of native PDMS, 
PDMS following a 90 second air plasma treatment, and subsequent APTMS functionalisation, taken 
from XPS survey scans. 
Membrane Sample 
Atomic percent (%) 
O N C Si 
Native PDMS 
1 23.17 < 0.1 47.83 29.00 
2 22.79 < 0.1 48.92 28.28 
Plasma treated PDMS 
1 44.80 0.56 23.22 31.42 
2 44.11 0.61 24.49 30.79 
APTMS silanised 
PDMS 
(PDMS-APTMS) 
1 22.01 6.89 49.64 21.46 
2 22.63 6.24 48.51 22.62 
 
An overall increase in the atomic percent of nitrogen, from 0.6 % in air plasma treated PDMS, to > 6 
% following treatment with APTMS, is indicative of successful alkoxysilane layer formation, in 
support of ATR-FTIR findings (Table 5.1), and is similar in magnitude to increases observed in similar 
work (Pakstis et al., 2010). This is further supported by an increase in the atomic percent of carbon 
following silanisation, from ~23 – 24 % in air plasma treated PDMS, to ~ 49 – 50 % in silanised PDMS, 
which was anticipated given the structure of the organosilane.  
The high resolution spectrum of the C 1s orbital (Figure 5.2) contains four signals at binding energies 
of 285.00 eV, 285.80 eV, 286.70 eV and 288.35 eV. The signals at 285.00 eV, 286.70 and 288.35 eV 
have been assigned previously, as methyl, alcohol and carbonyl containing groups, respectively 
(Section 3.2.1.3). The signal at 285.80 eV can be assigned to the primary amine of the silanising 
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reagent, and is within the range of values reported in literature for groups containing C-N bonds i.e. 
285.5 – 286.4 eV (Vesel et al., 2008; Yang et al., 2016). 
 
Figure 5.2 High resolution XPS spectrum of the C 1s orbital in APTMS silanised PDMS. 
Two peaks are observable at binding energies of 399.59 eV and 401.23 eV in the high resolution XPS 
spectra of the N 1s orbital in silanised PDMS (Figure 5.3), representing 91.69 atomic % and 8.31 
atomic %, respectively. The peak at 399.59 eV can be assigned to primary amine functionalities, 
supported by similar findings in literature (Hirata et al., 2008; Yang et al., 2016). The peak at the higher 
binding energy can be assigned to amide functionalities introduced during plasma processing, as noted 
previously (Section 3.2.1.3). This is supported by the relative quantity of the signal matching that of 
plasma introduced nitrogen-containing functionalities. Considering the signal at 401.23 eV represents 
8.31 % of 6.89 atomic % of nitrogen in the sample, this signal accounts for an overall atomic percentage 
of ~ 0.57 %, in line with the data obtained for plasma processed PDMS (Table 3.3). Furthermore, the 
higher binding energy of the group is expected, taking into account the increase in binding energy 
associated with an increase in electronegativity of neighbouring atoms i.e. oxygen. 
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Figure 5.3 High resolution XPS spectrum of the N 1s orbital in APTMS silanised PDMS. 
5.2.1.1.3. Scanning Electron Microscopy 
Scanning electron microscopy images of alkoxysilane functionalised PDMS were obtained in support 
of chemical analysis, in order to confirm monolayer formation, and observe changes in the 
morphological characteristics of the membrane (Figure 5.4). To date, reported examples of 
alkoxysilane functionalisation of PDMS have generally considered the effect of SAM formation on the 
wettability and chemical reactivity of the substrate, along with the behaviour of cells cultured on the 
substrate, but have displayed limited interest in the overall membrane integrity (Karakoy et al., 2014; 
Kuddannaya et al., 2013; Pakstis et al., 2010). General consideration of the membrane integrity of 
PDMS following various chemical treatments is of heightened interest to this project, since mechanical 
strain, structural damage, and crack formation, may result in increases in permeability.  
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Figure 5.4 APTMS silanised PDMS at a magnification of 500 X (A), 1000 X (B), and 1500 X (C) 
Scanning Electron Microscopy images of PDMS following 90 seconds air plasma treatment (A-C, 
500 X, 1000 X, and 1500 X magnification, respectively) and APTMS silanised PDMS. 
Successful silane layer formation is apparent in Figure 5.4 along with surface cracking, which is readily 
observable at a magnification of 1500 X. Surface cracking may be attributed to mechanical strain 
between the surface and the bulk, in line with observations made previously (Cordeiro et al., 2009).  
 
A 
B 
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D 
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5.2.1.2. N, N′-Dicylcohexylcarbodiimide coupling to Lysine  
A dicylohexylcarbodiimide coupling reaction between Boc-Lys(Z)-OH and APTMS functionalised 
PDMS was performed. The surface chemical composition was determined in order to confirm the 
occurrence of successful coupling between the amine terminated SAM (Section 4.1.1.1) and lysine 
using ATR-FTIR and XPS. 
5.2.1.2.1. Attenuated Total Reflectance - Fourier Transform Infrared Spectroscopy (ATR-
FTIR) 
ATR-FTIR analysis of PDMS following APTMS layer formation and lysine coupling was performed 
in order to confirm the occurrence of successful coupling (Table 5.3). The results of ATR-FTIR 
analysis of both APTMS functionalised PDMS and Boc-Lys(Z)-OH are also presented in Table 5.3 to 
enable facile identification of surface functionality. 
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Table 5.3 ATR-FTIR analysis of APTMS functionalised PDMS, Boc-Lys(Z)-OH, and Boc-Lys(Z)-
OH functionalised PDMS. 
Assignment 
νmax  (cm-1) 
APTMS 
functionalised PDMS 
(PDMS-APTMS) 
Boc-Lys(Z)-OH 
Boc-Lys(Z)-OH 
functionalised PDMS 
(PDMS-APTMS-Lys) 
ν(N-H) ~ 3335 3337.1 3307.3 
νas(CH3) 2961.6 2975.9 2962.0 
ν(C=O) N/A 
1678.8 
1738.2 
1651.2 
1695.1 
δ(NH2) 1567.3 N/A N/A 
ν(C-N) N/A 1551.2 1531.1 
δs(CH2) 1486.1 1456.1 1455.0 
Si-CH3 1258.3 N/A 1257.9 
Si-O-Si 1003.7 N/A 1004.1 
O-SiCH3 784.4 N/A 784.6 
C-SiCH3 699.9 N/A 698.1 
A band at 1695.1 cm-1 in the ATR-FTIR spectrum of Boc-Lys(Z)-OH functionalised PDMS, and 
1678.8 cm-1 in the ATR-FTIR spectrum of Boc-Lys(Z)-OH is indicative of the carbonyl group of the 
carbamate group present in both the tert-butyloxycarbonyl (Boc) and carboxybenzyl (Z) protecting 
group. The presence of an absorbance at 1651.2 cm-1 in the ATR-FTIR spectrum of Boc-Lys(Z)-OH 
functionalised PDMS is indicative of a carbonyl group in an amide link to the substrate. Furthermore, 
the presence of the symmetric stretch of the carbonyl group in the ATR-FTIR spectrum of Boc-Lys(Z)-
OH at 1738.2 cm-1, and its absence in the spectrum of Boc-Lys(Z)-OH functionalised PDMS confirms 
the covalent attachment of the amino acid to the surface. The presence of this signal additionally 
confirms that signals representative of the carbamate-containing protecting groups are not present as a 
result of the physisorption of lysine to PDMS.  
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An absorbance between 1570-1515 cm-1 present in both Boc-Lys(Z)-OH and Boc-Lys(Z)-OH 
functionalised PDMS i.e. at 1551.2 cm-1 and 1531.1 cm-1, respectively, is indicative of the presence of 
a secondary amide, present as a consequence of protection of both former primary amine sites. The 
ν(C-N) of a primary amine group appears at a lower frequency than that of amides (1220-1020 cm-1), 
and is not observed in the ATR-FTIR spectrum of APTMS silanised PDMS, most likely as it is orders 
of magnitudes smaller than the Si-CH3 and Si-O-Si bands observed in this region. However, the 
presence of asymmetric bending deformation of the methylene group at 1486.1 cm-1 indicates 
successful silanisation, along with the presence of an in-plane deformation vibration of the NH2 group 
of a primary amine at 1567.3 cm-1 in the ATR-FTIR spectrum of silanised PDMS.   
5.2.1.2.2. X-ray Photoelectron Spectroscopy (XPS) 
X-ray photoelectron spectroscopic analysis was also performed in order to confirm changes in the 
surface elemental composition of APTMS functionalised PDMS following coupling to Boc-Lys(Z)-
OH. Surface atomic percent of oxygen, carbon, nitrogen and silicon were obtained from survey scans 
(Appendix 4), and are presented in Table 5.4. 
Table 5.4 Atomic percent (%) of oxygen, nitrogen, carbon and silicon at the surface of  
Boc-Lys(Z)-OH APTMS functionalised PDMS (PDMS-APTMS-Lys), taken from XPS survey scans. 
Membrane Sample 
Atomic % 
O C N Si 
PDMS-
APTMS-Lys 
1 24.41 51.38 4.89 19.32 
2 25.30 51.14 5.02 18.54 
 
A small increase in the atomic percent of carbon, and a decrease in both the atomic percent of nitrogen 
and silicon at the surface of PDMS, is indicative of successful coupling, and is consistent with the 
structure of Boc-Lys(Z)-OH. In order to further confirm the occurrence of coupling, high resolution 
XPS spectra of the C 1s (Figure 5.5) and N 1s (Figure 5.6) orbitals were obtained, enabling the 
assignment of surface functionality.  
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Four peaks are resolvable in the high resolution XPS spectrum of the C 1s orbital in APTMS Boc-
Lys(Z)-OH functionalised PDMS at binding energies of  285.00 eV, 286.48 eV, 289.69 eV and 287.82 
eV. The signals at binding energies of 285.00 eV and 286.48 eV have been assigned previously to 
methyl, and alcohol groups, respectively (Sections 3.2.1.3 and 4.2.1.2). The notable absence of a signal 
at 285.80 eV, assigned previously as C-N the primary amine of APTMS, may suggest successful amide 
linkage to the amino acid. The two signals at binding energies of 287.82 eV and 289.69 eV, absent 
from the analogous spectrum for APTMS functionalised PDMS, match most closely those observed 
for carbonyl functionalities (Vesel et al., 2008; Yang et al., 2016). The binding energy of the former 
signal most closely matches that of amide groups, and the latter is markedly similar to reported values 
for carbamate groups i.e. 289.60 eV, present in the carboxybenzyl (Z) and tert-butyloxycarbonyl (Boc) 
protecting groups (Bittrich et al., 2014), supporting the occurrence of successful Boc-Lys(Z)-OH 
functionalisation.   
 
 
Figure 5.5 High resolution XPS spectrum of the C 1s orbital in APTMS-Boc-Lys(Z)-OH 
functionalised PDMS. 
The presence of only one peak in the high resolution XPS spectrum of the N 1s orbital of APTMS 
silanised PDMS (Figure 5.3), and the presence of an additional peak at 401.88 eV in the N 1s spectrum 
of Boc-Lys(Z)-OH functionalised PDMS is indicative of successful surface modification. Furthermore, 
the higher chemical shift of the additional signal is concomitant with the addition of nitrogen atoms 
with neighbouring electron withdrawing groups i.e. amide and carbamate groups. 
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N2 plasma-treated PDMS 
PDMS PDMS 
DCC 
Boc-Lys(Z)-OH 
 
Figure 5.6 High resolution XPS spectrum of the N 1s orbital in APTMS-Boc-Lys(Z)-OH 
functionalised PDMS. 
5.2.2. Coupling of Lysine to N2 Plasma-Treated PDMS 
Direct coupling of Boc-Lys(Z)-OH to PDMS, following surface amination using an N2 plasma 
treatment, was explored as a potential route to immobilising amine-group containing biomolecules at 
the surface of PDMS, surpassing the requirement for a surface silanisation step (Scheme 5.2).  
                                              
 
Scheme 5.2 Lysine functionalisation of N2 plasma treated PDMS. 
5.2.2.1. Attenuated Total Reflectance – Fourier Transform Infrared Spectroscopy (ATR-FTIR) 
ATR-FTIR analysis of N2 plasma treated PDMS following functionalisation with Boc-Lys(Z)-OH was 
performed in order to assign surface functionality. Data corresponding to Boc-Lys(Z)-OH 
functionalised PDMS is presented in Table 5.5, along with data corresponding to N2 plasma treated 
PDMS to enable facile comparison. 
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Table 5.5 ATR-FTIR analysis of N2 plasma treated PDMS prior to, and following, coupling with 
Boc-Lys(Z)-OH. 
Assignment 
νmax (cm-1) 
N2 plasma treated PDMS 
Boc-Lys(Z)-OH functionalised 
PDMS 
νs(CH3) 2962.1 2962.2 
ν(C=O) N/A 1693.8 
δas(CH3) 1412.4 1412.2 
δs(CH3) 1258.2 1258.2 
Si-O-Si 1005.7 1005.4 
O-SiCH3 785.1 785.2 
C-SiCH3 701.2 700.9 
 
The presence of surface methyl groups was confirmed by a symmetrical stretching vibration of the CH3 
group at 2962.2 cm-1, and the asymmetric and symmetric deformation of the CH3 group at 1412.2 and 
1258.2 cm-1. The Si-O-Si stretching vibration is observed at 1005.4 cm-1, along with absorptions at 
785.2 and 700.9 cm-1, confirming the presence of the O-SiCH3 and C-SiCH3 groups, respectively. An 
additional absorbance is observed at 1693.8 cm-1, attributed to the stretching vibration of the carbonyl 
of a carbamate group present in the carboxybenzyl (Z) and tert-butyloxycarbonyl (Boc) protecting 
groups. As expected, this absorption is absent from the spectra of both N2 plasma treated PDMS and 
APTMS silanised PDMS, and is present in the ATR-FTIR spectrum of APTMS silanised PDMS 
following coupling to Boc-Lys(Z)-OH (Table 5.3). Furthermore, this finding supports the presence of 
amine groups at the surface of PDMS following plasma treatment, as hypothesised following XPS 
analysis (Section 4.2.1.2). 
5.2.2.2. X-ray Photoelectron Spectroscopy (XPS) 
X-ray photoelectron spectroscopic analysis was performed in support of ATR-FTIR analysis, in order 
to confirm surface modification, and assign chemical functionality. Elemental composition was 
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obtained from XPS survey scans (Appendix 8 and Appendix 9), and is presented in Table 5.6. The 
physical adsorption, or physisorption, of ‘dynamic modifiers’ such as surfactants (Section 1.7.2) 
(Wang et al., 2006), and proteins (Pakstis et al., 2010) has recurrently been used as a modest approach 
to tailoring the surface properties of PDMS. Multiple authors have reported the limited robustness of 
such protocols, accredited to the known desorption of the modifier over time (Pakstis et al., 2010). In 
order to confirm that characteristic signals in both the ATR-FTIR and XPS spectra were not present as 
a consequence of van der Waals interactions between the amino acid and plasma modified surface i.e. 
physisorption, the coupling reaction was performed according to two protocols. The former protocol 
employed the use of an aprotic solvent, namely dichloromethane, i.e. N,N'-dicylohexylcarbodiimide 
coupling was known to occur, and the latter employed a protic solvent, namely ethanol, in which 
coupling was not possible. 
Table 5.6 Atomic percent (%) of oxygen, nitrogen, carbon and silicon at the surface of N2 plasma 
treated PDMS following coupling to Boc-Lys(Z)-OH in dichloromethane and ethanol, taken from 
XPS survey scans. 
Membrane Sample 
Atomic percent (%) 
O N C Si 
Boc-Lys(Z)-OH functionalised PDMS 
(Dichloromethane) 
1 23.82 6.48 58.58 11.12 
2 24.17 6.85 58.05 10.93 
Boc-Lys(Z)-OH functionalised PDMS 
(Ethanol) 
1 42.83 0.74 27.42 29.01 
2 41.64 0.92 29.05 28.05 
 
An increase in the atomic percent of nitrogen from 0.83 - 0.87 in N2 plasma treated PDMS (Table 4.2), 
to 6.48 - 6.85 %, was observed following surface modification using dichloromethane. Additionally, 
an increase in carbon percent was observed, resulting in an atomic percent of carbon greater than that 
observed following both XPS analysis of N2 plasma treatment (25.86 – 26.21 %), and native PDMS 
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(47.83 – 48.92 %), i.e. 58.05 – 58.58 atomic %. These results were anticipated in the event of successful 
coupling, given the structure of the amino acid. No such changes were observed following employment 
of a protic reaction solvent, and the values of atomic percent of carbon, oxygen, nitrogen, and silicone 
were all markedly similar to those observed previously, following N2 plasma treatment alone (Table 
4.2). From these results, it may be inferred that successful coupling has occurred. In order to further 
support this conclusion, high-resolution XPS spectra of the C 1s and N 1s orbitals were obtained. 
The high resolution spectrum of the C 1s orbital in Boc-Lys(Z)-OH functionalised PDMS 
(dichloromethane) (Figure 5.7) is markedly similar to that obtained following coupling of Boc-Lys(Z)-
OH to APTMS silanised PDMS (Figure 5.5) i.e. two signals at binding energies circa 288 and 290 eV 
were observed, associated with carbonyl containing functionalities. The high resolution spectrum of 
the C 1s orbital in Boc-Lys(Z)-OH functionalised PDMS (ethanol) (Figure 5.8) was notably similar to 
that observed following N2 plasma treatment alone (Figure 4.2), with regards to both the binding 
energies of the observed signals, and the percent area (%) of each. These observations further reaffirm 
the occurance of successful coupling in dichloromethane, and the absence of coupling in ethanol. 
 
Figure 5.7 High resolution XPS spectrum of the C 1s orbital in Boc-Lys(Z)-OH functionalised 
PDMS (dichloromethane). 
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Figure 5.8 High resolution XPS spectrum of the C 1s orbital in Boc-Lys(Z)-OH functionalised 
PDMS (ethanol). 
Analogous to the C 1s spectra, the high resolution XPS spectrum of the N 1s orbital in Boc-Lys(Z)-
OH functionalised PDMS (dichloromethane) (Figure 5.9) was similar to that obtained following 
coupling of Boc-Lys(Z)-OH to APTMS silanised PDMS (Figure 5.6). Two signals were present, in 
contrast to the spectra obtained corresponding to Boc-Lys(Z)-OH functionalised PDMS (ethanol) 
(Figure 5.10) for which only one signal was observed, analogous to the spectrum obtained following 
N2 plasma treatment (Figure 4.3). 
 
Figure 5.9 High resolution XPS spectrum of the N 1s orbital in Boc-Lys(Z)-OH functionalised 
PDMS (dichloromethane).  
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Figure 5.10 High resolution XPS spectrum of the N 1s orbital in Boc-Lys(Z)-OH functionalised 
PDMS (ethanol). 
Exposure of plasma-treated, or UV-O3-treated PDMS to aqueous solutions has repeatedly been 
investigated as a method of overcoming hydrophobic recovery, the success of which is thought to be 
attributed to hydrogen bonding between surface silanol groups and the solution, which may prevent 
the reorientation of polar functional groups towards the bulk (Ma et al., 2011; Williams et al., 2004; 
Zhao et al., 2012). Thus, in this work, it was hypothesised that the exposure of PDMS to non-polar 
solvents may result in the reorientation of hydrophilic species towards the bulk, affecting the extent of 
permeation through the membrane.  The effect of exposure of N2 plasma treated PDMS to various 
solvents on the membrane permeability was investigated using the model compound lidocaine (LID). 
The cumulative mass of LID permeated through native PDMS, PDMS following N2 plasma treatment, 
PDMS following storage in dichloromethane (DCM), and PDMS following storage in ethanol (EtOH) 
was calculated, and is presented in Table 5.7. A further aprotic solvent i.e. ethyl acetate (EtOAc), and 
a further protic solvent i.e. ultrapure water, were selected for comparative purposes. A storage time of 
three hours was selected, on par with the duration of the DCC coupling reaction. 
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Table 5.7 Effect of exposure of N2 plasma treated PDMS to various solvents on the cumulative mass 
of lidocaine (LID) permeated after 6 hours (mean ± standard deviation, 4 sig.fig. n = 3). 
Plasma treatment time Solvent treatment 
Cumulative mass permeated 
(µg) 
0 None 1292 ± 47 
150 None 464.1 ± 71.7 
150 Dichloromethane 1184 ± 69 
150 Ethanol 512.5 ± 102.1 
150 Ethyl acetate 1406 ± 90 
150 Deionised water 532.9 ± 141.5 
 
An overall statistically significant difference in the cumulative mass of lidocaine (LID) permeated after 
6 hours following exposure to various solvents was observed (F(5,12) = 65.45, p < 0.0010). Levene’s 
test for homogeneity of variance revealed data homoscedasticity (F(5,12) = 1.230, p = 0.354); thus, a 
post hoc Bonferroni test was used to perform pairwise comparisons.  
Statistically significant differences in LID permeation were found between native PDMS, compared 
with PDMS following N2 plasma treatment (p < 0.001), PDMS following storage in EtOH (p < 0.001), 
and PDMS following storage in ultrapure water (p < 0.001). No statistically significant differences 
were observed between permeation through N2 plasma-treated PDMS, and plasma-treated PDMS 
following storage in EtOH (p = 0.985), and H2O (p = 0.934). No statistically significant differences in 
permeation were observed following storage in EtOH compared with H2O (p = 1.00) i.e no statistically 
significant differences in permeation were observed between PDMS following storage in the two protic 
solvents.  
 No statistically significant differences in permeation of LID were observed through native PDMS 
compared with PDMS following storage in DCM (p = 0.704), and following storage in EtOAc (p = 
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0.658) i.e. no statistically significant differences in permeation were observed between permeation 
through native PDMS and N2 plasma-treated PDMS subsequently stored in either aprotic solvent. No 
statistically significant differences in permeation were observed between PDMS following storage in 
DCM compared with PDMS following storage in EtOAc (p = 0.178).  
These findings suggest that the storage of N2 plasma-treated PDMS in polar, protic solvents may 
prolong surface hydrophilicity, since such solvents can participate in hydrogen bonding with surface 
groups, on par with findings published by other authors (Ma et al., 2011; Williams et al., 2004; Zhao 
et al., 2012).  These findings must also be considered in the context of coupling reactions; if non-polar 
solvents, such as dichloromethane, result in the reorientation of amine groups towards the bulk, suitable 
surface groups available for biomolecule conjugation may become unavailable for reaction. 
Furthermore, non-polar solvents are known to swell PDMS (Lee et al., 2003), and may facilitate the 
diffusion of oligomers to the surface, aiding hydrophobic recovery. These findings may further suggest 
that greater surface coverage may be achieved following reactions which can be performed in polar 
media.  
5.2.3. Glutaraldehyde linker 
The covalent attachment of glutaraldehyde to aminated PDMS surfaces is expansively used as a 
prerequisite to the immobilisation of biomolecules on PDMS substrates (Kuddannaya et al., 2013; 
Shafieyan et al., 2012; Wipff et al., 2009). The reaction of glutaraldehyde with PDMS following amine 
functionalisation, for example with alkoxysilanes, can be performed in aqueous solution, typically 
isotonic pH 7.4 phosphate buffered saline, since many reports of biomolecule immobilisation on PDMS 
substrates are intended for cytological applications (Kuddannaya et al., 2013). Protocols generally 
entail the submersion of PDMS substrates in 0.1 – 6 % solutions of glutaraldehyde for 15 – 60 minutes 
(Shafieyan et al., 2012), followed by aqueous rinsing procedures, surpassing the need to consider the 
effect of exposure to organic solvents on PDMS membrane integrity. In this work, it was hypothesised 
that the use of a glutaraldehyde ‘linker’ molecule may provide a useful approach to circumventing the 
need for organic solvents, which may result in subsequent increases in permeability (Table 5.7), 
thought to be a consequence of accelerated hydrophobic recovery (Section 5.1.2.2). The use of 
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Silanised PDMS 
PDMS PDMS 
Glutaraldehyde 
PDMS 
Boc-Lys-OH 
glutaraldehyde required the de-protection of either the α or ε amine group in Boc-Lys(Z)-OH, and the 
absence of a coupling reagent rendered the use of protecting groups redundant since peptide formation 
did not need to be evaded. However, signals from carbamate groups present in both the butoxycarbonyl 
(Boc) and carboxybenzyl (Z) in both the ATR-FTIR spectra and XPS spectra previously proved a 
useful marker for successful biomolecule immobilisation (Sections 5.2.1 and 5.2.2), thus, one of two 
protecting groups were removed i.e. Nα-Boc-L-lysine was used to enable comparison with previous 
spectra. Thus, PDMS was functionalised with (3-aminopropyl)triethoxysilane (APTES), followed by 
glutaraldehyde (GA), according to reported methods (Farrell et al., 2010; Kuddannaya et al., 2013; 
Wipff et al., 2009), and was further functionalised with Nα-Boc-L-lysine i.e PDMS-APTES-GA-Lys 
(Scheme 5.3), and was subject to ATR-FTIR, XPS, and SEM analysis, as performed previously.  
                                                  
 
Scheme 5.3 Lysine immobilisation at the surface of silanised PDMS following glutaraldehyde 
functionalisation, where PG = tert-butyloxycarbonyl. 
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5.2.3.1. Attenuated Total Reflectance - Fourier Transform Infrared Spectroscopy (ATR-FTIR) 
Table 5.8 ATR-FTIR of native PDMS, and APTES silanised PDMS following glutaraldehyde and 
Boc-Lys(Z)-OH functionalisation (PDMS-APTES-GA-Lys). 
Assignment 
νmax (cm-1) 
Native PDMS PDMS-APTES-GA-Lys 
ν(N-H) N/A 3332.4 
νas(CH3) 2962.3 2962.1 
ν(C=O) N/A 1698.8 
ν(C-N) N/A 1530.6 
δs(CH2) 1412.6 1412.4 
Si-CH3 1258.2 1258.2 
Si-O-Si 1006.3 1005.7 
O-SiCH3 786.2 785.1 
C-SiCH3 701.4 701.2 
 
An absorbance at 1530.6 cm-1 in the ATR-FTIR spectrum of PDMS-APTES-GA-Lys is indicative of 
the presence of a secondary amide, and is markedly similar to that observed previously following Boc-
Lys(Z)-OH functionalisation of APTMS silanised PDMS (1531.1 cm-1) (Table 5.3), supporting the 
occurrence of successful amino acid functionalisation. Similarly, the presence of an absorption at 
1698.8 cm-1, comparable to that obtained previously following Boc-Lys(Z)-OH functionalisation i.e. 
at 1695.1 (Table 5.3), suggests the presence of a carbonyl group, indicating successful glutaraldehyde 
functionalisation, and may suggest successful Boc-Lys-OH functionalisation. As anticipated, the 
presence of surface methyl groups is confirmed by a symmetrical stretching vibration of the CH3 group 
at 2962.1 cm-1, and the asymmetric and symmetric deformation of the CH3 group at 1412.4 and 1258.2 
cm-1, respectively. The Si-O-Si stretching vibration is observed at 1005.7 cm-1, along with absorptions 
at 785.1 and 701.2 cm-1, confirming the presence of the O-SiCH3 and C-SiCH3 groups, respectively.   
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5.2.3.2. X-ray Photoelectron Spectroscopy (XPS) 
Quantitative elemental composition of the PDMS surface pre- and post-modification was determined 
using XPS survey scans (Appendix 5- Appendix 7), with data subsequently presented in the form of 
atomic percent (%) (Table 5.9). The O 1s, C 1s, N 1s and Si 2p orbitals were identified at binding 
energies circa 530 eV, 282 eV, 399 eV, and 100 eV, respectively. 
Table 5.9 Atomic percent (%) of oxygen, nitrogen, carbon and silicon at the surface of APTES 
functionalised PDMS (PDMS-APTES), APTES-glutaraldehyde funtionalised PDMS (PDMS-
APTES-GA), and PDMS-APTES-GA following functionalisation with Boc-Lys-OH (PDMS-
APTES-GA-Lys), taken from XPS survey scans. 
Membrane Sample 
Atomic percent (%) 
O N C Si 
PDMS-APTES 
1 23.97 0.25 45.60 30.18 
2 23.96 < 0.10 45.63 30.40 
PDMS-APTES-GA 
1 21.59 3.61 57.73 17.07 
2 21.61 2.63 57.37 18.40 
PDMS-APTES-GA-
Lys 
1 21.72 2.51 56.36 19.42 
2 23.51 2.69 54.01 17.49 
3 21.55 2.97 56.83 18.14 
4 22.56 3.25 55.03 18.09 
 
An increase in the atomic percent (%) of nitrogen was observed following APTES silanisation (PDMS-
APTES), compared with that obtained following similar analysis of native PDMS (Table 3.2).  
However, the increase in nitrogen observed was lower than that observed following air plasma 
treatment alone. Furthermore, the occurrence of this increase in only one of the duplicate samples 
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suggests surface heterogeneity, and an atomic percent of nitrogen lower than that of air plasma-treated 
PDMS suggests no attachment of APTES in the two sample areas tested, and may further suggest a 
degree of hydrophobic recovery occurring. These findings are supported by an increase in the atomic 
percent of nitrogen following glutaraldehyde functionalisation (PDMS-APTES-GA) i.e. the structure 
of glutaraldehyde is devoid of nitrogen. These results suggest a more extensive degree of silanisation, 
however, the nitrogen content observed was around half that observed previously following APTMS 
silanisation (Table 5.2). No significant changes in the surface chemical composition were observed 
following Boc-Lys-OH functionalisation (PDMS-APTES-GA-Lys), with regards to the atomic percent 
of carbon, oxygen, nitrogen and silicon.  The identification of changes in surface chemistry on the basis 
of data obtained from survey scans proved problematic since samples were generally found to be 
heterogeneous in nature, supported by visual examination of the membrane (Figure 5.11), despite an 
increase in the number of samples tested with regards to PDMS-APTES-GA-Lys. Thus, high resolution 
XPS spectra were obtained in order to identify surface functionality (Figure 5.12 - Figure 5.17).  
 
Figure 5.11  PDMS membrane following functionalisation with (3-aminopropyl)triethoxysilane, 
glutarladehyde, and Boc-Lys-OH  (PDMS-APTES-GA-Lys). 
High resolution XPS spectra of the C 1s orbital in PDMS-APTES, PDMS-APTES-GA, and PDMS-
APTES-GA-Lys were obtained, and are presented in Figure 5.12, Figure 5.13, and Figure 5.14, 
respectively. The high resolution XPS spectrum of the C 1s orbital  in PDMS following silanisation 
with (3-aminopropyl)triethoxylsilane (PDMS-APTES) (Figure 5.12) is markedly similar to that of 
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native PDMS (Figure 3.6), and suggests unsuccessful surface silanisation, supporting the findings of 
survey scans obtained at this sampling region on the substrate (Table 5.9). 
 
Figure 5.12 High resolution XPS spectra of the C 1s orbital in PDMS following (3-
aminopropyl)triethoxylsilane silanisation (PDMS-APTES). 
The high resolution XPS spectrum of the C 1s orbital of PDMS-APTES following glutaraldehyde 
functionalisation (PDMS-APTES-GA) (Figure 5.13) contains four signals at binding energies of 
284.99 eV, 285.82 eV, 286.83 eV and 288.03 eV, and is notably similar to that obtained previously 
following APTMS silanisation (Figure 5.2). Signals were previously assigned to methyl, amine, 
alcohol, and carbonyl-containing groups, respectively (Section 5.2.1.1.2). The atomic percent of the 
signal circa 288 eV, associated with carbonyl containing groups, is greater in PDMS-APTES-GA, in 
comparison to that obtained following APTMS silanisation (Figure 5.2) and air plasma treatement 
(Figure 3.7), as anticipated. The carbonyl signals obtained previously following APTMS silanisation 
and air plasma treatment, at binding energies of 288.35 eV and 288.50 eV, were attributed to amide 
groups introduced following plasma processing, based on the signal chemical shift, and the presence 
of a stoichiometric percent of nitrogen. The binding energy of the signal associated with carbonyl-
containing functionalities is lower in the C 1s spectrum of PDMS-APTES-GA i.e. at 288.03 eV, than 
the corresponding spectra for air plasma treated and APTMS silanised PDMS i.e. at 288.50 and 288.35, 
respectively. The binding energy obtained herein more closely matches the range quoted for aldehyde 
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groups i.e. 287.81-288.06 eV, than that corresponding to amide groups i.e. 287.97 – 288.59 eV (Bittrich 
et al., 2014), suggesting successful glutaraldehyde functionalisation, supporting the findings of ATR-
FTIR spectroscopic analysis (Table 5.8).  
 
Figure 5.13 High resolution XPS spectrum of the C 1s orbital in PDMS following (3-
aminopropyl)triethoxylsilane silanisation and glutaraldehyde functionalisation (PDMS-APTES-GA). 
The high resolution XPS spectrum of the C 1s orbital in PDMS-APTES-GA-Lys (Figure 5.14) 
similarly contains four signals, at binding energies of 285.00 eV, 286.01 eV, 286.95 eV and 288.18 
eV, matching those reported for methyl, amine, alcohol and carbonyl-containing groups, respectively. 
No significant deviations in the atomic percent of each signal were observed, in comparison with that 
obtained following similar analysis of PDMS-APTES-GA (Figure 5.13). Thus it was hypothesised that 
high resolution XPS spectra of the N 1s orbital would provide greater insight regarding the occurrence 
of surface lysine functionalisation (Figure 5.15 - Figure 5.17).  
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Figure 5.14 High resolution XPS spectrum of the C 1s orbital of PDMS following (3-
aminopropyl)triethoxylsilane silanisation, and functionalisation with glutaraldehyde and Boc-Lys-
OH (PDMS-APTES-GA-Lys). 
Only one peak was observed in the high resolution XPS spectrum of the N 1s orbital in PDMS-APTES. 
The binding energy is most similar to that obtained following APTMS silanisation i.e. 399.59 eV, 
matching that reported from primary amine groups (Figure 5.3), in comparison to that obtained 
corresponding to air plasma-treated PDMS i.e. 400.79 eV, matching that reported for amide groups 
(Figure 3.7) (Williams et al., 2004). 
  
Figure 5.15 High resolution XPS spectrum of the N 1s orbital of PDMS following (3-
aminopropyl)triethoxylsilane silanisation (PDMS-APTES).  
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Two peaks were observable in the high resolution N 1s spectrum in PDMS-APTES-GA, as anticipated 
following the analysis of survey spectra and high resolution C 1s spectra (Table 5.9 and Figure 5.14, 
respectively) i.e. the sample appeared to be more extensively silanised. Furthermore, the binding 
energies of each signal, and the relative percent of each, were similar to values obtained previously 
following APTMS silanisation (Figure 5.3). 
 
Figure 5.16 High resolution XPS spectrum of the N 1s orbital in PDMS following (3-
aminopropyl)triethoxylsilane silanisation and glutaraldehyde functionalisation (PDMS-APTES-GA). 
A similar scenario was observed in the high resolution XPS spectrum of PDMS-APTES-GA-Lys 
(Figure 5.17), with two peaks at 399.69 eV and 401.78 eV, corresponding to amine and amide groups, 
respectively (Williams et al., 2004). A small increase in the percent area of the latter signal was 
observed following coupling to Boc-Lys-OH and may suggest the presence of carbamate groups in the 
tert-butoxycarbonyl (Boc) protecting group. 
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Figure 5.17 High resolution XPS spectrum of the N 1s orbital in PDMS following (3-
aminopropyl)triethoxylsilane silanisation and functionalisation with glutaraldehyde and Boc-Lys-OH 
(PDMS-APTES-GA-Lys). 
5.2.3.3. Scanning Electron Microscopy 
Scanning electron microscopy images of silanised PDMS following glutaraldehyde functionalisation 
(PDMS-APTES-GA) and following subsequent Boc-Lys-OH functionalisation (PDMS-APTES-GA-
Lys) (Figure 5.18), were obtained in order to evaluate membrane integrity, and observe changes in 
surface morphology, which may affect the membrane permeability.  
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Figure 5.18 Scanning Electron Microscopy images of PDMS-APTES-GA (A-C, magnification 500 
X, 100 X and 1500 X, respectively) and PDMS-APTES-GA-Lys (D-F, magnification 500 X, 100 X 
and 1500 X, respectively) 
The morphology of the membrane following glutaraldehyde functionalisation is notably different from 
that observed immediately following silanisation (Figure 5.4) with an additional, heterogeneous 
superficial layer apparent. Similar observations were made following scanning electron microscopy 
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analysis of PDMS-APTES-GA following lysine functionalisation i.e. the membrane appeared different 
from silanised PDMS (Figure 5.4) and PDMS-APTES-GA (Figure 5.18).  
5.3. Conclusions 
In this chapter, three biomolecule immobilisation strategies were investigated for potential use in the 
attachment of biorelevant molecules to PDMS membranes, endeavouring to produce structurally 
relevant synthetic composite membranes for use in in vitro skin permeability studies.  Keratinocytes 
represent more than 95 % of epidermal cells (McKittrick et al., 2012), thus the attachment of keratin 
to PDMS is of heightened interest to this project. Lysine was selected as a model biomolecule to 
investigate the appropriateness of each immobilisation strategy, on the basis of its abundance in keratin, 
presence on the exterior structure of proteins, and commercial availability (Candi et al., 1998; Kim et 
al., 2013).  
The silanisation of PDMS was performed, according to reported methods, endeavouring to generate 
surface amine groups for the coupling of lysine. An N,N'-dicylohexylcarbodiimide coupling reaction 
was performed, according to protocols traditionally used in solid phase peptide synthesis. The presence 
of lysine at the surface of PDMS was confirmed following ATR-FTIR and XPS analysis, rendering the 
method a promising approach for the immobilisation of proteins. It was further hypothesised that the 
reaction could be extended to PDMS substrates following surface amination via an N2  plasma 
treatment, surpassing the need for a surface silanisation step. 
The direct coupling of lysine to N2 plasma treated PDMS was found to be a convenient method of 
biomolecule attachment, however, despite the confirmation of the presence of lysine at the surface of 
the modified membrane using ATR-FTIR and X-ray photoelectron spectroscopy, the surface of PDMS 
was found to primarily be oxidised. Thus, in order to further extend this method to the covalent 
attachment of keratin, the adjustment of plasma conditions may be necessary i.e. the use of a custom 
made plasma generator, with which purge-vacuum cycles can be performed in order to remove residual 
air and water vapour. Furthermore, the exposure of N2 plasma-treated PDMS to two aprotic solvents, 
namely dichloromethane and ethyl acetate, was found to result in an increase permeability, on par with 
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that obtained with native PDMS, hypothesised to be a consequence of the reorientation of polar surface 
groups. In order to enhance the degree of surface coverage, the use of coupling reagents with which 
coupling can be performed in polar solvents, such as N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC), should be investigated prior to the utilisation of this method in the development 
of polymeric skin mimics i.e. the permeation of pharmaceutical compounds through membranes 
prepared using this approach will not be considered in this thesis. 
The use of a glutaraldehyde ‘linker’ molecule was investigated as an approach to circumventing the 
need for aprotic solvents. Despite the frequency of reports, data deconvolution was problematic, 
attributed to the surface heterogeneity.  An absorbance at 1530.6 cm-1 in the ATR-FTIR spectrum of 
PDMS-APTES-GA-Lys, markedly similar to that observed previously following lysine coupling to 
APTMS silanised PDMS, was indicative of the presence of a secondary amide, and suggested 
successful surface functionalisation. These findings were supported by an increase in the percent area 
of the signal associated with amide functionalities in the N 1s spectrum of PDMS-APTES-GA 
following lysine functionalisation i.e. PDMS-APTES-GA-Lys. Distinct changes in the morphological 
properties of the membrane were observed in the scanning electron microscopy images of PDMS 
following glutaraldehyde functionalisation and lysine functionalisation, in comparison to that observed 
following silanisation alone. Additionally, visual examination of the membrane supported the findings 
of other authors that glutaraldehyde may reduce substrate uniformity (Pakstis et al., 2010). In any case, 
both the PDMS-APTMS-Lys and PDMS-APTES-GA-Lys membranes presented herein are of 
additional interest in permeation studies. 
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Chapter 6 The Effect of Biomolecule Conjugation on the 
Permeation of Pharmaceutical Compounds.  
6.1. Introduction 
In the previous chapter, three biomolecule immobilisation strategies were compared as potential routes 
to PDMS-protein composite membranes for use in in vitro permeation studies. The silanisation of PDMS 
using (3-aminopropyl)triethoxysilane (APTMS) followed by the N,N'-dicylohexylcarbodiimide (DCC) 
coupling of Boc-Lys(Z)-OH was found to be the most attractive method of surface modification, based 
on the abundance of surface amine groups available, and the apparent change in surface functionality 
following the coupling procedures, processes which were monitored using ATR-FTIR and X-ray 
photoelectron spectroscopy. Extension of this methodology to N2 plasma-generated surface amine groups 
was less favourable, on the basis of the limited number of surface amine groups generated, and the 
apparent change in surface hydrophilicity following exposure to non-polar, aprotic solvents.  However, 
this method still appears promising, providing amendments to the protocols can be performed i.e. 
removal of residual water vapour and O2 from the polymer and plasma process chamber, and the 
substitution of DCC with an aqueous soluble coupling reagent. A further method of surface modification 
was investigated, selected on the basis of the wealth of literature reporting its successful employment 
(Kuddannaya et al., 2013; Shafieyan et al., 2012; Wipff et al., 2009), and the lack of requirement for 
aprotic solvents. The findings of ATR-FTIR and XPS spectra were somewhat conflicting, attributed to 
the surface heterogeneity of the samples. Nonetheless, signals in the ATR-FTIR and XPS spectra 
indicated successful surface modification, and work by other authors finding the glutaraldehyde surface 
to be more hydrophilic than that observed following silanisation, rendered this technique promising 
(Pakstis et al., 2010). 
Work by Pakstis et al. aiming to screen surface modification methods suitable for the immobilisation of 
fibronectin and laminin, compared physisorption based, electrostatic based, and covalent bond 
generation based approaches to the production of substrates appropriate for the culture of smooth muscle 
cells. The authors noted the inadequate nature of physisorption based approaches for such purposes, 
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attributed to the known desorption of the surface ‘modifiers’ over time, and low protein density obtained. 
The authors further compared the protein density of (3-aminopropyl)trimethoxysilane modified PDMS 
(PDMS-APTMS), glutaraldehyde functionalised PDMS-APTMS, and PDMS following O2 plasma 
treatment and sequential use of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC). 
The authors found that hydrogen bonding and electrostatic interactions between fibronectin and surface 
amine groups, generated following APTMS silanisation, resulted in both superior protein coverage, and 
substrate uniformity, in contrast to the surfaces obtaining following EDC coupling to plasma generated 
carbonyl groups, and following the use of the glutaraldehyde linker. Interestingly, the authors also note 
the hydrophilicity of the glutaraldehyde surface to be around twice that observed following plasma 
treatment, APTMS silanisation, and EDC treated, following protein attachment (Pakstis et al., 2010).  
The work by Pakstis et al. represents an interesting example of the tailoring, and comparison, of the 
surface properties of PDMS for a specific application, following various surface modification 
procedures. No such work has been performed evaluating the permeability of modified PDMS to 
pharmaceutical compounds. Thus, in this chapter, the permeability of (3-aminopropyl)trimethoxysilane 
functionalised PDMS following the covalent attachment of lysine (PDMS-APTMS-Lys), and PDMS 
following silanisation, glutaraldehyde functionalisation, and lysine attachment (PDMS-APTES-GA-
Lys) was investigated. Four model pharmaceutical compounds were employed to encompass a range of 
physicochemical parameters; an anionic and cationic compound, namely benzoic acid (BA) and lidocaine 
(LID), and two compounds displaying a low degree of ionisation with a high and low log10 P values, 
namely methyl 4-aminobenzoate (MAB) and butyl paraben (BP).  It was hypothesised that the use of 
PDMS-biomolecule bilayers in a permeation study may support the identification of a suitable method 
of protein immobilisation for the production of lamellae-type structures of PDMS, in conjunction with 
data obtained previously (Chapter 5). 
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6.2 Results and Discussion 
6.2.1 N,N′-Dicyclohexylcarbodiimide Coupling of Lysine to Silanised PDMS (PDMS-APTMS-Lys) 
The silanisation of PDMS using (3-aminopropyl)trimethoxysilane, following by the N,N′-
dicyclohexylcarbodiimide coupling of Boc-Lys(Z)-OH appeared the most promising method of 
biomolecule immobilisation on the basis of the availability of surface amine groups, and the apparent 
change in surface functionalisation following lysine attachment. Thus, the permeability of the resultant 
membrane was of heightened interest to this work.  Further, the surface modification of PDMS was 
performed on one side of the membrane, based on a ‘top-up’ type surface modification i.e. it was 
hypothesised that the production of a polymer-biomolecule bilayer, followed by repeated steps of the 
spin-coating of a PDMS layer, followed by further biomolecule immobilisation may provide a suitable 
future method of lamellae formation (Figure 6.1).  
 
Figure 6.1 Proposed schematic of PDMS-biomolecule composite membrane formation. 
Consequently, in order to compare permeation through lysine-modified substrates with air plasma 
modified substrates, data obtained in Table 3.6 i.e. steady state flux (Jss) through air plasma-treated 
PDMS, was repeated, treating only one side of the membrane. Furthermore, the use of a flow-through 
type cell apparatus was found in earlier work to be a superior method of maintaining sink conditions, in 
comparison with static Franz cell type apparatus.  Therefore, data corresponding to air plasma-treated 
PDMS, along with that corresponding to native PDMS and PDMS-APTMS-Lys, obtained using the 
former cell type, is presented in Table 6.1, in the form of steady state flux (Jss).  
 
 
PDMS layer 
Spin coat 
Biomolecule 
immobilisation 
Protein layer 
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Table 6.1 Steady state flux (Jss) of lidocaine (LID), benzoic acid (BA), methyl aminobenzoate (MAB), 
and butyl paraben (BP) through native PDMS, PDMS following air plasma treatment, and PDMS 
following APTMS silanisation and lysine functionalisation (PDMS-APTMS-Lys) (mean ± standard 
deviation, 4 sig.fig., n = 3). 
Compound 
Steady-state flux (Jss, μg cm-2 min-1) 
Native PDMS Air plasma-treated 
PDMS 
PDMS-APTMS-Lys 
LID 16.40 ± 0.42 13.00 ± 0.94 14.99 ± 0.67 
BA 8.970 ± 0.695 7.356 ± 0.529 8.801 ± 0.259 
MAB 4.585 ± 0.126 2.964 ± 0.100 3.141 ± 0.058 
BP 1.603 ± 0.015 1.056 ± 0.051 1.436 ± 0.056 
 
The steady state flux of each compound through native, plasma-treated, and lysine functionalised PDMS 
(PDMS-APTMS-Lys) was compared using one-way ANOVA.  In all cases Levene’s test for the 
homogeneity of variance was insignificant with respect to all compounds i.e. p > 0.05, thus a post hoc 
Bonferroni test was performed in order to identify differences in permeation between each membrane 
type. In all cases, an increase in permeation was observed following the DCC coupling of Boc-Lys(Z)-
OH to APTMS silanised PDMS, in comparison to that obtained following plasma treatment alone, 
displayed graphically in Figure 6.2 and Figure 6.3 for methyl 4-aminobenzoate (MAB) and butyl paraben 
(BP), respectively. 
In the case of MAB, an overall statistically significant difference in Jss was observed (F(2,6) = 301.062, 
p < 0.001). Statistically significant differences in Jss through native, and plasma-treated PDMS were 
observed (p < 0.001), in line with previous data obtained corresponding to PDMS plasma-treated on both 
sides of the membrane (Table 3.6). Furthermore, statistically significant differences in permeation 
through PDMS-APTMS-Lys were observed, in comparison with that through native PDMS (p < 0.001). 
However, a statistically significant increase in permeation was observed following APTMS-Lys 
functionalisation of PDMS, in comparison with that obtained following plasma treatment alone (p = 
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0.004). A similar situation was observed in the case of BP (F(2,6) = 118.78, p < 0.001), whereby 
statistically significant differences in Jss through native and  plasma-treated PDMS were observed (p < 
0.001), along with statistically significant differences in permeation through PDMS-APTMS-Lys, in 
comparison with that obtained with  native PDMS (p = 0.011). Furthermore, a statistically significant 
increase in Jss was observed following APTMS-Lys functionalisation, in comparison with that obtained 
following air plasma treatment alone (p < 0.001). 
In the case of lidocaine (LID), an overall statistically significant difference in flux through the three 
membranes were obtained (F(2,6) = 17.87, p = 0.003). A statistically significant difference in permeation 
through plasma treated PDMS was observed in comparison with that obtained through native PDMS (p 
= 0.003). A statistically significant difference in flux through plasma-treated PDMS and PDMS-APTMS-
Lys was observed (p = 0.042), in contrast with that obtained between native PDMS and PDMS-APTMS-
Lys (p = 0.134). A similar situation was observed in the case of benzoic acid (BA) (F(2,6) = 8.127, p = 
0.020). A statistically significant difference in flux was observed between that obtained with native 
PDMS and plasma-treated PDMS (p = 0.033). A statistically significant increase in permeation was 
observed following APTMS-Lys functionalisation (p = 0.048), thus, no statistically significant difference 
in steady state flux through native PDMS and PDMS-APTMS-Lys was observed (p = 1.000).   
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Figure 6.2 Permeation of methyl 4-aminobenzoate (MAB) through native PDMS, PDMS following air 
plasma treatment, and APTMS silanised PDMS following lysine functionalisation (PDMS-APTMS-
Lys) (mean ± standard deviation, n = 3). 
 
Figure 6.3 Permeation of butyl paraben (BP) through native PDMS, PDMS following air plasma 
treatment, and APTMS silanised PDMS following lysine functionalisation (PDMS-APTMS-Lys) 
(mean ± standard deviation, n = 3). 
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In the case of all compounds tested, an increase in permeation was observed following APTMS-Lys 
functionalisation, with respect to that observed through plasma treated PDMS. Considering the findings 
presented in Table 5.7, the increase in permeation may be attributed to the hydrophobic recovery of 
PDMS and the reorientation of polar surface groups towards the bulk following exposure of plasma-
treated and silanised PDMS to non-polar, aprotic solvents. No significant increases in permeation were 
observed with respect to that obtained through native PDMS. In order to further investigate these 
findings, the steady state flux of the same four compounds through silanised, glutaraldehyde and lysine 
functionalised PDMS (PDMS-APTES-GA-Lys) was considered i.e. all functionalisation reactions were 
performed in EtOH and phosphate buffered saline. 
6.2.2. Use of Glutaraldehyde Linker (PDMS-APTES-GA-Lys).  
The use of a glutaraldehyde linker molecule was explored as a facile approach to circumventing the need 
for non-polar, aprotic solvents, such as dichloromethane, and preventing the observed increase in 
membrane permeability (Table 5.7 and Table 6.1). Interestingly, work by Pakstis et al., comparing 
multiple PDMS-biomolecule conjugation methods, found the surface of PDMS following 
functionalisation with glutaraldehyde and fibronectin to be more hydrophilic than plasma-treated PDMS, 
APTMS silanised PDMS, and PDMS functionalised with fibronectin using a carbodiimide coupling 
reagent, namely N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) (Pakstis et al., 
2010). In this work, the steady state flux of the same four compounds employed previously, namely 
lidocaine (LID), benzoic acid (BA), methyl 4-aminobenzoate (MAB) and butyl paraben (BP), was 
considered (Table 6.2). 
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Table 6.2 Steady state flux (Jss) of lidocaine (LID), benzoic acid (BA), methyl aminobenzoate (MAB), 
and butyl paraben (BP) through native PDMS, PDMS following air plasma treatment, and PDMS 
following APTMS silanisation, glutaraldehyde and lysine functionalisation (PDMS-APTES-GA-Lys) 
(mean ± standard deviation, 4 sig.fig., n = 3). 
Compound 
Steady-state flux (Jss, μg cm-2 min-1) 
Native PDMS Air plasma-treated 
PDMS 
PDMS-APTES-GA-
Lys 
LID 16.40 ± 0.42 13.00 ± 0.94 9.612 ± 0.454 
BA 8.970 ± 0.695 7.356 ± 0.529 7.146 ± 0.600 
MAB 4.585 ± 0.126 2.964 ± 0.100 2.686 ± 0.024 
BP 1.603 ± 0.015 1.056 ± 0.051 1.047 ± 0.069 
 
The steady state flux of each compound through native, plasma-treated, and lysine functionalised PDMS 
(PDMS-APTES-GA-Lys) was compared using one-way ANOVA.  In all cases Levene’s test for the 
homogeneity of variance was insignificant with respect to all compounds i.e. p > 0.05, thus a post hoc 
Bonferroni test was performed in order to identify differences in permeation between each membrane 
type. 
In the case of LID, an overall statistically significant difference in flux through the three membranes was 
observed (F(2,6) = 81.75, p < 0.001). A statistically significant difference in flux through native PDMS 
and PDMS-APTES-GA-Lys (p < 0.001) was observed, along with plasma-treated PDMS and PDMS-
APTES-GA-Lys (p = 0.002). In the case of MAB, an overall statistically significant difference in 
permeation was observed (F(2,6) = 406.52,  p < 0.001). The steady state flux of MAB through native 
PDMS was found to differ to that through PDMS-APTES-GA-Lys (p < 0.0001), however, no statistically 
significant differences in Jss through plasma-treated PDMS and PDMS-APTES-GA-Lys were observed 
(p = 1.00). Similar scenarios were also observed in the case of BP (F(2,6) = 120.20,  p < 0.001), and BA 
(F(2,6) = 7.536,  p = 0.023) i.e. statistically significant differences in permeation through native PDMS 
and PDMS-APTES-GA-Lys were observed (p < 0.001 and p < 0.023 for BP and BA, respectively). No 
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statistically significant differences in permeation through plasma-treated PDMS and PDMS-APTES-
GA-Lys were observed in the case of both compounds (p = 1.00).  
In contrast to data obtained previously (Table 6.1, Figure 6.2 and Figure 6.3), no statistically significant 
increases in permeation were observed following APTES-GA-Lys functionalisation, in comparison to 
following plasma treatment alone, displayed graphically in Figure 6.4 and Figure 6.5 in the case of MAB 
and BP, respectively.  
 
Figure 6.4 Permeation of methyl 4-aminobenzoate (MAB) through native PDMS, PDMS following air 
plasma treatment, and APTES silanised PDMS following glutaraldehyde and lysine functionalisation 
(PDMS-APTES-GA-Lys) (mean ± standard deviation, n = 3). 
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Figure 6.5 Permeation of butyl paraben (BP) through native PDMS, PDMS following air plasma 
treatment, and APTES silanised PDMS following glutaraldehyde and lysine functionalisation (PDMS-
APTES-GA-Lys) (mean ± standard deviation, n = 3). 
A statistically significant reduction in permeation was observed in the case of only one of the four 
compounds tested in this study, namely lidocaine (LID). Considering the physicochemical properties of 
the penetrant, LID displays a polar surface area (PSA) of 36, close to that displayed by BA, i.e. 37, for 
which no statistically significant reduction in permeation was observed. Furthermore, LID displays a 
log10 P similar to that of BP i.e. 3.63 and 3.46, respectively. LID represents the only cationic compound 
in this study, with a saturated suspension above the initial buffer pH i.e. a pH of 8.3 (Appendix 11). 
To date, no consensus has been reached regarding the mechanism of the reaction of glutaraldehyde with 
proteins. Although it is generally assumed that protein immobilisation on solid substrates occurs as a 
consequence of a reaction between the nucleophilic ε-amino groups of lysine residues on the exterior of 
proteins, no unanimity exists regarding the reactive glutaraldehyde species. As many as thirteen different 
forms of glutaraldehyde in solution have been noted, including α,β-unsaturated aldehydes and their 
resultant cyclic aldol condensation products, hydrated forms, cyclic hemiacetals and oligomers, poly-
glutaraldehyde structures including dimers, tetramers, and pentamers with a single available aldehyde 
group, and various aldol condensation polymeric products ranging in their degree of aldehyde, hydroxyl 
and carboxylic acid functionalisation (Migneault et al., 2004). The relative proportion of each species in 
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solution has been found to be heavily dependent on solution pH, oxygen content, and concentration. For 
example, the dilution of a 70 % glutaraldehyde solution, known to contain a significant quantity of 
polymerised species, has been found to result in increased conversion to monomeric species (Kawahara 
et al., 1992). Furthermore, in the pH range of 3.0 – 8.0, glutaraldehyde solutions have been found to 
consist mainly of monomeric, cyclic hemiacetals formed following the intramolecular reaction of a 
hydroxyl group with the carbonyl. Moreover, quandary surrounds the reaction via which glutaraldehyde 
mediated protein crosslinking occurs; both Micheal-type additions and Schiff base formation have been 
proposed as possible reaction mechanisms of glutaraldehyde based protein immobilisation, with the 
product of the latter represented in Scheme 5.3. Glutaraldehyde has been shown to react with multiple 
functional groups of proteins including thiol, phenol, amine and imidazole (Migneault et al., 2004).  
In this work, the surface was found to be heterogeneous, and the occurrence of a limited number of 
signals associated with Nα-Boc-L-lysine in the XPS and ATR-FTIR spectra of PDMS-APTES-GA-Lys 
(Section 5.2.3) may suggest the presence of free aldehyde groups. Considering this in the context of 
permeation studies, where the surface of modified PDMS may encounter a range of pH values of 
saturated suspensions or formulations, and penetrants may contain multiple functional groups known to 
react with glutaraldehyde, the use of glutaraldehyde for such purpose may be complex. For example, in 
the case of LID, the saturated suspension displayed a pH of 8.3. Schiff base formation is known to be 
reversible under basic conditions, and may result in increasing numbers of uncrosslinked glutaraldehyde 
molecules. The reduction of Schiff bases may be performed with sodium cyanoborohydride, resulting in 
the conversion of the imine to a secondary amine, which is stable to hydrolysis (Migneault et al., 2004). 
It is apparent that knowledge of the mechanism of reaction of the amine group with glutaraldehyde serves 
as a prerequisite to the introduction of this step. The reduced nucelophillicity of amide groups, in 
comparison to that of amine groups, renders the reaction of lidocaine with glutaraldehyde unlikely in any 
case, however electrostatic interactions between deprotonated hydrated forms of glutaraldehyde and 
cationic lidocaine are highly likely. 
The lack of permeability increase following lysine functionalisation may be attributed to a lack of 
hydrophobic recovery, as a consequence of the performance of all reactions in polar media i.e. 
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silanisation was performed in EtOH, and glutaraldehyde and lysine functionalisation was performed in 
phosphate buffered saline. Furthermore, the membrane heterogeneity observed previously (Section 
5.2.3) did not appear to be problematic with regards to the permeation of pharmaceutical compounds i.e. 
coefficients of variation were all < 10 %, on par with those obtained following the employment of native 
and plasma-treated PDMS.  
6.3. Conclusions  
In this chapter, the permeation of pharmaceutical compounds through biomolecule-functionalised PDMS 
was considered. The silanisation of PDMS followed by the DCC coupling of lysine (PDMS-APTMS-
Lys) appeared to be the most promising method of biomolecule conjugation, on the basis of the 
abundance of surface amine groups available for coupling, and distinct signals in the ATR-FTIR and 
XPS spectra following lysine functionalisation. However, increases in the permeation of four 
pharmaceutical compounds were observed following the employment of the membrane as a skin mimic 
in a flow-through cell type permeation study. It was hypothesised that such an increase was a 
consequence of the exposure of the polar PDMS surface to a non-polar solvent, namely dichloromethane, 
in support of earlier findings. Thus, the permeation of pharmaceutical compounds through PDMS 
functionalised with lysine via the use of a glutaraldehyde linker molecule (PDMS-APTES-GA-Lys) was 
considered. In contrast to the data obtained with PDMS-APTMS-Lys, no increase in permeation was 
observed following biomolecule immobilisation, attributed to the absence of non-polar solvents in the 
immobilisation process. A decrease in permeation was observed in the case of only one compound, 
namely lidocaine (LID), thought to be a consequence of interactions between cationic penetrant 
molecules and uncrosslinked glutaraldehyde molecules. In general, the immobilisation of lysine was 
found not to increase the permeation of pharmaceutical compounds, with respect to that through native 
PDMS. Such a finding indicates that, in the case of the compounds tested in this work, the overall rate 
of permeation appears to be largely controlled by permeation through the native bulk substrate. Since the 
objective of this work was to identify a suitable method of biomolecule attachment for the production of 
PDMS-protein lamellae structures, the aims of this work were met, despite no further decreases in 
permeation being observed in the case of three quarters of the compounds tested. Based on the surface 
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heterogeneity observed, and known complexity of the glutaraldehyde based protein immobilisation 
process, it may be taken that the immobilisation of biomolecules for the purpose of skin permeation 
studies should be performed using diimide based coupling reagents. It also must be noted that whilst no 
decrease in permeation was observed for lysine-PDMS bilayers, these findings cannot be extended to 
keratin-PDMS multilayers, rendering the continuation of this work promising, providing that a larger 
range of pharmaceutical compounds are tested.  
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Chapter 7 Conclusions and Future Work 
A primary objective of the work presented in this thesis was to evaluate various polymer modification 
methods as potential approaches to producing a lamellae-type PDMS membranes, parallel to the 
structure of the stratum corneum, for use in in vitro skin permeation studies. The effect of the plasma 
treatment of PDMS on the permeation of pharmaceutical compounds, representing a range of 
physicochemical properties and therapeutic classes, was considered. The air plasma treatment of PDMS 
was found to result in the formation of polar surface functionalities, namely silanol groups, in line with 
literature reports (Chen et al., 2007), and rendered the membrane less permeable to fourteen 
pharmaceutical compounds. Furthermore, an increase in correlation between permeability coefficients 
obtained using the synthetic substitute, and literature permeability coefficients obtained using excised 
human epidermal tissue, was observed. 
 It was further hypothesised that amine-functionalised PDMS surfaces may provide a useful platform 
for the attachment of biomolecules in order to enhance the biorelevance of PDMS skin mimics. Thus, 
an additional aim of the work presented in this thesis was to consider the effect of the N2 plasma 
treatment of PDMS was as a prerequisite to such work, on the basis of the large body of literature 
reporting the generation of surface amine groups following the N2 plasma treatment of PDMS (Williams 
et al., 2004; Yang et al., 2016). With regards to the permeation of pharmaceutical compounds through 
N2 plasma treated PDMS alone, a reduction in the permeation of nine pharmaceutical compounds was 
observed. No increase in correlation between permeability coefficients obtained using the synthetic 
substitute, and those obtained using epidermal tissue, was observed, despite the occurrence of greater 
reductions in the permeation of pharmaceutical compounds.  
 A third aim of the work presented in this thesis was to evaluate potential methods of immobilising 
amine group containing biomolecules at the surface of PDMS, to assist in the development of a method 
of producing a lipid-protein multilayer membrane, similar to the stratum corneum, appropriate for skin 
permeation assays. Two alkoxysilane based biomolecule immobilisation strategies were investigated, 
namely alkoxysilane layer formation followed by the N,N'-dicylohexylcarbodiimide (DCC) coupling of 
Boc-Lys(Z)-OH (PDMS-APTMS-Lys), and alkoxysilane layer formation followed by Boc-Lys-OH 
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functionalisation using a glutaraldehyde ‘linker’ molecule (PDMS-APTES-GA-Lys). The silanisation 
of PDMS and sequential DCC coupling reaction method appeared to be the most promising in terms of 
the abundance of surface amine groups available, and distinct signals in the ATR-FTIR and XPS spectra, 
indicating successful lysine functionalisation. However, moderate increases in the permeation of 
pharmaceutical compounds were observed following the employment of the membrane as a skin mimic, 
with respect to permeation following plasma alone, thought to be a result of the exposure of PDMS to 
non-polar, aprotic solvents. No such increases in permeation were observed following the employment 
of PDMS-APTES-GA-Lys, selected on the basis of the performance of all functionalisation reactions in 
polar media, and the reported surface hydrophilicity (Pakstis et al., 2010). Deconvolution of the surface 
analysis data, i.e. ATR-FTIR and XPS data, corresponding to the latter membrane type, was more 
problematic, attributed to the heterogeneity of the modified polymer surface. Thus, a logical progression 
of this work is to explore the potential of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC), an aqueous soluble diimide coupling reagent, in the production of biomolecule 
functionalised PDMS skin mimics, allowing for the performance of coupling in polar media, and 
potentially circumventing the permeability increase observed following the use of DCC.  
The N2 plasma treatment of PDMS was hypothesised to be a facile alternative to the air plasma treatment 
of PDMS and sequential silanisation reaction, in the generation of surface amine groups. A significant 
level of surface oxidation was observed i.e. the major species found to be introduced were silanol groups. 
It was hypothesised that the significant degree of surface oxidation was a consequence of residual air 
and water vapour in the polymer and the plasma process chamber. Upon employment of this membrane 
in the DCC coupling of Boc-Lys(Z)-OH, successful surface amino acid functionalisation at the limited 
number of surface amine sites was observed. In order to extend the use of N2 plasma treatments to the 
immobilisation of biomolecules at the surface of PDMS, such as proteins, via amide bond formation, 
the use of a custom built plasma generator should be considered, allowing for more precise control over 
the resultant surface chemical functionality. For example, the plasma system utilised in this work 
performs only one chamber evacuation, via use of a vacuum pump, prior to the introduction of the 
process gas to the chamber and plasma ignition. Multiple purge-vacuum cycles may assist the removal 
of residual air and water vapour. The use of an in-line drying agent e.g. anhydrous calcium chloride 
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should be investigated as a modest approach to the removal of residual water vapour from the N2 process 
gas. Additionally, the direct attachment of the plasma generator to an N2 cylinder, for which the 
composition is more highly chemically characterised, should be considered as an alternative to the gas 
line system utilised in this work in order to minimise the influx of water vapour.  
Sequential work should also consider alterations in the mechanical properties, such as the Young’s 
modulus, of PDMS membranes following the physical and chemical based modification protocols 
explored in this thesis; variations in the elasticity of modified PDMS-based skin mimics may be 
correlated to crack formation, and subsequent increases in the permeation of pharmaceutical 
compounds. Following the exposure of PDMS membranes to oxidising plasma treatments, Si-CH3 and 
Si-O bond cleavage is known to occur, inevitably resulting in alterations in the degree of cross-linking 
of polymer chains at the membrane surface i.e. quaternary siloxane units are formed (Owen et al., 2012). 
At temperatures above the glass transition, polymers that are weakly cross-linked typically display 
‘rubber-like’ behaviour, whilst polymers that are highly cross-linked display ‘stiff viscoelastic’ 
properties (Bergstrom, 2015). Such observations are particularly relevant to the development of PDMS-
based polymeric skin mimics for which the glass transition temperature is low (-120 - -125 °C in the 
case of native PDMS) (Bosq et al., 2014; Dollase et al., 2003; Zhou et al., 2010), and for which a range 
of storage and experimental temperatures may be employed. 
Further logical progression of this work is the production of PDMS-biomolecule multilayers via multiple 
spin-coating and biomolecule immobilisation steps (Figure 6.1). Moreover, keratin extraction 
procedures should be optimised, allowing for keratin-PDMS multilayer formation. For example, keratin 
has successfully been extracted from sheep wool by sulfitolysis. Furthermore, it is hypothesised here 
that keratin from sheep wool may provide a suitable substitute for that in the stratum corneum barrier 
i.e. both are α-keratins, consisting of polypeptides in an α-helix conformation, in comparison to the β-
pleated sheet conformation observed in reptilian and avian tissues, such as scales and feathers (Wang et 
al., 2016). Although no further decreases in permeation were observed following biomolecule 
immobilisation in this work, these findings are not necessarily applicable to multilayers and/or 
alternative biomolecules. Other interesting progressions of this work include the possible ‘corneocyte 
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patterning’ of PDMS prior to biomolecule immobilisation, to enable a more accurate representation of 
the structural properties of the stratum corneum i.e. distinct proteinaceous regions surrounded by a 
continuous lipophilic region. The patterning of corneocyte bricks on the surface of PDMS may be 
possible by the production of a ‘grid’ or ‘mesh’ protective template that may be mounted onto the PDMS 
membrane prior to plasma processing (Figure 7.1). Since protected regions will be rendered chemically 
inert, it may be possible to selectively bio-functionalise the oxidised/aminated regions.   
 
Figure 7.1 The corneocyte patterning of PDMS by use of a ‘grid’ template during plasma processing.  
 
In summary, the aims of the work presented in this thesis were met i.e. the potential of the air plasma 
treatment of PDMS to produce lamellae-type structures suitable for skin permeation studies was 
investigated. Moreover, the potential of N2 plasma treatment to aminate the surface of PDMS was 
considered, and three methods of biomolecule immobilisation were compared. Consequently, the work 
presented in this thesis provides a considerable insight of the effect of multiple biomolecule 
immobilisation strategies on the permeation of pharmaceutical compounds through PDMS. In general, 
plasma treatments appeared to reduce the permeation of pharmaceutical compounds through PDMS, a 
frequently employed skin mimic with which over estimations in percutaneous adsorption are often 
observed. The chemical immobilisation of lysine at the surface of PDMS did not significantly increase 
the permeation of pharmaceutical compounds, with respect to that through native PDMS, thus, the work 
may further facilitate the development of biorelevant polymeric skin mimics for use in permeation 
studies. 
PDMS substrate 
Grid 
Plasma 
PDMS substrate 
Oxidised PDMS 
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Appendix 2 
Assumptions of statistical tests used in this thesis. 
Test Assumptions 
Independent samples T-test Normal distribution of the dependent variable, 
independence of observations, homogeneity of variance. 
One-way analysis of variance (ANOVA) Normal distribution of the dependent variable residuals, 
independence of observations, homogeneity of variance. 
Levene’s test for the homogeneity of variance Independence of observations, variables are measured at 
the interval or ratio level.  
Welch’s F test Normal distribution of the dependent variable residuals.  
Pearson’s correlation coefficient Homoscedasticity, variables are measured at the interval 
or ratio level, approximate normal distribution of the 
variables.   
Spearman’s rho Variables are measured at the ordinal, interval, or ratio 
level. 
Post hoc Bonferroni test Homogeneity of variance. 
Post hoc-Games Howell Heteroscedasticity of variance. 
  
Appendix 3 
XPS survey scan of APTMS silanised PDMS.  
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Appendix 4 
XPS survey scan of PDMS-APTMS-Lys. 
 
Appendix 5 
XPS survey scan of PDMS-APTES. 
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Appendix 6 
XPS survey scan of PDMS-APTES-GA. 
 
Appendix 7 
XPS survey scan of PDMS-APTES-GA-Lys 
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Appendix 8 
Boc-Lys(Z)-OH functionalised PDMS (Dichloromethane). 
 
Appendix 9 
Boc-Lys(Z)-OH functionalised PDMS (EtOH). 
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Appendix 10 
Specifications of PDMS, as provided by the manufacturer. 
Product reference: 7458 
Lot number: 1504028 
Supplier: ATOS Medical 
Sheet size: 150 x 200 mm  
Sheet thickness: 0.13 mm  
Grade: Medical grade (without polyester reinforcement) 
Density:  1102.6 kg m-3 
Tensile strength: 1038 psi 
Percent elongation:  516 % 
Extractables: Dichloromethane (4.8 % by weight loss), Ethanol (3.5 % by weight loss)  
Trace metals analysis: None detectable  
Crystallinity: No crystalline silica detected 
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Appendix 11 
pH of saturated suspensions of ibuprofen (IBU), flurbiprofen (FLP), ketoprofen (KTP), caffeine (CAF), 
lidocaine (LID), benzoic acid (BA), salicylic acid (SA), acetyl salicylic acid (ASA), aminopyrine (AMP), 
methyl paraben (MP), ethyl paraben (EP), propyl paraben (PP), butyl paraben (BP), methyl 4-
aminobenzoate (MAB), benzocaine (EAB), risocaine (PAB), butamben (BAB) and diclofenac (DF). 
Compound 
pH of saturated suspension 
(air plasma) 
pH of saturated suspension (N2 
plasma) 
IBU 6.49 ± 0.01 N/A 
FLP 6.58 ± 0.08 N/A 
KTP 6.01 ± 0.01 N/A 
CAF 7.52 ± 0.01 7.40 ± 0.00 
LID 8.32 ± 0.03 8.33 ± 0.02 
BA 4.16 ± 0.01 4.16 ± 0.00 
SA 3.28 ± 0.02 N/A 
ASA 3.45 ± 0.05 N/A 
AMP 7.48 ± 0.05 N/A  
MP 7.25 ± 0.00 7.27 ± 0.00 
EP 7.35 ± 0.00 7.38 ± 0.00  
PP 7.31 ± 0.01 7.37 ± 0.00 
BP 7.37 ± 0.01 7.36 ± 0.00 
MAB 7.38 ± 0.01 7.40 ± 0.00 
EAB 7.39 ± 0.01 7.44 ± 0.00  
PAB 7.41 ± 0.01 7.37 ± 0.00 
BAB 7.36 ± 0.00 7.43 ± 0.01 
DF 7.09 ± 0.01 N/A 
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Appendix 12 
Concentration (mg mL-1) of saturated solutions of caffeine (CAF), lidocaine (LID), benzoic acid (BA), 
methyl paraben (MP), ethyl paraben (EP), propyl paraben (PP), butyl paraben (BP), methyl 4-
aminobenzoate (MAB), benzocaine (EAB), risocaine (PAB), and butamben (BAB). 
 
Compound Donor solution concentration (mg 
mL-1) 
MP 2.929 ± 0.233 
EP 1.226 ± 0.009 
PP 0.4493 ± 0.0081 
BP 0.3063 ± 0.0007 
MAB 1.838 ± 0.017 
EAB 1.213 ± 0.093 
PAB 0.6074 ± 0.0139 
BAB 0.1786 ± 0.0057 
LID  3.931 ± 0.052 
CAF 22.56 ± 2.54 
BA 8.557 ± 0.111 
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Appendix 13 
Linear range, linearity, intermediate precision, intra assay precision, limit of detection (LOD), and limit of quantification for high performance liquid 
chromatography methods used in the quantification of caffeine (CAF), lidocaine (LID), benzoic acid (BA), methyl paraben (MP), ethyl paraben (EP), 
propyl paraben (PP), butyl paraben (BP), methyl 4-aminobenzoate (MAB), benzocaine (EAB), risocaine (PAB), and butamben (BAB). 
Compound 
Range 
(µg mL-1) 
Linearity 
(R2) 
Intermediate precision 
RSD (%) 
Intra assay precision 
RSD (%) 
LOD 
(µg mL-1) 
LOQ 
(µg mL-1) 
MP 0.1 – 80 ≥ 0.999 
0.1 µg mL-1: 9.15 
10 µg mL-1: 2.90 
50 µg mL-1: 2.57 
0.1 µg mL-1: 7.56 
10 µg mL-1: 0.07 
50 µg mL-1: 1.03 
0.064 0.195 
EP 0.1 – 100 ≥ 0.999 
0.1 µg mL-1: 6.86 
10 µg mL-1: 2.27 
50 µg mL-1: 3.43 
0.1 µg mL-1: 1.44 
10 µg mL-1: 0.24 
50 µg mL-1: 0.35 
0.047 0.142 
PP 0.1 – 50 ≥ 0.999 
0.1 µg mL-1: 5.26 
10 µg mL-1: 3.49 
50 µg mL-1: 2.24 
0.1 µg mL-1: 0.40 
10 µg mL-1: 0.21 
50 µg mL-1: 0.08 
0.028 0.084 
BP 0.1 – 50 ≥ 0.999 
0.1 µg mL-1: 2.76 
10 µg mL-1: 2.39 
50 µg mL-1: 4.01 
0.1 µg mL-1: 1.87 
10 µg mL-1: 2.41 
50 µg mL-1: 1.07 
0.056 0.169 
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Compound 
Range 
(µg mL-1) 
Linearity 
(R2) 
Intermediate precision 
RSD (%) 
Intra assay precision 
RSD (%) 
LOD 
(µg mL-1) 
LOQ 
(µg mL-1) 
MAB 2.5 – 50 ≥ 0.999 
2.5 µg mL-1: 4.17 
10 µg mL-1: 4.29 
30 µg mL-1: 5.14 
2.5 µg mL-1: 4.17 
10 µg mL-1: 4.29 
30 µg mL-1: 5.14 
0.070 0.211 
EAB 1 – 50 ≥ 0.999 
2.5 µg mL-1: 4.59 
10 µg mL-1: 4.96 
30 µg mL-1: 7.33 
2.5 µg mL-1: 0.08 
10 µg mL-1: 0.14 
30 µg mL-1: 0.56 
0.049 0.147 
PAB 0.25 – 20 ≥ 0.999 
1 µg mL-1: 8.66 
2.5 µg mL-1: 4.58 
10 µg mL-1: 5.03 
1 µg mL-1: 0.40 
2.5 µg mL-1: 0.76 
10 µg mL-1: 0.95 
0.093 0.283 
BAB 0.25 – 20 ≥ 0.999 
1 µg mL-1: 8.68 
2.5 µg mL-1: 10.38 
10 µg mL-1: 8.17 
1 µg mL-1: 2.54 
2.5 µg mL-1: 2.58 
10 µg mL-1: 2.09 
0.107 0.323 
LID 0.6 – 60 ≥ 0.999 
0.6 µg mL-1: 1.52 
3 µg mL-1: 6.17 
15 µg mL-1: 2.76 
0.6 µg mL-1: 0.8 
3 µg mL-1: 0.28 
15 µg mL-1: 0.43 
0.030 0.092 
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Compound 
Range 
(µg mL-1) 
Linearity 
(R2) 
Intermediate precision 
RSD (%) 
Intra assay precision 
RSD (%) 
LOD 
(µg mL-1) 
LOQ 
(µg mL-1) 
CAF 0.05 – 50 ≥ 0.999 
0.05 µg mL-1: 15.45 
2 µg mL-1: 2.15 
10 µg mL-1: 4.07 
0.25 µg mL-1: 2.69 
2 µg mL-1: 12.39 
10 µg mL-1: 0.07 
0.022 0.066 
BA 0.05 – 60 ≥ 0.999 
5 µg mL-1: 6.76 
20 µg mL-1: 4.81 
40 µg mL-1: 3.13 
5 µg mL-1: 0.17 
20 µg mL-1: 0.16 
40 µg mL-1: 0.08 
0.126 0.381 
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Appendix 14 
Permeability coefficients (Kp) of ibuprofen (IBU), flurbiprofen (FLP), ketoprofen (KTP), caffeine (CAF), lidocaine (LID), benzoic acid (BA), salicylic 
acid (SA), acetyl salicylic acid (ASA), aminopyrine (AMP), methyl paraben (MP), ethyl paraben (EP), propyl paraben (PP), butyl paraben (BP), methyl 
4-aminobenzoate (MAB), benzocaine (EAB), risocaine (PAB), butamben (BAB) and diclofenac (DF) extracted from literature. 
Compound Permeability coefficient (Kp, cm min-1) 
IBU 6.0513 x 10-4 
(Degim et al., 1998) 
b, g. 
5.60 x 10-5 
(Zhang et al., 2012) 
b, f. 
 
 
KTP 6.474 x 10-4 
(Miki et al., 2015) 
b, e. 
1.170 x 10-4 
(Zhang et al., 2012) 
b, f. 
  
FLP 7.082 x 10-3 
(Miki et al., 2015) 
b, e. 
3.786 x 10-5 
(Zhang et al., 2012) 
b, f. 
  
DF 1.67 x 10-5 
(Degim et al., 1998) 
b, g. 
   
LID 4.209 x 10-4 
(Miki et al., 2015) 
b, e. 
4.0 x 10-7 
(Trovatti et al., 2012) 
b, i. 
0.084 x 10-4 
(Uchida et al., 2015) 
c, p. 
 
CAF 1.08 x 10-5 
(Uchida et al., 2015) 
c, f. 
1.267 x 10-6 
(Schreiber et al., 2005) 
c, j. 
3.6 x 10-6 
(Schäfer-Korting, 2006) 
d, j. 
2.83 x 10-6 
(Nanayakkara et al., 
2005) 
b, f. 
BA 4.1865 x 10-4 
(Degim et al., 1998) 
b, h. 
2.94 x 10-4 
(Zhang et al., 2012) 
b, g. 
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Compound Permeability coefficient (Kp, cm min-1) 
SA 2.3006 x 10-4 
(Degim et al., 1998) 
b, h. 
1.4 x 10-5 
(Smith et al., 2000) 
b, k. 
4.384 x 10-4 
(Qvist et al., 2000) 
b, l. 
2.83 x 10-4 
(Smith et al., 2000) 
b, o. 
ASA 8.5 x 10-6 
(Walker et al., 1997) 
c, n. 
   
AMP 1.98 x 10-5 
(Uchida et al., 2015) 
c, f. 
1.854 x 10-5 
(Miki et al., 2015) 
b, e. 
  
MAB 1.104 x 10-3 
(Uchida et al., 2015) 
c, f. 
3.8 x 10-4 
(Roy et al., 1993) 
a, e. 
  
EAB 1.21 x 10-3 
(Uchida et al., 2015) 
c, f. 
3.3 x 10-4 
(Roy et al., 1993) 
a, e. 
  
PAB 1.34 x 10-3 
(Uchida et al., 2015) 
c, f. 
   
BAB 1.21 x 10-3 
(Uchida et al., 2015) 
c, f. 
1.4 x 10-3 
(Roy et al., 1993) 
a, e. 
  
MP 1.49 x 10-4 
(Uchida et al., 2015) 
c, f. 
5.67 x 10-4 
(Nanayakkara et al., 2005) 
b, f. 
3.306 x 10-4 
(Akomeah, 2007) 
b, f. 
3.550 x 10-4 
(Akomeah et al., 
2004) 
b, m. 
EP 2.32 x 10-4 
(Uchida et al., 2015) 
c, f. 
   
PP 2.18 x 10-4 
(Uchida et al., 2015) 
c, f. 
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a. 25 °C 
b. 37 °C.  
c. 32 °C.  
d. 33.5 °C. 
e. Donor solution: Saturated solution in purified water. Receptor solution: Purified water.  
f. Donor solution: Saturated solution in pH 7.4 phosphate buffered saline. Receptor solution: pH 7.4 phosphate buffered saline.  
g. Donor solution: Saturated solution in pH 7.4 phosphate buffered saline diluted to 80 % saturation. Receptor solution: pH 7.4 phosphate buffered saline.  
h. Donor solution: Aqueous solution. Receptor solution: pH 7.4 phosphate buffered saline.  
i. Donor solution: 2 % (w/w) aqueous solution. Receptor solution: Isotonic pH 7.4 phosphate buffered saline. 
j. Donor solution: 0.1 % in pH 7.4 phosphate buffered saline. Receptor solution: pH 7.4 phosphate buffered saline.  
k. Donor solution: 2 mg/mL solution in pH 5.13 McIIVaine buffer. Receptor solution: pH 5.13 McIIvaine buffer.  
l. Donor solution: 2 mg/ml solution in pH 7.4 phosphate buffer adjusted to pH 2.5. Receptor solution pH 7.4 phosphate buffer.  
m. Donor solution: Saturated solution in deionised water. Receptor solution: pH 7.4 phosphate buffered saline. 
n. Donor solution: Not stated. Receptor solution: distilled water.  
o. Donor solution: Saturated suspension in pH 3.14 McIIVaine buffer. Receptor solution: pH 5.13 McIIvaine buffer.  
p. Donor solution: Saturated solution in pH 7.4 phosphate buffered saline, adjusted to pH 7.9. Receptor solution: pH 7.4 phosphate buffered saline
Compound Permeability coefficient (Kp, cm min-1) 
BP 2.12 x 10-4 
(Uchida et al., 2015) 
c, f. 
1.564 x 10-3 
(Nanayakkara et al., 2005) 
b, f. 
1.71 x 10-3 
(Akomeah, 2007) 
b, f. 
1.6619 x 10-3 
(Akomeah et al., 
2004) 
b, m. 
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